<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN"  "JATS-archivearticle1-mathml3.dtd"><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.2"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic" pub-type="epub">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">75631</article-id><article-id pub-id-type="doi">10.7554/eLife.75631</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Neuroscience</subject></subj-group></article-categories><title-group><article-title>NPAS4 in the medial prefrontal cortex mediates chronic social defeat stress-induced anhedonia-like behavior and reductions in excitatory synapses</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-263557"><name><surname>Hughes</surname><given-names>Brandon W</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-2742-6453</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund2"/><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-263558"><name><surname>Siemsen</surname><given-names>Benjamin M</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-6105-6054</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="pa1">†</xref><xref ref-type="other" rid="fund3"/><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-300190"><name><surname>Tsvetkov</surname><given-names>Evgeny</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-272607"><name><surname>Berto</surname><given-names>Stefano</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-64017"><name><surname>Kumar</surname><given-names>Jaswinder</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-263559"><name><surname>Cornbrooks</surname><given-names>Rebecca G</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-263560"><name><surname>Akiki</surname><given-names>Rose Marie</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-120735"><name><surname>Cho</surname><given-names>Jennifer Y</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con8"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-263561"><name><surname>Carter</surname><given-names>Jordan S</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con9"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-300191"><name><surname>Snyder</surname><given-names>Kirsten K</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con10"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-300192"><name><surname>Assali</surname><given-names>Ahlem</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con11"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-259272"><name><surname>Scofield</surname><given-names>Michael D</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con12"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" corresp="yes" id="author-63340"><name><surname>Cowan</surname><given-names>Christopher W</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-5472-3296</contrib-id><email>cowanc@musc.edu</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="other" rid="fund6"/><xref ref-type="other" rid="fund7"/><xref ref-type="fn" rid="con13"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-261030"><name><surname>Taniguchi</surname><given-names>Makoto</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-6356-2463</contrib-id><email>taniguch@musc.edu</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="other" rid="fund4"/><xref ref-type="other" rid="fund5"/><xref ref-type="other" rid="fund7"/><xref ref-type="fn" rid="con14"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/012jban78</institution-id><institution>Department of Neuroscience, Medical University of South Carolina</institution></institution-wrap><addr-line><named-content content-type="city">Charleston</named-content></addr-line><country>United States</country></aff><aff id="aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/012jban78</institution-id><institution>Department of Anesthesiology, Medical University of South Carolina</institution></institution-wrap><addr-line><named-content content-type="city">Charleston</named-content></addr-line><country>United States</country></aff><aff id="aff3"><label>3</label><institution>Department of Psychiatry, Harvard Medical School</institution><addr-line><named-content content-type="city">Belmont</named-content></addr-line><country>United States</country></aff><aff id="aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00t9vx427</institution-id><institution>Neuroscience Graduate Program, University of Texas Southwestern Medical Center</institution></institution-wrap><addr-line><named-content content-type="city">Dallas</named-content></addr-line><country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Wassum</surname><given-names>Kate M</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/046rm7j60</institution-id><institution>University of California, Los Angeles</institution></institution-wrap><country>United States</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Wassum</surname><given-names>Kate M</given-names></name><role>Senior Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/046rm7j60</institution-id><institution>University of California, Los Angeles</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group><author-notes><fn fn-type="present-address" id="pa1"><label>†</label><p>Supernus Pharmaceuticals, Inc, Rockville, United States</p></fn></author-notes><pub-date publication-format="electronic" date-type="publication"><day>13</day><month>02</month><year>2023</year></pub-date><pub-date pub-type="collection"><year>2023</year></pub-date><volume>12</volume><elocation-id>e75631</elocation-id><history><date date-type="received" iso-8601-date="2021-11-16"><day>16</day><month>11</month><year>2021</year></date><date date-type="accepted" iso-8601-date="2023-01-29"><day>29</day><month>01</month><year>2023</year></date></history><pub-history><event><event-desc>This manuscript was published as a preprint at bioRxiv.</event-desc><date date-type="preprint" iso-8601-date="2021-03-04"><day>04</day><month>03</month><year>2021</year></date><self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2021.03.04.433930"/></event></pub-history><permissions><copyright-statement>© 2023, Hughes et al</copyright-statement><copyright-year>2023</copyright-year><copyright-holder>Hughes et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-75631-v1.pdf"/><self-uri content-type="figures-pdf" xlink:href="elife-75631-figures-v1.pdf"/><abstract><p>Chronic stress can produce reward system deficits (i.e., anhedonia) and other common symptoms associated with depressive disorders, as well as neural circuit hypofunction in the medial prefrontal cortex (mPFC). However, the molecular mechanisms by which chronic stress promotes depressive-like behavior and hypofrontality remain unclear. We show here that the neuronal activity-regulated transcription factor, NPAS4, in the mPFC is regulated by chronic social defeat stress (CSDS), and it is required in this brain region for CSDS-induced changes in sucrose preference and natural reward motivation in the mice. Interestingly, NPAS4 is not required for CSDS-induced social avoidance or anxiety-like behavior. We also find that mPFC NPAS4 is required for CSDS-induced reductions in pyramidal neuron dendritic spine density, excitatory synaptic transmission, and presynaptic function, revealing a relationship between perturbation in excitatory synaptic transmission and the expression of anhedonia-like behavior in the mice. Finally, analysis of the mice mPFC tissues revealed that NPAS4 regulates the expression of numerous genes linked to glutamatergic synapses and ribosomal function, the expression of upregulated genes in CSDS-susceptible animals, and differentially expressed genes in postmortem human brains of patients with common neuropsychiatric disorders, including depression. Together, our findings position NPAS4 as a key mediator of chronic stress-induced hypofrontal states and anhedonia-like behavior.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>Anhedonia</kwd><kwd>hypofrontality</kwd><kwd>chronic social defeat stress</kwd><kwd>prefrontal cortex</kwd><kwd>NPAS4</kwd><kwd>RNA-sequencing</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Mouse</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>F31 DA048557</award-id><principal-award-recipient><name><surname>Hughes</surname><given-names>Brandon W</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>T32 DA07288</award-id><principal-award-recipient><name><surname>Hughes</surname><given-names>Brandon W</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>F32 DA050427</award-id><principal-award-recipient><name><surname>Siemsen</surname><given-names>Benjamin M</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000874</institution-id><institution>Brain and Behavior Research Foundation</institution></institution-wrap></funding-source><award-id>F32 DA050427</award-id><principal-award-recipient><name><surname>Taniguchi</surname><given-names>Makoto</given-names></name></principal-award-recipient></award-group><award-group id="fund5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>UL1 TR001450</award-id><principal-award-recipient><name><surname>Taniguchi</surname><given-names>Makoto</given-names></name></principal-award-recipient></award-group><award-group id="fund6"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>R01 DA032708</award-id><principal-award-recipient><name><surname>Cowan</surname><given-names>Christopher W</given-names></name></principal-award-recipient></award-group><award-group id="fund7"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>DA046373</award-id><principal-award-recipient><name><surname>Cowan</surname><given-names>Christopher W</given-names></name><name><surname>Taniguchi</surname><given-names>Makoto</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>Social defeat stress induces transcription factor Npas4 expression in the medial prefrontal cortex and its chronic stress-induced changes in excitatory synaptic transmission, reduction of dendritic spine density, and anhedonia-like behaviors.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Stress-related mental disorders continue to be a leading cause of disability and financial burden on society (<xref ref-type="bibr" rid="bib80">Rehm and Shield, 2019</xref>). The associated symptom domains of stress-related disorders are diverse and present with a high degree of comorbidity, thus treatment strategies for these disorders represent a major healthcare challenge. The rodent chronic social defeat stress (CSDS) paradigm produces multiple behavioral and neural phenotypes reminiscent of stress-related and depressive disorders in humans, including anhedonia-like behaviors and social avoidance (<xref ref-type="bibr" rid="bib5">Berton et al., 2006</xref>; <xref ref-type="bibr" rid="bib17">Covington et al., 2010</xref>; <xref ref-type="bibr" rid="bib16">Covington et al., 2009</xref>; <xref ref-type="bibr" rid="bib33">Golden et al., 2011</xref>; <xref ref-type="bibr" rid="bib50">Krishnan et al., 2007</xref>; <xref ref-type="bibr" rid="bib51">Krishnan and Nestler, 2008</xref>; <xref ref-type="bibr" rid="bib94">Venzala et al., 2012</xref>; <xref ref-type="bibr" rid="bib95">Venzala et al., 2013</xref>; <xref ref-type="bibr" rid="bib96">Vialou et al., 2014</xref>; <xref ref-type="bibr" rid="bib99">Ye et al., 2016</xref>). CSDS produces social avoidance in a subset of mice (i.e., stress-susceptible), whereas the resilient subpopulation displays normal social behavior and typically accounts for around 35–50% of the total population (<xref ref-type="bibr" rid="bib50">Krishnan et al., 2007</xref>; <xref ref-type="bibr" rid="bib51">Krishnan and Nestler, 2008</xref>; <xref ref-type="bibr" rid="bib52">Krishnan and Nestler, 2011</xref>). Notably, these differences are analogous to human responses following chronic stress, where resilient individuals display greater optimism and cognitive flexibility, opposed to stress susceptibly increasing adverse responses to stress that can manifest as depression (<xref ref-type="bibr" rid="bib18">Dantzer et al., 2018</xref>; <xref ref-type="bibr" rid="bib37">Han and Nestler, 2017</xref>). Another CSDS-induced behavior is anhedonia, a core symptom of major depressive disorder (MDD) that is associated with deficits in hedonic capacity, reward evaluation, decision-making, and motivation to obtain rewards, as well as risk for suicide and treatment resistance (<xref ref-type="bibr" rid="bib20">Der-Avakian and Markou, 2012</xref>; <xref ref-type="bibr" rid="bib42">Heshmati and Russo, 2015</xref>; <xref ref-type="bibr" rid="bib60">Llorca and Gourion, 2015</xref>; <xref ref-type="bibr" rid="bib70">Pizzagalli, 2014</xref>; <xref ref-type="bibr" rid="bib93">Treadway and Zald, 2011</xref>). Individuals who suffer from pathological stress often exhibit deficits in motivated, effort-based decision-making (<xref ref-type="bibr" rid="bib1">American Psychiatric Association, 2013</xref>; <xref ref-type="bibr" rid="bib11">Chen et al., 2015</xref>; <xref ref-type="bibr" rid="bib41">Henriques and Davidson, 2000</xref>; <xref ref-type="bibr" rid="bib68">Pechtel et al., 2013</xref>; <xref ref-type="bibr" rid="bib72">Porcelli and Delgado, 2017</xref>), though clinical studies indicate that some individuals can exhibit positive behavioral outcomes following stress (i.e., stress resilience) (<xref ref-type="bibr" rid="bib58">Linley and Joseph, 2004</xref>). Although these studies examined the differences in stress-related behaviors, including susceptibility vs. resilience, the neural mechanisms by which chronic stress produces anhedonia remain unclear. Multiple preclinical and clinical studies have revealed reduced function of the medial prefrontal cortex (mPFC), which is caused, at least in part, by stress-induced loss of structural and functional synaptic connections and circuits within this brain region (<xref ref-type="bibr" rid="bib3">Arnsten et al., 2015</xref>; <xref ref-type="bibr" rid="bib15">Covington et al., 2005</xref>; <xref ref-type="bibr" rid="bib17">Covington et al., 2010</xref>; <xref ref-type="bibr" rid="bib44">Holmes and Wellman, 2009</xref>; <xref ref-type="bibr" rid="bib77">Radley et al., 2006a</xref>). Furthermore, chronic stress-induced hypofrontality is thought to underlie many symptoms of MDD (<xref ref-type="bibr" rid="bib29">Galynker et al., 1998</xref>; <xref ref-type="bibr" rid="bib60">Llorca and Gourion, 2015</xref>; <xref ref-type="bibr" rid="bib61">Matsuo et al., 2000</xref>; <xref ref-type="bibr" rid="bib90">Suto et al., 2004</xref>) and contribute to the neuropathology of treatment-resistant depression (<xref ref-type="bibr" rid="bib56">Li et al., 2015</xref>), including the potential for anhedonia susceptibility (<xref ref-type="bibr" rid="bib36">Gong et al., 2018</xref>; <xref ref-type="bibr" rid="bib35">Gong et al., 2017</xref>).</p><p>In this study, we investigated the role of Neuronal PAS domain Protein 4 (NPAS4) in chronic stress-induced brain and behavior dysfunction. NPAS4 is an early response gene and transcription factor that modulates synaptic connections on excitatory (E) and inhibitory (I) neurons in response to synaptic activity – a proposed homeostatic mechanism to modulate E/I balance in strongly activated neural circuits (<xref ref-type="bibr" rid="bib6">Bloodgood et al., 2013</xref>; <xref ref-type="bibr" rid="bib7">Brigidi et al., 2019</xref>; <xref ref-type="bibr" rid="bib57">Lin et al., 2008</xref>; <xref ref-type="bibr" rid="bib83">Sharma et al., 2019</xref>; <xref ref-type="bibr" rid="bib87">Sim et al., 2013</xref>; <xref ref-type="bibr" rid="bib88">Spiegel et al., 2014</xref>; <xref ref-type="bibr" rid="bib89">Sun and Lin, 2016</xref>). Previous studies have shown that <italic>Npas4</italic> KO mice have reduced anxiety (<xref ref-type="bibr" rid="bib47">Jaehne et al., 2015</xref>), and that <italic>Npas4</italic> heterozygous mice have increased depression-like behavior in the forced swim test (<xref ref-type="bibr" rid="bib84">Shepard et al., 2019</xref>). Stress exposure, including prenatal stress, maternal separation, restraint stress, and corticosterone administration in prenatal stages and adults, changes <italic>Npas4</italic> mRNA and protein expression in multiple brain regions (<xref ref-type="bibr" rid="bib43">Heslin and Coutellier, 2018</xref>; <xref ref-type="bibr" rid="bib101">Yun et al., 2010</xref>). However, the region-specific role of NPAS4 in the adult brain in response to stress is poorly understood. In the adult brain, NPAS4 is required in the hippocampus and amygdala for contextual fear learning (<xref ref-type="bibr" rid="bib71">Ploski et al., 2011</xref>; <xref ref-type="bibr" rid="bib79">Ramamoorthi et al., 2011</xref>), in the visual cortex for social recognition (<xref ref-type="bibr" rid="bib43">Heslin and Coutellier, 2018</xref>), and in the nucleus accumbens (NAc) for cocaine reward-context learning and memory (<xref ref-type="bibr" rid="bib92">Taniguchi et al., 2017</xref>). As such, NPAS4 is well-positioned to mediate adaptive cellular and synaptic changes produced by strong circuit activity, such as that produced in the mPFC by acute and chronic stress. Here, we discovered that acute and chronic social defeat stress induce NPAS4 expression in the mPFC, and that NPAS4 in this brain region is required for CSDS-induced anhedonia and attenuated excitatory input to mPFC pyramidal neurons, as well as reduced pyramidal neuron dendritic spine density. Similarly, we found that reducing mPFC <italic>Npas4</italic> alters expression of numerous downstream genes reported to be upregulated in stress-susceptible animals (<xref ref-type="bibr" rid="bib4">Bagot et al., 2016</xref>) that are important for ribosome function or excitatory synapse organization, activity, and signaling – the majority of which are differentially expressed in human patients with MDD (<xref ref-type="bibr" rid="bib54">Labonté et al., 2017</xref>). Our findings revealed an essential role for a NPAS4 in chronic stress-induced mPFC hypofrontality and anhedonia-like behavior.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>Social defeat stress induces NPAS4 expression in the medial prefrontal cortex</title><p>We first characterized the cell type-specific <italic>Npas4</italic> mRNA expression in the mPFC, a key region associated with stress and reward, using a single-nuclei RNA-sequencing (snRNA-seq) approach. Consistent with the previous reports (<xref ref-type="bibr" rid="bib57">Lin et al., 2008</xref>; <xref ref-type="bibr" rid="bib88">Spiegel et al., 2014</xref>), <italic>Npas4</italic> is expressed only in the neurons, and we did not detect it in astrocytes or glial cells. <italic>Npas4</italic> mRNA is predominantly expressed in excitatory neurons (92.6%) throughout cortical layers 2 and 5/6, while a small fraction (7.4%) were found in multiple classes of GABAergic inhibitory neurons (7.4%), including <italic>Adarrb2</italic>-, <italic>Pvalb</italic>-, and <italic>Sst</italic>-positive neurons (<xref ref-type="fig" rid="fig1">Figure 1A–D</xref>). Also, 7% of all mPFC excitatory neurons expressed detectable <italic>Npas4</italic> mRNA, opposed to expression in only 2.5% of inhibitory neurons (<xref ref-type="fig" rid="fig1">Figure 1D</xref>). Next, we examined the expression of <italic>Npas4</italic> mRNA in two key corticolimbic regions, the mPFC and the nucleus accumbens (NAc), following 11 days of CSDS. We compared CSDS responses to a single social defeat stress experience (acute stress; <xref ref-type="fig" rid="fig1">Figure 1E</xref>). We observed a very rapid and transient induction of <italic>Npas4</italic> mRNA in the mPFC (<xref ref-type="fig" rid="fig1">Figure 1F</xref>, two-way ANOVA, F value = 16.6 and df = 77, Tukey’s post hoc analysis: control vs. acute stress at 5 min, p&lt;0.0001, control vs. chronic stress at 5 min, p&lt;0.0001, acute vs. chronic stress at 5 min, p&lt;0.0001, n = 9–10 per group, control vs. acute stress at 15 min, p&lt;0.0001, control vs. chronic stress at 15 min, p&lt;0.0001, acute vs. chronic stress at 15 min, p&lt;0.0001, n = 6–10 per group) and NAc (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1A</xref>). We observed a similar response with <italic>cFos</italic> mRNA in the mPFC, albeit a slower induction and longer duration of expression (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1B</xref>). Interestingly, CSDS-induced expression of both <italic>Npas4</italic> and <italic>cFos</italic> was observed, although it was reduced compared to the acute stress response (<xref ref-type="fig" rid="fig1">Figure 1F</xref>, <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1B</xref>), possibly due to CSDS-induced mPFC hypofunction. In contrast, the CSDS-induced attenuation of <italic>Npas4</italic> induction was not observed in the NAc (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1A</xref>). Analogous to stress-induced increases in <italic>Npas4</italic> mRNA, we observed a significant increase in NPAS4 protein at 1 hr following CSDS or acute stress exposure in multiple mPFC regions, including the anterior cingulate and prelimbic cortex subregions (<xref ref-type="fig" rid="fig1">Figure 1G</xref>, two-way ANOVA, F value = 9.695 and Df = 27, Tukey’s post hoc analysis: control vs. acute stress in anterior cingulate cortex, p=0.0267, control vs. chronic stress in anterior cingulate cortex, p=0.0462, n = 3–5 per group, control vs. acute stress in prelimbic cortex, p=0.0281, control vs. chronic stress in prelimbic cortex, p=0.0474, n = 3–5 per group). Consistent with the snRNA-seq data (<xref ref-type="fig" rid="fig1">Figure 1A–D</xref>), the vast majority (&gt;75%) of NPAS4+ neurons in the mPFC were co-expressed with CaMKIIα, a classical protein-marker for excitatory pyramidal neurons (<xref ref-type="fig" rid="fig1">Figure 1H</xref>, two-way ANOVA, F value = 5.645 and Df = 24, Tukey’s post hoc analysis: control vs. acute stress in CaMKIIα(+) cells, p=0.0131, control vs. chronic stress in CaMKIIα(+) cells, p&lt;0.0001, n = 8–11 per group), with practically no detectable NPAS4 expression in parvalbumin- or somatostatin-expressing GABAergic interneurons (<xref ref-type="fig" rid="fig1">Figure 1I and J</xref>). Similar to <italic>Npas4</italic> mRNA, the relative NPAS4 protein expression per cell was highest following acute stress (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1C</xref>), suggesting that acute stress and CSDS activate a similar number of NPAS4-positive mPFC neurons, but the NPAS4 expression level within each cell is lower following repeated psychosocial stress.</p><fig-group><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>Social defeat stress induces NPAS4 expression in the medial prefrontal cortex (mPFC).</title><p>(<bold>A, B</bold>) Uniform manifold approximation and projection (UMAP) plot of the mPFC single cells colored by cell type (<bold>A</bold>) and <italic>Npsa4</italic> mRNA expression (<bold>B</bold>). Cell types were defined by known markers and confirmed by predictive modeling using a single-cell mPFC atlas. (<bold>C</bold>) Donut chart represents the percentage of cell types that express <italic>Npas4</italic> mRNA. (<bold>D</bold>) Dot plot represents the percentage of <italic>Npas4</italic> mRNA expressing neurons in each cell type. (<bold>E</bold>) Schematic illustration of experimental timeline of gene expression analyses following acute social defeat stress and 10 days of chronic social defeat stress (CSDS). (<bold>F</bold>) Data plot represents the quantification of <italic>Npas4</italic> mRNA expression following acute and chronic social defeat stress at 5 min, 15 min, 1 hr, and 24 hr (n = 5–10/condition). (<bold>G</bold>) Quantification of fold change in NPAS4-positive cell number following acute and chronic social defeat stress in subregions of the mPFC, including the anterior cingulate, prelimbic, and infralimbic cortices (n = 3–5/condition). (<bold>H</bold>) Quantification of mPFC NPAS4-positive cells relative to the number of CaMKIIα-positive cells in control/no-stress mice. (<bold>I, J</bold>) Data plot shows the percentage of CaMKIIα-, somatostatin (SST)-, and parvalbumin (PV)-positive cells in NPAS4-positive cells within the mPFC after acute stress and CSDS (n = 3–9/condition), as well as representative IHC images of NPAS4 colocalization in these respective cell type. Scale bar, 10 μm. Data shown are mean ± SEM; *p&lt;0.05, ****p&lt;0.0001. Also see <xref ref-type="supplementary-material" rid="sdata1">Source data 1</xref> for detailed statistical analyses.</p><p><supplementary-material id="fig1sdata1"><label>Figure 1—source data 1.</label><caption><title><xref ref-type="fig" rid="fig1">Figure 1F</xref>.</title><p><italic>Npas4</italic> mRNA expression in the medial prefrontal cortex (mPFC) after acute and chronic social defeat stress.</p></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-75631-fig1-data1-v1.xlsx"/></supplementary-material></p><p><supplementary-material id="fig1sdata2"><label>Figure 1—source data 2.</label><caption><title><xref ref-type="fig" rid="fig1">Figure 1G</xref>.</title><p>Number of NPAS4(+) cells in the medial prefrontal cortex (mPFC) after acute and chronic social defeat stress.</p></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-75631-fig1-data2-v1.xlsx"/></supplementary-material></p><p><supplementary-material id="fig1sdata3"><label>Figure 1—source data 3.</label><caption><title><xref ref-type="fig" rid="fig1">Figure 1H</xref>.</title><p>Number of NPAS4(+) cells in the medial prefrontal cortex (mPFC) in the CaMKIIα-positive or -negative cells after acute and chronic social defeat stress.</p></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-75631-fig1-data3-v1.xlsx"/></supplementary-material></p><p><supplementary-material id="fig1sdata4"><label>Figure 1—source data 4.</label><caption><title><xref ref-type="fig" rid="fig1">Figure 1I</xref>.</title><p>% of cellular marker expression in the NPAS4(+) cells in the medial prefrontal cortex (mPFC) after acute and chronic social defeat stress.</p></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-75631-fig1-data4-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-75631-fig1-v1.tif"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 1.</label><caption><title>Social defeat stress induces NPAS4 and cFos expression in the nucleus accumbens (NAc) and medial prefrontal cortex (mPFC).</title><p>(<bold>A</bold>) Quantification of <italic>Npas4</italic> mRNA expression in the NAc following acute and chronic social defeat stress at 15 min, 1 hr, and 24 hr (two-way ANOVA, Tukey’s post hoc analysis: control vs. acute stress at 15 min, p&lt;0.0001, control vs. chronic stress at 15 min, p&lt;0.0001, n = 5–10 per group). (<bold>B</bold>) Quantification of <italic>cFos</italic> mRNA expression in the mPFC following acute and chronic social defeat stress at 15 min, 1 hr, and 24 hr (two-way ANOVA, Tukey’s post hoc analysis: control vs. acute stress at 15 min, p&lt;0.0001, control vs. chronic stress at 15 min, p&lt;0.0001, acute vs. chronic stress at 15 min, p=0.0021, control vs. acute stress at 1 hr, p&lt;0.0001, control vs. chronic stress at 1 hr, p&lt;0.0001, acute vs. chronic stress at 1 hr, p=0.0055, n = 5–10 per group). (<bold>C</bold>) Data plot represents fold change of NPAS4 signal intensity in CaMKIIα-positive pyramidal excitatory neurons of the mPFC (one-way ANOVA, Tukey’s post hoc analysis: control vs. acute stress, p=0.0002, control vs. chronic stress, p=0.8222, acute vs. chronic stress, p=0.0001, n = 45–87 cells/3–5 animals/condition). Data shown are mean ± SEM; **p&lt;0.01, ***p&lt;0.001, ****p&lt;0.0001. Also see <xref ref-type="supplementary-material" rid="sdata1">Source data 1</xref> for detailed for detailed statistical analyses.</p><p><supplementary-material id="fig1s1sdata1"><label>Figure 1—figure supplement 1—source data 1.</label><caption><title><xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1A</xref>.</title><p><italic>Npas4</italic> mRNA expression in the nucleus accumbens (NAc) after acute and chronic social defeat stress.</p></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-75631-fig1-figsupp1-data1-v1.xlsx"/></supplementary-material></p><p><supplementary-material id="fig1s1sdata2"><label>Figure 1—figure supplement 1—source data 2.</label><caption><title><xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1B</xref>.</title><p><italic>cFos</italic> mRNA expression in the medial prefrontal cortex (mPFC) after acute and chronic social defeat stress.</p></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-75631-fig1-figsupp1-data2-v1.xlsx"/></supplementary-material></p><p><supplementary-material id="fig1s1sdata3"><label>Figure 1—figure supplement 1—source data 3.</label><caption><title><xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1C</xref>.</title><p>NPAS4 signal intensity in the CaMKIIα-positive cells after acute and chronic social defeat stress.</p></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-75631-fig1-figsupp1-data3-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-75631-fig1-figsupp1-v1.tif"/></fig></fig-group></sec><sec id="s2-2"><title>NPAS4 in the mPFC is required for CSDS-induced anhedonia-like behavior</title><p>To examine the function of NPAS4 in CSDS-induced behaviors (<xref ref-type="fig" rid="fig2">Figure 2A</xref>), we employed a neurotropic AAV-mediated RNA-interference approach to reduce endogenous <italic>Npas4</italic> in the mPFC using a prevalidated <italic>Npas4</italic> short hairpin RNA (shRNA) (AAV2-<italic>Npas4</italic> shRNA<sup>PFC</sup> and <xref ref-type="fig" rid="fig2">Figure 2B</xref>, paired <italic>t-</italic>test, t value = 3.7 and Df = 3, p=0.0343, n = 4 per group), which reliably reduces NPAS4 expression in multiple studies, and where knockdown effects have been repeatedly validated using <italic>Npas4</italic> conditional KO mice (<xref ref-type="bibr" rid="bib57">Lin et al., 2008</xref>; <xref ref-type="bibr" rid="bib62">Maya-Vetencourt et al., 2012</xref>; <xref ref-type="bibr" rid="bib92">Taniguchi et al., 2017</xref>). Adult male mice (C57BL/6J) received a bilateral injection of AAV2-<italic>Npas4</italic> shRNA<sup>PFC</sup> or AAV2-shRNA scrambled control (AAV2-SC shRNA<sup>PFC</sup>). Mice were subjected to 10 days of CSDS or no stress control condition, and then they were tested for sociability, natural reward preference and motivation, and anxiety-like behavior (<xref ref-type="fig" rid="fig2">Figure 2A</xref>). The CSDS-treated SC shRNA<sup>PFC</sup> and <italic>Npas4</italic> shRNA<sup>PFC</sup> mice showed a significant reduction in the time spent interacting with a novel social target, as shown by time spent in the interaction zone in the presence a social target (<xref ref-type="fig" rid="fig2">Figure 2C</xref>, SC shRNA<sup>PFC</sup> mice, two-way ANOVA, F value = 6.69 and Df = 41, Bonferroni post hoc analysis, interaction partner (-) vs. (+) in control no stress animals, p&lt;0.0001, interaction partner (-) vs. (+) in CSDS animals, p=0.0099, control no stress animals vs. CSDS animals in interaction partner (+), p=0.0005, n = 18–25 per group, <italic>Npas4</italic> shRNA<sup>PFC</sup> mice, two-way ANOVA, F value = 7.553 and Df = 39, Bonferroni post hoc analysis, interaction partner (-) vs. (+) in control no stress animals, p&lt;0.0001, interaction partner (-) vs. (+) in CSDS animals, p=0.0021, control no stress animals vs. CSDS animals in interaction partner (+), p=0.0034, n = 19–22 per group). In addition, there was a main effect of CSDS, but no significant difference between <italic>Npas4</italic> shRNA<sup>PFC</sup> vs. SC shRNA<sup>PFC</sup> mice in the relative distribution of social interaction ratio in CSDS-treated mice (<xref ref-type="fig" rid="fig2">Figure 2D</xref>, two-way ANOVA, main effect of CSDS, F value = 10.01 and Df = 78, p=0.0022, n = 18–25). Both <italic>Npas4</italic> shRNA<sup>PFC</sup> and SC shRNA<sup>PFC</sup> mice showed significantly increased social avoidance time and ratio following CSDS (<xref ref-type="fig" rid="fig2">Figure 2E and F</xref>; <xref ref-type="fig" rid="fig2">Figure 2E</xref>, SC shRNA<sup>PFC</sup> mice, two-way ANOVA, F value = 5.541 and Df = 38, Bonferroni post hoc analysis, control no stress animals vs. CSDS animals in interaction partner (+), p&lt;0.0001, n = 16–24 per group, <italic>Npas4</italic> shRNA<sup>PFC</sup> mice, two-way ANOVA, F value = 4.666 and Df = 38, Bonferroni post hoc analysis, control no stress animals vs. CSDS animals in interaction partner (+), p=0.0015, n = 19–21 per group; <xref ref-type="fig" rid="fig2">Figure 2F</xref>, two-way ANOVA, main effect of CSDS, F value = 15.64 and Df = 76, p=0.0002, n = 16–24 per group), suggesting that mPFC NPAS4 is not required for CSDS-induced social avoidance. However, unlike the CSDS-treated SC shRNA<sup>PFC</sup> mice, CSDS-treated <italic>Npas4</italic> shRNA<sup>PFC</sup> mice did not develop anhedonia-like behavior, as detected by a significant reduction in sucrose preference in the two-bottle choice test (<xref ref-type="fig" rid="fig2">Figure 2G</xref> and <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1A</xref>; <xref ref-type="fig" rid="fig2">Figure 2G</xref>, two-way ANOVA, F value = 5.548 and Df = 65, Tukey’s post hoc analysis, control no stress vs. CSDS in SC shRNA<sup>PFC</sup> mice, p=0.0291, SC shRNA<sup>PFC</sup> vs. <italic>Npas4</italic> shRNA<sup>PFC</sup> mice with CSDS, p=0.0492, n = 11–24 per group). Interestingly, CSDS increased anxiety-like behavior, as measured in the elevated plus maze, in both SC shRNA<sup>PFC</sup> and <italic>Npas4</italic> shRNA<sup>PFC</sup> mice (<xref ref-type="fig" rid="fig2">Figure 2H</xref>, two-way ANOVA, main effect of CSDS, F value = 8.087 and Df = 59, p=0.0061, n = 14–18 per group), indicating that mPFC NPAS4 function is required for some, but not all, of the behavioral sequelae of CSDS. These data suggest that the molecular and circuit mechanisms of CSDS-induced social avoidance, anhedonia, and anxiety might be distinct. Moreover, the presence of CSDS-induced social avoidance and anxiety-related behavior in <italic>Npas4</italic> shRNA<sup>PFC</sup> mice argues against the possibility that they are simply less sensitive to stress and/or have deficits in threat/fear-related learning and memory.</p><fig-group><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>NPAS4 in the medial prefrontal cortex (mPFC) is required for chronic social defeat stress (CSDS)-induced anhedonia-like behavior.</title><p>(<bold>A</bold>) Schematic illustration of experimental timeline of behavioral test battery consisting of CSDS followed by social interaction (SI; <bold>C–F</bold>), sucrose preference (SP; <bold>G</bold>), elevated plus maze (EPM; <bold>H</bold>), sucrose self-administration, and progressive ratio testing (Suc-SA and PR; <xref ref-type="fig" rid="fig3">Figure 3A–D</xref>). (<bold>B</bold>) AAV2-<italic>Npas4</italic> shRNA in the adult male mPFC decreases stress-induced NPAS4 protein expression. Left: representative image showing AAV2-shRNA expression viral vector-mediated eGFP expression in the adult mice mPFC. Right: quantification of NPAS4-positive cells/100 μm<sup>2</sup> (n = 4/condition). (<bold>C</bold>) and (<bold>D</bold>) CSDS decreases the time spent in the social interaction zone (<bold>C</bold>) and the social interaction ratio (<bold>D</bold>) in SC shRNA<sup>PFC</sup> and <italic>Npas4</italic> shRNA<sup>PFC</sup> mice after CSDS (n = 18–25/condition). (<bold>E</bold>) and (<bold>F</bold>) CSDS increases the time spent in the avoidance corner zone and social avoidance ratio in SC shRNA<sup>PFC</sup> and Npas4 shRNA<sup>PFC</sup> mice (n = 16–24/condition). (<bold>G</bold>) CSDS-induced reduction of sucrose preference is blocked by <italic>Npas4</italic> shRNA in the mPFC (<bold>F</bold>; n = 11–24). (<bold>H</bold>) CSDS reduces time spent in open arms (sec) in SC shRNA<sup>PFC</sup> and <italic>Npas4</italic> shRNA<sup>PFC</sup> mice (n =14–18).</p><p><supplementary-material id="fig2sdata1"><label>Figure 2—source data 1.</label><caption><title><xref ref-type="fig" rid="fig2">Figure 2B</xref>.</title><p>NPAS4 (+) cells/100 μm<sup>2</sup>.</p></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-75631-fig2-data1-v1.xlsx"/></supplementary-material></p><p><supplementary-material id="fig2sdata2"><label>Figure 2—source data 2.</label><caption><title><xref ref-type="fig" rid="fig2">Figure 2C</xref>.</title><p>Time spent in interaction zone (s) in the social interaction assay.</p></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-75631-fig2-data2-v1.xlsx"/></supplementary-material></p><p><supplementary-material id="fig2sdata3"><label>Figure 2—source data 3.</label><caption><title><xref ref-type="fig" rid="fig2">Figure 2D</xref>.</title><p>Social interaction ratio in the social interaction assay.</p></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-75631-fig2-data3-v1.xlsx"/></supplementary-material></p><p><supplementary-material id="fig2sdata4"><label>Figure 2—source data 4.</label><caption><title><xref ref-type="fig" rid="fig2">Figure 2E</xref>.</title><p>Time spent in avoidance corner zone (s) in the social interaction assay.</p></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-75631-fig2-data4-v1.xlsx"/></supplementary-material></p><p><supplementary-material id="fig2sdata5"><label>Figure 2—source data 5.</label><caption><title><xref ref-type="fig" rid="fig2">Figure 2F</xref>.</title><p>Social avoidance ratio in the social interaction assay.</p></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-75631-fig2-data5-v1.xlsx"/></supplementary-material></p><p><supplementary-material id="fig2sdata6"><label>Figure 2—source data 6.</label><caption><title><xref ref-type="fig" rid="fig2">Figure 2G</xref>.</title><p>Sucrose preference (%).</p></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-75631-fig2-data6-v1.xlsx"/></supplementary-material></p><p><supplementary-material id="fig2sdata7"><label>Figure 2—source data 7.</label><caption><title><xref ref-type="fig" rid="fig2">Figure 2H</xref>.</title><p>Time spent in Opem Arm (s).</p></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-75631-fig2-data7-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-75631-fig2-v1.tif"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 1.</label><caption><title>NPAS4 in the medial prefrontal cortex (mPFC) is required for chronic social defeat stress (CSDS)-induced reduction of sucrose consumption.</title><p>Chart represents the amount of consumption of water and 1% sucrose solution in each day SC shRNA<sup>PFC</sup> and <italic>Npas4</italic> shRNA<sup>PFC</sup> mice after CSDS (two-way ANOVA, Tukey’s post hoc analysis: control vs. CSDS in SC shRNA<sup>PFC</sup> mice, p=0.0624, SC shRNA versus Npas4 shRNA animals with CSDS, p=0.0504, n = 11–24 per group). Data shown are mean ± SEM; Also see <xref ref-type="supplementary-material" rid="sdata1">Source data 1</xref> for detailed statistical analyses.</p><p><supplementary-material id="fig2s1sdata1"><label>Figure 2—figure supplement 1—source data 1.</label><caption><title><xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>.</title><p>Amount of liquid consumption (mL) in the sucrose preference assay.</p></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-75631-fig2-figsupp1-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-75631-fig2-figsupp1-v1.tif"/></fig></fig-group><p>Individuals who suffer from pathological stress often exhibit reduced motivation to pursue rewards (<xref ref-type="bibr" rid="bib1">American Psychiatric Association, 2013</xref>; <xref ref-type="bibr" rid="bib11">Chen et al., 2015</xref>); however, it is also commonly reported that a subset of individuals can exhibit positive behavioral outcomes following stress (i.e., stress resilience) (<xref ref-type="bibr" rid="bib58">Linley and Joseph, 2004</xref>). To examine the role of NPAS4 in CSDS-induced changes in reward motivation, <italic>Npas4</italic> shRNA<sup>PFC</sup> or SC shRNA<sup>PFC</sup> mice were subjected to CSDS or the ‘no stress’ condition, and then they were allowed to self-administer sucrose (sucrose SA) under operant conditions. After stable sucrose SA was established, we examined motivation to work for a sucrose reward using the progressive ratio (PR) schedule of reinforcement. Compared to SC shRNA<sup>PFC</sup> controls, <italic>Npas4</italic> shRNA<sup>PFC</sup> mice displayed no differences in acquisition of sucrose SA (<xref ref-type="fig" rid="fig3">Figure 3A</xref>) or operant discrimination learning (nosepokes in the active vs. inactive port) (<xref ref-type="fig" rid="fig3">Figure 3B</xref>). Interestingly, <italic>Npas4</italic> shRNA<sup>PFC</sup> significantly increased PR breakpoint – the maximum number of nose-pokes an animal was willing to perform to receive a single sucrose reward (<xref ref-type="fig" rid="fig3">Figure 3C</xref>, two-way ANOVA, main effect of shRNA expression, F value = 5.92 and Df = 58, p=0.0181, n = 13–19 per group), suggesting that reducing levels of mPFC NPAS4 might enhance reward motivation. Notably, in animals susceptible to CSDS, <italic>Npas4</italic> shRNA significantly increased motivation to obtain sucrose, with no change in PR breakpoint after <italic>Npas4</italic> shRNA in resilient animals (<xref ref-type="fig" rid="fig3">Figure 3D</xref>, two-way ANOVA, F value = 5.685 and Df = 31, Bonferroni post hoc analysis, SC shRNA<sup>PFC</sup> and <italic>Npas4</italic> shRNA<sup>PFC</sup> mice in susceptible group, p=0.0353, n = 3–14 per group), suggesting that CSDS-induced mPFC NPAS4 influences natural reward motivation.</p><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>NPAS4 in the medial prefrontal cortex (mPFC) regulates effort-based motivated behavior during sucrose SA following chronic social defeat stress (CSDS).</title><p>(<bold>A, B</bold>) Data plots showing the acquisition period of sucrose self-administration in SC shRNA<sup>PFC</sup> and <italic>Npas4</italic> shRNA<sup>PFC</sup> mice after CSDS or no stress control condition, with no change in the number of sucrose delivery (<bold>A</bold>) and in the discrimination ratio between the active and inactive nosepokes (<bold>B</bold>; n = 14–18/group). (<bold>C</bold>) Data plot showing the maximum number of active nose pokes required to receive a sucrose reward (breakpoint) after CSDS in the PR test of both SC shRNA<sup>PFC</sup> and <italic>Npas4</italic> shRNA<sup>PFC</sup> mice. <italic>Npas4</italic> shRNA<sup>PFC</sup> mice demonstrated a significantly higher PR breakpoint compared to control SC shRNA<sup>PFC</sup> mice (n = 13–19/group). (<bold>D</bold>) <italic>Npas4</italic> shRNA<sup>PFC</sup> mice susceptible, but not resilience, to CSDS demonstrated a significantly higher breakpoint compared to SC shRNA<sup>PFC</sup> mice after CSDS (n =3–14/group).</p><p><supplementary-material id="fig3sdata1"><label>Figure 3—source data 1.</label><caption><title><xref ref-type="fig" rid="fig3">Figure 3A</xref>.</title><p>Sucrose delivery in the sucrose self-administration.</p></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-75631-fig3-data1-v1.xlsx"/></supplementary-material></p><p><supplementary-material id="fig3sdata2"><label>Figure 3—source data 2.</label><caption><title><xref ref-type="fig" rid="fig3">Figure 3B</xref>.</title><p>Discrimination index in the sucrose self-administration.</p></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-75631-fig3-data2-v1.xlsx"/></supplementary-material></p><p><supplementary-material id="fig3sdata3"><label>Figure 3—source data 3.</label><caption><title><xref ref-type="fig" rid="fig3">Figure 3C</xref>.</title><p>Breakpoint in the sucrose self-administration.</p></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-75631-fig3-data3-v1.xlsx"/></supplementary-material></p><p><supplementary-material id="fig3sdata4"><label>Figure 3—source data 4.</label><caption><title><xref ref-type="fig" rid="fig3">Figure 3D</xref>.</title><p>Breakpoint of animals after chronic social defeat stress (CSDS) in the sucrose self-administration.</p></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-75631-fig3-data4-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-75631-fig3-v1.tif"/></fig></sec><sec id="s2-3"><title>NPAS4 regulates CSDS-induced reductions in mPFC dendritic spine density and excitatory synaptic transmission</title><p>CSDS-induced reduction of dendritic spine density on mPFC pyramidal neurons is a putative pathophysiological underpinning of depression-associated behavior (<xref ref-type="bibr" rid="bib10">Cerqueira et al., 2007</xref>; <xref ref-type="bibr" rid="bib13">Colyn et al., 2019</xref>; <xref ref-type="bibr" rid="bib59">Liston et al., 2006</xref>; <xref ref-type="bibr" rid="bib64">McKlveen et al., 2013</xref>; <xref ref-type="bibr" rid="bib67">Ota and Duman, 2013</xref>; <xref ref-type="bibr" rid="bib73">Qiao et al., 2016</xref>; <xref ref-type="bibr" rid="bib74">Qu et al., 2018</xref>; <xref ref-type="bibr" rid="bib85">Shu and Xu, 2017</xref>). As such, we quantified dendritic spine density on deep-layer pyramidal neurons in SC shRNA<sup>PFC</sup> or <italic>Npas4</italic> shRNA<sup>PFC</sup> mice after CSDS compared to nonstressed mice. As expected, we observed a CSDS-induced reduction in dendritic spine density in SC shRNA control mice (<xref ref-type="fig" rid="fig4">Figure 4A</xref>, top; <xref ref-type="fig" rid="fig4">Figure 4B</xref>, left). In contrast, we observed no CSDS-induced changes in mPFC dendritic spine density in <italic>Npas4</italic> shRNA<sup>PFC</sup> mice (<xref ref-type="fig" rid="fig4">Figure 4A</xref>, bottom; <xref ref-type="fig" rid="fig4">Figure 4B</xref>, right), suggesting that NPAS4, either directly or indirectly, is required for this chronic stress-induced structural synaptic change in the mPFC (<xref ref-type="fig" rid="fig4">Figure 4B</xref>, two-way ANOVA, F value = 9.864 and Df = 162, Tukey’s post hoc analysis, control no stress vs. CSDS in SC shRNA<sup>PFC</sup> mice, p=0.0056, SC shRNA<sup>PFC</sup> vs. <italic>Npas4</italic> shRNA<sup>PFC</sup> mice after CSDS, p&lt;0.0001, n = 34–55 dendrites/8 animals per group). Of note, no changes in mPFC dendritic spine density were observed in nonstressed <italic>Npas4</italic> shRNA<sup>PFC</sup> mice (<xref ref-type="fig" rid="fig4">Figure 4A and B</xref>), indicating that steady-state dendritic spine density in adult mPFC pyramidal neurons of nonstressed animals does not require normal NPAS4 expression levels. In addition, neither <italic>Npas4</italic> shRNA nor CSDS produced any detectable changes in mean dendritic spine head diameter or distribution (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1</xref>).</p><fig-group><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>NPAS4 regulates chronic social defeat stress (CSDS)-induced reductions in medial prefrontal cortex (mPFC) dendritic spine density and excitatory synaptic transmission.</title><p>(<bold>A, B</bold>) NPAS4 regulates CSDS-induced reduction of dendritic spine density in the mPFC. (<bold>A</bold>) Representative images showing AAV2-shRNA expression viral vector-mediated eGFP expression. Scale bar, 3 μm. (<bold>B</bold>) Quantification of dendritic spine density of deep layer mPFC pyramidal neurons from SC shRNAPFC and <italic>Npas4</italic> shRNA<sup>PFC</sup> mice after CSDS or in no stress controls (n = 34–55 branch/8 animals/condition). (<bold>C</bold>) Inter-event interval after <italic>Npas4</italic> knockdown and CSDS. (<bold>D</bold>) Cumulative probability of inter-event interval after CSDS after SC shRNA<sup>PFC</sup> and <italic>Npas4</italic> shRNA<sup>PFC</sup>. (<bold>E</bold>) Miniature excitatory postsynaptic current (mEPSC) amplitude after <italic>Npas4</italic> knockdown and CSDS. (<bold>F</bold>) Cumulative probability of mEPSCC amplitude after CSDS after SC shRNA<sup>PFC</sup> and <italic>Npas4</italic> shRNA<sup>PFC</sup>. (<bold>G</bold>) Representative mEPSC traces. (<bold>H</bold>) Paired-pulse ratio recordings after <italic>Npas4</italic> knockdown and CSDS. Data shown are mean ± SEM; *p&lt;0.05, ***p&lt;0.001. Also see <xref ref-type="supplementary-material" rid="sdata1">Source data 1</xref> for detailed statistical analyses.</p><p><supplementary-material id="fig4sdata1"><label>Figure 4—source data 1.</label><caption><title><xref ref-type="fig" rid="fig4">Figure 4B</xref>.</title><p>Dendritic spine density/μm.</p></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-75631-fig4-data1-v1.xlsx"/></supplementary-material></p><p><supplementary-material id="fig4sdata2"><label>Figure 4—source data 2.</label><caption><title><xref ref-type="fig" rid="fig4">Figure 4C</xref>.</title><p>Inter-event interval (ms).</p></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-75631-fig4-data2-v1.xlsx"/></supplementary-material></p><p><supplementary-material id="fig4sdata3"><label>Figure 4—source data 3.</label><caption><title><xref ref-type="fig" rid="fig4">Figure 4D</xref>.</title><p>Cumulative probability of inter-event interval (ms).</p></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-75631-fig4-data3-v1.xlsx"/></supplementary-material></p><p><supplementary-material id="fig4sdata4"><label>Figure 4—source data 4.</label><caption><title><xref ref-type="fig" rid="fig4">Figure 4E</xref>.</title><p>mEPSC amplitude (pA).</p></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-75631-fig4-data4-v1.xlsx"/></supplementary-material></p><p><supplementary-material id="fig4sdata5"><label>Figure 4—source data 5.</label><caption><title><xref ref-type="fig" rid="fig4">Figure 4E</xref>.</title><p>Cumulative probability of mEPSC amplitude (pA).</p></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-75631-fig4-data5-v1.xlsx"/></supplementary-material></p><p><supplementary-material id="fig4sdata6"><label>Figure 4—source data 6.</label><caption><title><xref ref-type="fig" rid="fig4">Figure 4H</xref>.</title><p>Paired-pulse ratios.</p></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-75631-fig4-data6-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-75631-fig4-v1.tif"/></fig><fig id="fig4s1" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 1.</label><caption><title>Medial prefrontal cortex (mPFC) dendritic spine morphological analyses in the mPFC of SC shRNA<sup>PFC</sup> and <italic>Npas4</italic> shRNA<sup>PFC</sup> mice after chronic social defeat stress (CSDS).</title><p>Data plots represent spine head diameter of AAV2-SC shRNA or <italic>Npas4</italic> shRNA viral vector-mediated eGFP-positive mPFC pyramidal neurons after CSDS (two-way ANOVA, n =34–55 branch/8 animals/condition).</p><p><supplementary-material id="fig4s1sdata1"><label>Figure 4—figure supplement 1—source data 1.</label><caption><title><xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1</xref>.</title><p>Spine head diameter.</p></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-75631-fig4-figsupp1-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-75631-fig4-figsupp1-v1.tif"/></fig></fig-group><p>Rodent models show that chronic restraint, unpredictable (<xref ref-type="bibr" rid="bib100">Yuen et al., 2012</xref>), or social defeat stress (<xref ref-type="bibr" rid="bib53">Kuang et al., 2022</xref>) decreases excitatory transmission onto mPFC pyramidal neurons. Furthermore, the administration of ketamine increases excitatory transmission in cultured neurons in vitro (<xref ref-type="bibr" rid="bib31">Gerhard et al., 2020</xref>) and in mPFC pyramidal neurons in vivo (<xref ref-type="bibr" rid="bib102">Zhang et al., 2020</xref>), and it alleviates symptoms of depression in human MDD patients through increased mPFC activity (<xref ref-type="bibr" rid="bib38">Hare and Duman, 2020</xref>). In line with these data and our findings on CSDS-induced decreases in dendritic spine density (<xref ref-type="fig" rid="fig4">Figure 4B</xref>), CSDS in control animals significantly increased the miniature excitatory postsynaptic current (mEPSC) inter-event interval in the layer 5 mPFC pyramidal neurons of SC shRNA<sup>PFC</sup> mice (<xref ref-type="fig" rid="fig4">Figure 4C and D</xref>), consistent with a decrease in presynaptic function and/or reduction in synapse number. However, this change in mEPSC frequency was absent in the CSDS-treated <italic>Npas4</italic> shRNA<sup>PFC</sup> mice (<xref ref-type="fig" rid="fig4">Figure 4C and D</xref>; <xref ref-type="fig" rid="fig4">Figure 4C</xref>, two-way ANOVA, F value = 14.57, and Df = 4251, Tukey’s post hoc analysis, control no stress vs. CSDS in SC shRNA<sup>PFC</sup> mice, p&lt;0.0001, SC shRNA<sup>PFC</sup> vs. <italic>Npas4</italic> shRNA<sup>PFC</sup> mice after CSDS, p&lt;0.0001, n = 648–1240 events/6–12 neurons/2–4 animals per group). Notably, <italic>Npas4</italic> shRNA<sup>PFC</sup> also produced a significant increase in mEPSC amplitude in mPFC pyramidal neurons (<xref ref-type="fig" rid="fig4">Figure 4E–G</xref>; main effect of <italic>Npas4</italic> shRNA), but CSDS did not have this effect (<xref ref-type="fig" rid="fig4">Figure 4E–G</xref>; <xref ref-type="fig" rid="fig4">Figure 4E</xref>, two-way ANOVA, F value = 6.992 and Df = 4301, Tukey’s post hoc analysis, SC shRNA<sup>PFC</sup> vs. <italic>Npas4</italic> shRNA<sup>PFC</sup> mice with control no stress, p&lt;0.0001, SC shRNA<sup>PFC</sup> vs. <italic>Npas4</italic> shRNA<sup>PFC</sup> mice with CSDS, p&lt;0.0001, n = 654–1253 events/6–12 neurons/2–4 animals per group), suggesting that NPAS4 limits glutamatergic synaptic strength on mPFC pyramidal neurons. Finally, CSDS in control animals significantly increased the paired-pulse ratio (PPR) in excitatory pyramidal neurons, suggesting a reduction presynaptic release probability, but this CSDS-induced effect on presynaptic function was blocked by <italic>Npas4</italic> shRNA (<xref ref-type="fig" rid="fig4">Figure 4H</xref>, Two-way ANOVA, F value = 5.883 and Df = 561, Tukey’s post hoc analysis, control no stress vs. CSDS in SC shRNA<sup>PFC</sup> mice, p=0.0002, SC shRNA<sup>PFC</sup> vs. <italic>Npas4</italic> shRNA<sup>PFC</sup> mice with CSDS, p&lt;0.0056, n = 133–191 events/10–17 neurons/3–5 animals per group). Together, our data reveal that NPAS4 in mPFC is required for reductions in excitatory synaptic transmission and synapse density following chronic psychosocial stress, and that NPAS4 limits basal glutamatergic synaptic strength of deep-layer pyramidal neurons.</p></sec><sec id="s2-4"><title>NPAS4 regulates the expression of ribosomal and glutamatergic synapse genes</title><p>To analyze the influence of NPAS4 on the mPFC transcriptome, we performed RNA-seq analyses with mPFC tissue isolated from SC shRNA<sup>PFC</sup> and <italic>Npas4</italic> shRNA<sup>PFC</sup> mice. Of the ~700 differentially expressed genes (DEGs, FDR &lt; 0.05, log<sub>2</sub> (FC) &gt; |0.3|) following <italic>Npas4</italic> mRNA knockdown in mPFC, 267 were downregulated and 365 were upregulated (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>). Downregulated genes included <italic>Spata3, Defb1, Cidea, Psmb10,</italic> and <italic>Rspo3</italic> and upregulated genes included <italic>Arc, Igfn1</italic>, <italic>Schip1, Apcdd1,</italic> and <italic>Dapk2</italic> (<xref ref-type="fig" rid="fig5">Figure 5A and B</xref>). A subset of these DEGs was independently validated by qRT-PCR using independent mPFC samples isolated from SC shRNA<sup>PFC</sup> and <italic>Npas4</italic> shRNA<sup>PFC</sup> mice 1 hr after acute social defeat or control, no stress conditions, including <italic>Npas4</italic>;Two-way ANOVA, F value = 6.736 and Df = 24, Tukey’s post hoc analysis, control SC shRNA vs. <italic>Npas4</italic> shRNA mice after acute social defeat, p&lt;0.0159, n = 7 animals per group<italic>, Ache</italic> (acetylcholinesterase; two-way ANOVA, main effect of <italic>Npas4</italic> shRNA, F value = 20 and Df = 24, p=0.0002, n = 7 animals per group), <italic>Arpp21</italic> (cAMP regulated phosphoprotein 21; two-way ANOVA, main effect of <italic>Npas4</italic> shRNA, F value = 7.433 and Df = 24, p=0.0118, n = 7 animals per group), <italic>Dhcr7</italic> (7-dehydrocholesterole reductase; two-way ANOVA, main effect of <italic>Npas4</italic> shRNA, F value = 10 and Df = 24, p=0.0042, n = 7 animals per group), <italic>Hps4</italic> (HPS4 biogenesis of lysosomal organelles complex 3 subunit 2; two-way ANOVA, main effect of <italic>Npas4</italic> shRNA, F value = 7.36 and Df = 24, p=0.0121, n = 7 animals per group)<italic>, Nfix</italic> (nuclear factor I X; two-way ANOVA, main effect of <italic>Npas4</italic> shRNA, F value = 6.568 and Df = 24, p=0.0171, n = 7 animals per group), and <italic>Sst</italic> (somatostatin; two-way ANOVA, main effect of <italic>Npas4</italic> shRNA, F value = 5.496 and Df = 23, p=0.0281, n = 6–7 animals per group) (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1</xref>). Interestingly, <italic>Npas4</italic> shRNA upregulated DEGs were significantly enriched in the Midnightblue (MB) module of DEGs that was identified by Bagot and colleagues (<xref ref-type="fig" rid="fig5">Figure 5C</xref>, top) (<xref ref-type="bibr" rid="bib4">Bagot et al., 2016</xref>). This module consists of genes that are upregulated in the PFC of resilient mice, and gene ontology (GO) analysis showed significant enrichment of cell–cell signaling and synaptic transmission genes (<xref ref-type="bibr" rid="bib4">Bagot et al., 2016</xref>). Furthermore, <italic>Npas4</italic> shRNA DEGs were significantly enriched in two PsychENCODE modules (<xref ref-type="fig" rid="fig5">Figure 5C</xref>, bottom) (<xref ref-type="bibr" rid="bib30">Gandal et al., 2018</xref>; <xref ref-type="bibr" rid="bib97">Wang et al., 2018</xref>); <italic>Npas4</italic> shRNA-downregulated DEGs showed significant enrichment within gene module M15, an excitatory neuron module of genes that are associated with ribosome function and upregulated in Autism Spectrum Disorder (ASD) and Bipolar Disorder (BD), while <italic>Npas4</italic> shRNA-upregulated DEGs showed significant enrichment in gene module M1, an excitatory neuron module of downregulated genes in ASD that are linked to glutamate-driven neuronal excitability (<xref ref-type="bibr" rid="bib30">Gandal et al., 2018</xref>). Additionally, functional pathway analysis of <italic>Npas4</italic> shRNA-downregulated DEGs revealed significant enrichment of genes linked to ribosome function and protein synthesis. <italic>Npas4</italic> shRNA-upregulated DEGs showed significant enrichment of glutamatergic synapse-related genes important for synaptic signaling and organization (<xref ref-type="fig" rid="fig5">Figure 5D</xref>). To determine whether these mPFC DEGs are putative direct targets of NPAS4, we compared our data to previously published NPAS4 ChIP-seq studies (<xref ref-type="bibr" rid="bib7">Brigidi et al., 2019</xref>; <xref ref-type="bibr" rid="bib48">Kim et al., 2010</xref>) and found significant genomic enrichment of NPAS4 binding to promoter, intron, exon, and distal intergenic genomic regions (<xref ref-type="fig" rid="fig5">Figure 5E</xref>), suggesting that NPAS4 may directly regulate several key mPFC genes involved in the regulation of glutamatergic synapses and ribosomes. Interestingly, RNA-seq from human postmortem brains (BA8/9) of male MDD patients indicated significant enrichment of differentially expressed genes (p&lt;0.05) in ribosome-related pathways, including 57 significantly upregulated genes (<xref ref-type="fig" rid="fig5">Figure 5F</xref>; <xref ref-type="bibr" rid="bib54">Labonté et al., 2017</xref>). Of note, the enrichment of ribosomal genes was not observed in female MDD brains (BA8/9), where only one gene, <italic>RPS28</italic>, exhibited significant differential expression. Moreover, the majority (66.2%) of the <italic>Npas4</italic> shRNA-downregulated genes from our analysis overlapped with upregulated genes in human MDD patients (<xref ref-type="fig" rid="fig5">Figure 5F</xref>), suggesting that <italic>Npas4</italic> expression could contribute to vulnerability to depression in the human brain. Finally, NPAS4 ChIP-seq in hippocampal neurons (<xref ref-type="bibr" rid="bib7">Brigidi et al., 2019</xref>) indicates that NPAS4 directly associates with 55% (42 of 77) of ribosome-related genes classified in the pathway ‘co-translational protein targeting membrane’ (<xref ref-type="fig" rid="fig5">Figure 5G</xref>). We detected 92 total ribosome-related genes in the mPFC that are classified in this pathway, with 68 downregulated and 2 upregulated (p&lt;0.05) by <italic>Npas4</italic> shRNA (<xref ref-type="fig" rid="fig5">Figure 5G</xref>). Finally, we used qRT-PCR to validate several mPFC genes regulated by <italic>Npas4</italic> shRNA and acute social defeat stress and found that <italic>Npas4</italic> itself was the only regulated transcript at 1 hr following acute social defeat stress (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1</xref>). Together, our data suggest that mPFC NPAS4 regulates numerous genes related to glutamatergic synapse regulation and ribosomal function and positions it as a key regulator of healthy mPFC function.</p><fig-group><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>NPAS4 regulates the expression of ribosomal and glutamatergic synapse genes.</title><p>(<bold>A</bold>, <bold>B</bold>) List of top differentially expressed genes in medial prefrontal cortex (mPFC) of <italic>Npas4</italic> shRNAPFC mice (<bold>A</bold>) and corresponding volcano plot of all significant DEGs (FDR &lt; 0.05, log2 (FC) &gt; |0.3|, red) compared to those that were not significant (gray; <bold>B</bold>). (<bold>C</bold>) <italic>Npas4</italic> DEG enrichment in gene modules that are deferentially regulated in Resilience and Susceptible animals in <xref ref-type="bibr" rid="bib4">Bagot et al., 2016</xref> and are dysregulated in neuropsychiatric disorders; Modules M1 and M15, as shown by PsychENCODE. (<bold>D</bold>) Gene ontology analysis of down- and upregulated DEGs in <italic>Npas4</italic> shRNA<sup>PFC</sup> mice. (<bold>E</bold>) Comparison of mPFC genes regulated by <italic>Npas4</italic> shRNA<sup>PFC</sup> compared to previously published Npas4 ChIP-seq data (<xref ref-type="bibr" rid="bib48">Kim et al., 2010</xref>; <xref ref-type="bibr" rid="bib7">Brigidi et al., 2019</xref>). (<bold>F</bold>) Overlap of significantly differential expression genes (p&lt;0.05) in <italic>Npas4</italic> shRNA<sup>PFC</sup> mice (left; blue) and differential expression genes (p&lt;0.05) in BA8/9 of human major depressive disorder (MDD) patients (right; pink). (<bold>G</bold>) ChIP-seq analysis of NPAS4 association with significant ribosome-related differential expression genes identified from this study.</p><p><supplementary-material id="fig5sdata1"><label>Figure 5—source data 1.</label><caption><title><xref ref-type="fig" rid="fig5">Figure 5A</xref>.</title><p>Table for NPAS4-mediated genes.</p></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-75631-fig5-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-75631-fig5-v1.tif"/></fig><fig id="fig5s1" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 1.</label><caption><title>Differential expression genes in the medial prefrontal cortex (mPFC) of <italic>Npas4</italic> shRNA mice.</title><p>Data plots represent the relative mRNA expression in the mPFC of SC shRNA and <italic>Npas4</italic> shRNA mice (two-way ANOVA, <italic>Npas4,</italic> main effect of <italic>Npas4</italic> shRNA, Tukey’s post hoc analysis, SC shRNA<sup>PFC</sup> and <italic>Npas4</italic> shRNA<sup>PFC</sup> mice with acute social defeat stress [SDS], p=0.0005, <italic>Ache</italic>, main effect of <italic>Npas4</italic> shRNA, p=0.0002, <italic>Arpp21,</italic> main effect of <italic>Npas4</italic> shRNA, p=0.118, <italic>Dhcr7,</italic> main effect of <italic>Npas4</italic> shRNA, p=0.0042, <italic>Hps4,</italic> main effect of <italic>Npas4</italic> shRNA, p=0.0121, <italic>Nfix,</italic> main effect of <italic>Npas4</italic> shRNA, p=0.0171, <italic>Sst,</italic> main effect of <italic>Npas4</italic> shRNA, p=0.0281 [n = 7 per group]). Data shown are mean ± SEM; *p&lt;0.05, **p&lt;0.01. Also see <xref ref-type="supplementary-material" rid="sdata1">Source data 1</xref> for detailed statistical analyses.</p><p><supplementary-material id="fig5s1sdata1"><label>Figure 5—figure supplement 1—source data 1.</label><caption><title><xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1</xref>.</title><p>Differentially expression mRNA.</p></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-75631-fig5-figsupp1-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-75631-fig5-figsupp1-v1.tif"/></fig></fig-group></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>Here we find that social defeat stress (acute or chronic) induces rapid and transient expression of NPAS4 in mPFC neurons, and that NPAS4 in the mPFC is required for CSDS-induced anhedonia-like behavior, changes in effort-based reward seeking-motivated behavior, and CSDS-induced dendritic spine loss and suppression of excitatory synaptic transmission on mPFC pyramidal neurons. However, mPFC NPAS4 was not required for CSDS-induced social avoidance or anxiety-like behavior, suggesting that CSDS produces those phenotypes through distinct molecular and/or circuit mechanisms devoid of NPAS4 function. We found that NPAS4 influences the expression of hundreds of mPFC genes, including upregulated genes reported in stress-resilient animals and genes linked to glutamatergic synapses. As such, CSDS-induced NPAS4 could directly or indirectly downregulate these synapse-related genes and facilitate reductions in mPFC excitatory synaptic transmission. We also detected strong enrichment of downregulated ribosomal genes, many of which are also dysregulated in human MDD, suggesting that ribosomal gene dysregulation could be potential biomarkers of depression. Together, our findings reveal a novel and essential role for NPAS4 in chronic stress-induced anhedonia-like behavior and suppression of mPFC excitatory synaptic function.</p><p>NPAS4 is a neuronal-specific, synaptic activity-regulated transcription factor that regulates excitatory/inhibitory synapse balance and synaptic transmission (<xref ref-type="bibr" rid="bib6">Bloodgood et al., 2013</xref>; <xref ref-type="bibr" rid="bib7">Brigidi et al., 2019</xref>; <xref ref-type="bibr" rid="bib39">Hartzell et al., 2018</xref>; <xref ref-type="bibr" rid="bib57">Lin et al., 2008</xref>; <xref ref-type="bibr" rid="bib88">Spiegel et al., 2014</xref>; <xref ref-type="bibr" rid="bib89">Sun and Lin, 2016</xref>). Synaptic activity-dependent induction of NPAS4 in pyramidal neurons reduces excitatory synaptic transmission onto these neurons (<xref ref-type="bibr" rid="bib57">Lin et al., 2008</xref>) and decreases excitatory synaptic inputs (<xref ref-type="bibr" rid="bib87">Sim et al., 2013</xref>), consistent with our finding that NPAS4 is required for CSDS-induced loss of mPFC pyramidal neuron dendritic spine density and reduction of excitatory synaptic transmission. While one report indicated that CSDS-induced reduction of dendritic spine density is associated with social avoidance phenotypes (<xref ref-type="bibr" rid="bib74">Qu et al., 2018</xref>), we observed that mPFC NPAS4 reduction selectively blocked CSDS-induced spine loss and anhedonia-like behavior, but social avoidance and anxiety-like behavior were not impacted, suggesting that deep-layer mPFC pyramidal cell spine loss, per se, is not strictly required for CSDS-induced social- and anxiety-related phenotypes.</p><p>Notably, we found that CSDS increased the mEPSC inter-event interval in mPFC pyramidal neurons in SC shRNA<sup>PFC</sup> control mice, which is consistent with reported effects of chronic restraint or unpredictable stress (<xref ref-type="bibr" rid="bib100">Yuen et al., 2012</xref>). In contrast, Yuen et al. demonstrated that chronic stress also decreased mEPSC amplitude (<xref ref-type="bibr" rid="bib100">Yuen et al., 2012</xref>), which we did not observe following CSDS, suggesting possible model-specific differences in mPFC neuroadaptations and highlighting the considerable heterogeneity of stress biology (<xref ref-type="bibr" rid="bib23">Duman et al., 2016</xref>). In the future, it would be interesting to examine the role of NPAS4 in the other aversive experience-induced (e.g., chronic restraint or unpredictable stress) changes in mPFC pyramidal neuron excitatory synaptic transmission and depression-like behavior. In addition, mPFC NPAS4 mediates CSDS-induced reduction of glutamatergic presynaptic function (i.e., increased PPR), which could be a non-cell-autonomous effect of NPAS4 on long-range inputs to the mPFC deep-layer pyramidal neurons. It is interesting to note that the stress-independent increase in mEPSC amplitude produced by <italic>Npas4</italic> shRNA might produce a preexisting mPFC hyperfunction that protects the mPFC pyramidal neurons from CSDS-induced effects. Future studies will be important for understanding precisely how mPFC NPAS4 promotes mPFC hypofunction and anhedonia-like behavior, and whether therapeutic interventions, such as ketamine or antidepressant treatment, intersect with NPAS4-dependent mechanisms of stress-induced neuronal plasticity.</p><p>Although we targeted both the prelimbic and infralimbic subregions of the mPFC, studies show that these subregions can differentially regulate reward-related behavior (<xref ref-type="bibr" rid="bib9">Capuzzo and Floresco, 2020</xref>; <xref ref-type="bibr" rid="bib81">Riaz et al., 2019</xref>). As such, future studies examining the role of NPAS4 in these mPFC subregions following CSDS might provide valuable insights into NPAS4’s influence on anhedonia-like behavior. Additionally, although we were unable to study females in our CSDS model, chronic exposure to stress hormones, chronic mild unpredictable stress, and chronic restraint stress all induce anhedonia-like behavior and dendritic spine loss in both sexes (<xref ref-type="bibr" rid="bib8">Brown et al., 2005</xref>; <xref ref-type="bibr" rid="bib12">Christoffel et al., 2011</xref>; <xref ref-type="bibr" rid="bib14">Cook and Wellman, 2004</xref>; <xref ref-type="bibr" rid="bib34">Goldwater et al., 2009</xref>; <xref ref-type="bibr" rid="bib59">Liston et al., 2006</xref>; <xref ref-type="bibr" rid="bib63">Mayanagi and Sobue, 2019</xref>; <xref ref-type="bibr" rid="bib73">Qiao et al., 2016</xref>; <xref ref-type="bibr" rid="bib77">Radley et al., 2006a</xref>; <xref ref-type="bibr" rid="bib76">Radley et al., 2005</xref>; <xref ref-type="bibr" rid="bib78">Radley et al., 2006b</xref>; <xref ref-type="bibr" rid="bib75">Radley et al., 2004</xref>). Moreover, PFC pyramidal cell dendritic spine density is also reduced in human postmortem brains of individuals diagnosed with anhedonia-associated neuropsychiatric disorders, such as SCZ, BD, and MDD (<xref ref-type="bibr" rid="bib12">Christoffel et al., 2011</xref>; <xref ref-type="bibr" rid="bib22">Duman and Duman, 2015</xref>; <xref ref-type="bibr" rid="bib26">Forrest et al., 2018</xref>; <xref ref-type="bibr" rid="bib32">Glausier and Lewis, 2013</xref>; <xref ref-type="bibr" rid="bib45">Holmes et al., 2019</xref>; <xref ref-type="bibr" rid="bib49">Konopaske et al., 2014</xref>; <xref ref-type="bibr" rid="bib55">Lewis and González-Burgos, 2008</xref>; <xref ref-type="bibr" rid="bib65">Moda-Sava et al., 2019</xref>; <xref ref-type="bibr" rid="bib66">Moyer et al., 2015</xref>; <xref ref-type="bibr" rid="bib73">Qiao et al., 2016</xref>). These data support the functional relationship between excitatory neuronal transmission onto mPFC pyramidal neurons and anhedonia, and suggest the effects shown here are not sex-specific. However, future studies in female mice will be essential to interrogate this hypothesis.</p><p>NPAS4 in cultured neurons regulates a large, cell type-specific program of gene expression, including key targets like brain-derived neurotropic factor (BDNF), that alter E/I synapse balance (<xref ref-type="bibr" rid="bib6">Bloodgood et al., 2013</xref>; <xref ref-type="bibr" rid="bib57">Lin et al., 2008</xref>; <xref ref-type="bibr" rid="bib79">Ramamoorthi et al., 2011</xref>; <xref ref-type="bibr" rid="bib87">Sim et al., 2013</xref>; <xref ref-type="bibr" rid="bib88">Spiegel et al., 2014</xref>; <xref ref-type="bibr" rid="bib89">Sun and Lin, 2016</xref>; <xref ref-type="bibr" rid="bib99">Ye et al., 2016</xref>). However, social defeat stress failed to induce <italic>Bdnf</italic> mRNA in mPFC and <italic>Npas4</italic> knockdown did not alter basal mPFC <italic>Bdnf</italic> expression (data not shown and <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>), suggesting that <italic>Bdnf</italic> is not a key downstream target of mPFC NPAS4 in the context of CSDS. Our RNA-seq analysis of mPFC tissues, with or without <italic>Npas4</italic> shRNA, revealed an abundance of significant DEGs (<xref ref-type="fig" rid="fig5">Figure 5</xref>). We found that <italic>Npas4</italic> shRNA-upregulated DEGs in the mPFC are also significantly enriched in the DEG module (MB) of the upregulated genes in the PFC of resilience animals (<xref ref-type="bibr" rid="bib4">Bagot et al., 2016</xref>). Although NPAS4 did not influence CSDS-induced social avoidance, these resilience genes could reveal an underlying mechanism to ameliorate or reverse the deficits in reward-related behaviors. Additionally, recent research has shown that analysis of PFC DEGs revealed sex-specific transcriptomic profiles in human depression (<xref ref-type="bibr" rid="bib54">Labonté et al., 2017</xref>), with only 5–10% of genes overlapping between males and females across all brain regions analyzed. This is possibly due to the sex-specific changes in MDD (<xref ref-type="bibr" rid="bib54">Labonté et al., 2017</xref>) as the significant enrichment of ribosomal DEGs was observed only in males, but not females. Although we did not examine sex differences in this study, it will be important to elucidate the NPAS4-mediated transcriptome in females, especially in the mPFC following chronic stress. Of the upregulated DEGs, GO pathway analysis revealed enrichment of genes linked to glutamatergic synaptic transmission and excitability, and PsychENCODE analysis identified a neuronal module of genes linked to glutamatergic excitability that are downregulated in autism spectrum disorders (<xref ref-type="bibr" rid="bib30">Gandal et al., 2018</xref>), suggesting the possibility that CSDS-induced mPFC dendritic spine density loss and excitatory synaptic transmission are produced, in part, by one or more of these synapse-linked genes that are downregulated following stress-induced mPFC NPAS4 expression. Interestingly, 22% of these upregulated DEGs overlapped with NPAS4 target genes identified by ChIP-seq analysis from cultured pyramidal neurons (<xref ref-type="bibr" rid="bib48">Kim et al., 2010</xref>), suggesting that some of the upregulated, synapse-related DEGs could be direct NPAS4 gene targets. Furthermore, we found significant enrichment of DEGs with NPAS4 target genes from an additional NPAS4 ChIP-seq studies (<xref ref-type="bibr" rid="bib7">Brigidi et al., 2019</xref>; <xref ref-type="bibr" rid="bib48">Kim et al., 2010</xref>), suggesting that there may be MDD-related genes directly regulated by NPAS4. Although we did not perform RNA-seq with <italic>Npas4</italic> shRNA after CSDS specifically, this would be an interesting avenue of investigation to determine genes regulated by chronic stress independent of NPAS4. Individual qPCR analyses confirmed the effect of NPAS4 on several genes; however, we saw no effect of acute social defeat stress on the expression of those genes 1 hr after stress exposure (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1</xref>), indicating NPAS4 controls those genes independent of stress exposure. It would be important research to investigate the transcription factor NPAS4-mediated transcriptome (e.g.<italic>,</italic> early and late response genes) in response to stress exposure. In contrast to the upregulated genes, <italic>Npas4</italic> shRNA-downregulated genes showed strong enrichment for ribosomal function and a PsychENCODE module (M15) of excitatory neuron genes associated with ribosome function that is upregulated in ASD and BD, and more than half of these downregulated <italic>Npas4</italic> shRNA genes are associated with NPAS4 protein (<xref ref-type="fig" rid="fig5">Figure 5F</xref>). While the functional relevance of ribosome gene enrichment is unclear, the marked enrichment of ribosome-related DEGs is very striking – microarray analysis of blood samples from stress-vulnerable vs. stress-resilient adult human patients found DEGs that were most markedly enriched in ribosome-related pathways and were upregulated based on stress vulnerability (<xref ref-type="bibr" rid="bib46">Hori et al., 2018</xref>). Additionally, RNA-seq analyses from orbitofrontal cortex of postmortem human brains with SCZ, BD, and MDD also identified DEGs enriched for the ribosomal pathway, most of which were upregulated in patient samples (<xref ref-type="bibr" rid="bib19">Darby et al., 2016</xref>). Finally, given that NPAS4 regulates the expression of SST (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1</xref>), it is possible that there are cell extrinsic mechanisms of NPAS4 expression in CaMKIIα neurons on other PFC cell types (i.e., GABAergic interneurons). Therefore, it would be interesting to perform single-cell transcriptomic analysis of PFC tissue following <italic>Npas4</italic> knockdown in excitatory pyramidal neurons following acute or chronic stress, as NPAS4 may influence interneuron (e.g., SST, PV, VIP) gene expression in a non-cell autonomous manner. A remaining question is if lack of NPAS4 in PFC excitatory neurons allows for compensatory increases in other IEGs, such as <italic>Fos</italic> and <italic>Arc</italic>, which could also be answered with a single-cell RNA-sequencing approach. Moreover, it would also be interesting to determine whether NPAS4 overexpression in mPFC enhances CSDS-induced anhedonia-like behavior or a reduction in the proportion of resilience mice.</p><p>Overall, our findings reveal a novel role for mPFC NPAS4 in CSDS-induced reductions in mPFC pyramidal neuron excitatory synaptic transmission and dendritic spine loss, including the emergence of anhedonia-like behaviors, though mPFC NPAS4 did not impact CSDS-induced social avoidance or anxiety-like behavior (<xref ref-type="fig" rid="fig6">Figure 6</xref>). We found that mPFC NPAS4 regulates hundreds of genes, including clusters of genes linked to glutamatergic synapse function and ribosomal function, both of which are well-positioned to alter neuronal function. Future strategies targeting these <italic>Npas4</italic>-regulated pathways could be a novel approach to develop therapeutic treatments for hypofrontality and anhedonia-related symptoms in patients struggling with depression, bipolar disorder, and other stress-related neuropsychiatric disorders.</p><fig id="fig6" position="float"><label>Figure 6.</label><caption><title>Summary for NPAS4 in the medial prefrontal cortex (mPFC) mediates chronic social defeat stress (CSDS)-induced anhedonia-like behavior and reductions in excitatory synapses.</title></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-75631-fig6-v1.tif"/></fig></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><table-wrap id="keyresource" position="anchor"><label>Key resources table</label><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">Reagent type (species) or resource</th><th align="left" valign="bottom">Designation</th><th align="left" valign="bottom">Source or reference</th><th align="left" valign="bottom">Identifiers</th><th align="left" valign="bottom">Additional information</th></tr></thead><tbody><tr><td align="left" valign="bottom">Transfected construct (<italic>Mus musculus</italic>)</td><td align="left" valign="bottom">AAV2-Anti-Npas4 shRNA</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib92">Taniguchi et al., 2017</xref>, obtained from UNC vector Core and USC vector Core</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Transfected construct (<italic>M. musculus</italic>)</td><td align="left" valign="bottom">AAV2-Scramble shRNA</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib92">Taniguchi et al., 2017</xref>, obtained from UNC vector Core and USC vector Core</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Biological sample (<italic>M. musculus</italic>)</td><td align="left" valign="bottom">C57Bl6J mice</td><td align="left" valign="bottom">The Jackson laboratory</td><td align="left" valign="bottom">Strain# 000664; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:IMSR_JAX:000664">IMSR_JAX:000664</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-CaMKIIalpha (mouse monoclonal)</td><td align="left" valign="bottom">Enzo Life Sciences</td><td align="left" valign="bottom">Cat# KAM-CA002D; RRID<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_1659580">:AB_1659580</ext-link></td><td align="left" valign="bottom">IF(1:1000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-somatostatin (rat monoclonal)</td><td align="left" valign="bottom">Millipore</td><td align="left" valign="bottom">Cat# MAB354;<break/>RRID<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2255365">:AB_2255365</ext-link></td><td align="left" valign="bottom">IF(1:1000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti- parvalbumin (mouse monoclonal)</td><td align="left" valign="bottom">Aves</td><td align="left" valign="bottom">Cat# MAB1572; RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2174013">AB_2174013</ext-link></td><td align="left" valign="bottom">IF(1:1000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-GFP (chicken polyclonal)</td><td align="left" valign="bottom">Aves</td><td align="left" valign="bottom">Cat# GFP-1020; RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_10000240">AB_10000240</ext-link></td><td align="left" valign="bottom">IF(1:1000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-Npas4 (rabbit polyclonal)</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib57">Lin et al., 2008</xref></td><td align="left" valign="bottom"/><td align="left" valign="bottom">IF(1:1000–2000)</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Scramble shRNA</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib57">Lin et al., 2008</xref></td><td align="left" valign="bottom"/><td align="left" valign="bottom">GGTTCAGCGTCATAATT<break/>TATTCAAGAGATAAATTA<break/>TGACGCTGAACC</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom"><italic>Npas4</italic> shRNA</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib57">Lin et al., 2008</xref></td><td align="left" valign="bottom"/><td align="left" valign="bottom">GGTTGACCCTGATAATT<break/>TATTCAAGAGATAAATTA<break/>TCAGGGTCAACC</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom"><italic>Npas4</italic> forward primer</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib28">Furukawa-Hibi et al., 2012</xref></td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">AGCATTCCAGGCT<break/>CATCTGAA</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom"><italic>Npas4</italic> reverse primer</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib28">Furukawa-Hibi et al., 2012</xref></td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">GGCGAAGTAAGT<break/>CTTGGTAGGATT</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom"><italic>Npas4</italic> forward primer</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib57">Lin et al., 2008</xref></td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">GCTATA CTCAGAAGG<break/>TCCAGAAGGC</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom"><italic>Npas4</italic> reverse primer</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib57">Lin et al., 2008</xref></td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">TCAGAGAATGAG<break/>GGTAGCACAGC</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom"><italic>Gapdh</italic> forward primer</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib50">Krishnan et al., 2007</xref></td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">AGGTCGGTGTG<break/>AACGGATTTG</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom"><italic>Gapdh</italic> reverse primer</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib50">Krishnan et al., 2007</xref></td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">TGTAGACCATGT<break/>AGTTGAGGTCA</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom"><italic>β-tubulin</italic> forward primer</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib57">Lin et al., 2008</xref></td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">CGAC AATGAAG<break/>CCCTCTACGAC</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom"><italic>β-tubulin</italic> reverse primer</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib57">Lin et al., 2008</xref></td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">ATGGTGGCAGAC<break/>ACAAGGTGGTTG</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom"><italic>cFos</italic> forward primer</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib98">Watanabe et al., 2009</xref></td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">GTCGACCTAGGG<break/>AGGACCTTAC</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom"><italic>cFos</italic> reverse primer</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib98">Watanabe et al., 2009</xref></td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">CATCTCTGGAAG<break/>AGGTGAGGAC</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom"><italic>Nfix</italic> forward primer</td><td align="left" valign="bottom">MGH, Harvard Medical School, Primer Bank</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">AGCCCCAGCTA<break/>CTACAACATA</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom"><italic>Nfix</italic> reverse primer</td><td align="left" valign="bottom">MGH, Harvard Medical School, Primer Bank</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">AGTCCAGCTTT<break/>CCTGACTTCT</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom"><italic>Sst</italic> forward primer</td><td align="left" valign="bottom">MGH, Harvard Medical School, Primer Bank</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">ACCGGGAAAC<break/>AGGAACTGG</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom"><italic>Sst</italic> reverse primer</td><td align="left" valign="bottom">MGH, Harvard Medical School, Primer Bank</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">TTGCTGGGTT<break/>CGAGTTGGC</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom"><italic>Dhcr7</italic> forward primer</td><td align="left" valign="bottom">ORIGENE</td><td align="left" valign="bottom">PCR primers, Cat# MP200098</td><td align="left" valign="bottom">CAAGACACCAC<break/>CTGTGACAGCT</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom"><italic>Dhcr7</italic> reverse primer</td><td align="left" valign="bottom">ORIGENE</td><td align="left" valign="bottom">PCR primers, Cat# MP200098</td><td align="left" valign="bottom">CTGCTGGAGTAA<break/>TGGCACCTTC</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom"><italic>Arpp21</italic> forward primer</td><td align="left" valign="bottom">ORIGENE</td><td align="left" valign="bottom">PCR primers, Cat# MP221281</td><td align="left" valign="bottom">GGAGTCAGCAAA<break/>TACCACAGACC</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom"><italic>Arpp21</italic> reverse primer</td><td align="left" valign="bottom">ORIGENE</td><td align="left" valign="bottom">PCR primers, Cat#: MP221281</td><td align="left" valign="bottom">CTCCTTGCTGA<break/>CTGCTCATCAC</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom"><italic>Hps4</italic> forward primer</td><td align="left" valign="bottom">ORIGENE</td><td align="left" valign="bottom">PCR primers, Cat# MP206052</td><td align="left" valign="bottom">AGTGTGAACGGA<break/>CTGGTGCTGT</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom"><italic>Hps4</italic> reverse primer</td><td align="left" valign="bottom">ORIGENE</td><td align="left" valign="bottom">PCR primers, Cat# MP206052</td><td align="left" valign="bottom">GTCTCCTTCAGG<break/>TGGACTTCCA</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom"><italic>Ache</italic> forward primer</td><td align="left" valign="bottom">ORIGENE</td><td align="left" valign="bottom">PCR primers, Cat# MP200188</td><td align="left" valign="bottom">TTCCTTCGTGCC<break/>TGTGGTAGAC</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom"><italic>Ache</italic> reverse primer</td><td align="left" valign="bottom">ORIGENE</td><td align="left" valign="bottom">PCR primers, Cat# MP200188</td><td align="left" valign="bottom">CCGTAAACCAGAA<break/>AGTAGGAGCC</td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">HOMER</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib40">Heinz et al., 2010</xref></td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">STAR</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib21">Dobin et al., 2013</xref></td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">HTseq</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib2">Anders et al., 2015</xref></td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">biomaRt</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib24">Durinck et al., 2009</xref></td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">GOstats</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib25">Falcon and Gentleman, 2007</xref></td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">Single-nuclei RNA-seq with mPFC from control C57BL/6J mice</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">GSE165586</td><td align="left" valign="bottom">snRNA-seq analysis data <break/>assocciated with <break/><xref ref-type="fig" rid="fig1">Figure 1A-D</xref>.</td></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">RNA-seq with mPFC from AAV-<italic>Npas4</italic> mRNA shRNA mice</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">GSE165586</td><td align="left" valign="bottom">RNA-seq analysis data <break/>associated with <break/><xref ref-type="fig" rid="fig5">Figure 5</xref>.</td></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">ChIP-Seq, NPAS4</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib7">Brigidi et al., 2019</xref></td><td align="left" valign="bottom">GSE127793</td><td align="left" valign="bottom">ChIP-seq analysis data <break/>associated with <break/><xref ref-type="fig" rid="fig5">Figure 5E</xref>.</td></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">ChIP-Seq, NPAS4</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib48">Kim et al., 2010</xref></td><td align="left" valign="bottom">GSE21161</td><td align="left" valign="bottom">ChIP-seq analysis data <break/>associated with <break/><xref ref-type="fig" rid="fig5">Figure 5E</xref>.</td></tr></tbody></table></table-wrap><sec id="s4-1"><title>Recombinant plasmids and shRNA expression viral vectors</title><p>For knockdown of endogenous <italic>Npas4</italic> mRNA expression in mPFC, a previously validated <italic>Npas4</italic> shRNA, specific to the <italic>Npas4 gene</italic>, or scramble (SC) shRNA control was cloned into the pAAV-shRNA vector as previously described (<xref ref-type="bibr" rid="bib57">Lin et al., 2008</xref>; <xref ref-type="bibr" rid="bib71">Ploski et al., 2011</xref>; <xref ref-type="bibr" rid="bib79">Ramamoorthi et al., 2011</xref>; <xref ref-type="bibr" rid="bib92">Taniguchi et al., 2017</xref>). The adeno-associated virus serotype 2 (AAV2) vector consists of a CMV promoter driving eGFP with a SV40 polyadenylation signal, followed downstream by a U6 RNA polymerase III promoter and <italic>Npas4</italic> shRNA or scrambled (SC) shRNA oligonucleotides, then a polymerase III termination signal – all flanked by AAV2 inverted terminal repeats. AAV2-<italic>Npas4</italic> shRNA and SC shRNA were processed for packaging and purification by the UNC Vector Core (Chapel Hill, NC).</p></sec><sec id="s4-2"><title>Animals</title><p>C57BL/6 adult male mice were purchased from Jackson Laboratory (ME) and tested between 8 and 20 weeks of age. Mice were allowed access to food and water ad libitum and were kept on a 12 hr light-dark cycle. All procedures were in accordance with Institutional Animal Care and Use (IACUC) guidelines.</p></sec><sec id="s4-3"><title>Viral-mediated gene transfer</title><p>Stereotaxic surgery was performed under general anesthesia with a ketamine/xylazine cocktail (120 mg/kg: 16 mg/kg) or isoflurane (induction 4% v/v, maintenance 1–2% v/v). Coordinates to target the mPFC (ventral portion of cingulate, prelimbic, and infralimbic cortices) were +1.85–1.95 mm anterior, +0.75 mm lateral, and 2.65–2.25 mm ventral from bregma (relative to skull) at a 15° angle in all mice (<xref ref-type="bibr" rid="bib17">Covington et al., 2010</xref>). AAV2-scramble (SC) shRNA (2.9 * 10^<sup>9</sup> and 1.1 * 10<sup>12</sup> GC/mL) and AAV2-<italic>Npas4</italic> shRNA (4.3 * 10^<sup>9</sup> and 3.1 * 10<sup>12</sup> GC/mL) were delivered using Hamilton syringes or nanoinjectors with pulled glass capillaries at a rate of 0.1 μL/min for 0.4 μL total at the dorsoventral sites, followed by raising the needle and an additional 0.4 μL delivery of virus. After waiting for an additional 5–10 min, needles were completely retracted. Viral placements were confirmed through immunohistochemistry for bicistronic expression of eGFP from the AAV2 viral vectors by experimenters blinded to the experimental conditions. Animals with off-target virus infection or no infection in one or both hemispheres were excluded from the analysis of behavioral phenotypes.</p></sec><sec id="s4-4"><title>Single-nuclei RNA-seq and bioinformatic analysis</title><p>Control C57BL/6J mice (Vgat-cre positive) were live-decapitated at 8 weeks of age. Brains were rapidly extracted into a supplemented 4°C Hibernate A medium, with GlutaMAX supplement (Fisher), B27 supplement (Fisher), and NxGen RNase inhibitor (0.2 U/uL, Lucigen), and incubated for 30 s. The brain was sectioned into 1 mm sections using a brain matrix. The prefrontal cortex (PFC) was dissected with fine forceps, flash frozen on dry ice, and stored at –80°C. The nuclear isolation protocol was modified from <xref ref-type="bibr" rid="bib82">Savell et al., 2020</xref>. On the day of nuclear dissociation, the frozen tissue was slowly thawed on ice and chopped with a scalpel blade 100 times in two orthogonal directions on a glass Petri dish. The chopped tissue of three PFCs were pooled and transferred to a hypotonic lysis buffer (10 mM Tris-HCl, 10 mM NaCl, 3 mM MgCl2, 0.1% IGEPAL [Sigma] in Nuclease-Free Water). Supplemented Hibernate A medium was added, and the tissue was triturated ~30 times/sample using three glass pipettes of decreasing diameter. The tissue was then filtered using a 40 micron filter (Fisher). The nuclei were isolated using 500 × <italic>g</italic> centrifugation and washed with 1× PBS + 1.0% BSA and 0.2 U/uL RNase inhibitor. Nuclei were incubated with 7-aminoactinomycin D (7-AAD) (Invitrogen) for 5 min and sorted for 7-AAD-positive single nuclei using fluorescence-activated nuclear sorting on the Aria II. Samples were counted and diluted to 1500 nuclei/uL before immediate processing on the 10X Genomics Single-Cell Protocol by the MUSC Translation Science Lab. Libraries were constructed using the Chromium Single Cell 3’ Library Construction Kit (10X Genomics, v3.1) and sequenced at Vanderbilt’s Next Gen Sequencing Core (Illumina NovaSeq 6000). Raw sequencing data were processed with Cell Ranger (v6.1.2) (PMID: 28091601). Cellranger mkfastq command was used to demultiplex the different samples and cellranger count command was used to generate gene–cell expression matrices. Ambient RNA contamination was inferred and removed using CellBender (v0.232) with standard parameters. Mouse genome mm10 was used for the alignment, and genecode vM25 was used for gene annotation and coordinates (<xref ref-type="bibr" rid="bib27">Frankish et al., 2021</xref>).</p></sec><sec id="s4-5"><title>Chronic social defeat stress</title><p>CSDS was performed as previously described (<xref ref-type="bibr" rid="bib33">Golden et al., 2011</xref>; <xref ref-type="bibr" rid="bib50">Krishnan et al., 2007</xref>). CD1 retired male breeders (Charles River Laboratory, CA) were single-housed for 3–5 days before CSDS procedures to establish their territorial cage, then pre-screened for aggressive behavior. Experimental C57BL/6J male mice were introduced to the aggressor’s territorial cage, physically contacted and attacked by the aggressor for 5–10 min, and then separated by a clear plastic board with multiple small holes for 24 hr. Experimental mice were introduced to a new CD1 aggressor each day. The no stress control mice were housed with another non-stressed C57BL/6J male mouse, separated by the same plastic board, and the cage partner was changed every day for 10 days of the CSDS experiment.</p></sec><sec id="s4-6"><title>qRT-PCR for gene expression</title><p>Brain tissue was collected at the described time point after social defeat stress, or no stress control condition, and kept frozen at –80°C until processed for the following steps. RNA isolation, reverse transcription, and quantitative real-time PCR were carried out as described previously (<xref ref-type="bibr" rid="bib92">Taniguchi et al., 2017</xref>). Mouse tissue samples were homogenized in QIAzol solution and processed for RNA purification using the miRNeasy kit (QIAGEN, MD) following the manufacture’s protocol. The total RNA was reverse transcribed using SuperScript III (Invitrogen) with a random hexamer primer following the manufacturer’s instructions. Quantitative PCR (qPCR) was performed using SYBR Green (Bio-Rad, CA). The level of mRNA expression was analyzed by the fold change relative to <italic>Gapdh</italic> or <italic>β-tubulin</italic> expression. The relative mRNA level was analyzed as the difference from experimental condition relative to controls. Please see Key Resources Table for primer sequences.</p></sec><sec id="s4-7"><title>Immunohistochemistry</title><p>Mouse brains were fixed overnight in 4% PFA in 1× PBS and transferred to a 30% sucrose solution in 1× PBS before slicing (40 or 50 μm) with a microtome. The slices were permeabilized and blocked in 3% BSA, 0.3% Triton X-100, 0.2% Tween-20, 3% normal donkey or goat serum in PBS, then incubated with primary antibodies: anti-GFP (1:1000, Aves Labs, Inc, OR; 1:1000–10,000, Invitrogen), anti-NPAS4 (1:1000, rabbit, kindly provided by Dr. Michael Greenberg’s lab), anti-CaMKIIα (1:1000, Enzo, NY, 6G9), anti-somatostatin (SST) (1:1000, Millipore MAB354), and anti-parvalbumin (PV) (1:1000, Millipore MAB1572) in blocking buffer at room temperature for 2–4 hr or at 4°C overnight. Following a series of 1× PBS rinses, slices were incubated for 1–3 hr at room temperature with secondary antibodies (donkey anti-rabbit 488, goat anti-mouse 594, donkey anti-mouse Cy3, or donkey anti-chicken 488) while protected from light. Slices were counterstained with Hoechst, mounted, and coverslipped on glass slides using AquaMount (Thermo Scientific, MA) or ProlongGold (Thermo Scientific, MA) and analyzed with confocal microscopy (Zeiss LSM 880). The expression level of NPAS4 protein in each cell was measured using ImageJ software in CaMKIIα-positive cells under experimenter-blinded conditions.</p></sec><sec id="s4-8"><title>Social interaction assay</title><p>Social interaction (SI) assay was performed as previously described (<xref ref-type="bibr" rid="bib33">Golden et al., 2011</xref>; <xref ref-type="bibr" rid="bib50">Krishnan et al., 2007</xref>). The social interaction assay was performed 24 hr after the last CSDS procedure. The assay was performed in an open-field arena (44 cm × 44 cm) with the social target’s holding cage. The time mice spent in the interaction zone (8 cm from the social target) was examined for 5 min in the absence and then the presence of a novel CD1 mouse, of which the experimental animal never met, under dim red light using AnyMaze 5.1 (Stoelting Co, Wood Dale) or Ethovision 3.0 software (Noldus, Leesburg, VA). The social interaction ratio was calculated as the time spent in the social interaction zone in the presence of an interaction partner divided by the time in the absence.</p></sec><sec id="s4-9"><title>Sucrose preference test</title><p>The sucrose preference procedure was performed as previously described (<xref ref-type="bibr" rid="bib91">Taniguchi et al., 2012</xref>). Single-housed mice were provided with Division of Laboratory Animal Resources-approved tap water in two identical double-ball-bearing sipper-style bottles for 2 days, followed by 2 days of 1% (w/v) sucrose solution in tap water to allow for acclimation. Mice were then given one bottle containing tap water and another containing the 1% sucrose solution. Consumption from each bottle was measured every 24 hr for 4 days, and bottle positions were swapped each day to avoid potential side bias. The sucrose preference was calculated by percentage of 1% sucrose consumption volume divided by total liquid consumption volume (sucrose + tap water). Measurement of liquid consumption volume was performed with experimenters blinded to conditions.</p></sec><sec id="s4-10"><title>Elevated plus maze</title><p>The elevated plus maze (EPM) was conducted under the bright light (80 Lux at the closed arm) as previously performed (<xref ref-type="bibr" rid="bib92">Taniguchi et al., 2017</xref>). Mice were positioned in the center of the maze, and behavior was recorded by video tracking using AnyMaze 5.1 or Ethovision 3.0 software as previously performed (<xref ref-type="bibr" rid="bib69">Penrod et al., 2019</xref>). The time spent in the open arms was recorded for 5 min.</p></sec><sec id="s4-11"><title>Sucrose self-administration assay</title><p>Sucrose self-administration was conducted for 2 hr at the same time each day for 9–10 days of acquisition training, followed by a progressive ratio schedule as described previously (<xref ref-type="bibr" rid="bib92">Taniguchi et al., 2017</xref>). Briefly, sucrose availability was signaled both by the house light and a light above the active nosepoke hole. Following a poke in the active hole, both availability lights went off and a cue light inside the nose poke hole was illuminated. Sucrose pellets were delivered immediately upon the active nosepoke, followed by a 10 s time-out period. Nose pokes in the inactive hole were without programmed consequences. During a progressive ratio schedule of reinforcement, the requirements for a sucrose delivery were increased on a subsequent sucrose delivery in an exponential manner. Animals were allowed to self-administer until they failed to earn a sucrose pellet in a 60 min time frame. The last sucrose pellet achieved is reported as an indicator of how much animals consumed before reaching breakpoint.</p></sec><sec id="s4-12"><title>Dendritic spine morphometric analyses</title><p>Mouse brains were collected with rapid live decapitation 24 hr after the social interaction assay and fixed overnight in 4% PFA in 1× PB, then transferred to a 30% sucrose solution in 1× PB before slicing (40 μm) with a vibratome. Deep layer eGFP-expressing pyramidal neurons in the prelimbic cortex were sampled for dendritic spine analyses as described previously (<xref ref-type="bibr" rid="bib86">Siemsen et al., 2019</xref>). Briefly, proximal apical dendrites were imaged with a Leica SP8 laser scanning confocal microscope equipped with HyD detectors for enhanced sensitivity. Dendritic spine segments were selected only if they satisfied the following criteria: (1) could clearly be traced back to a cell body of origin, (2) were not obfuscated by other dendrites, and (3) were proximal to the branch point separating the apical tuft from the proximal apical dendrite. Images were collected with a ×63 oil immersion objective (1.4 N.A.) at 1024 × 1024 frame size, 4.1× digital zoom, and a 0.1 µm Z-step size (0.04 × 0.04 × 0.1 µm voxel size). Pinhole was set at 0.8 airy units and held constant. Laser power and gain were empirically determined and then held relatively constant, only adjusting to avoid saturated voxels. Huygens Software (Scientific Volume Imaging, Hilversum, NL) was used to deconvolve 3D Z-stacks. Deconvolved Z-stacks were then imported into Imaris (version 9.0.1) software (Bitplane, Zurich, CH). The filament tool was then used to trace and assign the dendrite shaft. Dendritic spines were then semi-automatically traced using the autopath function, and an automatic threshold was used to determine dendritic spine head diameter. Variables exported included the average spine head diameter (in µm) as well as the number of dendritic spines per µm of dendrite (spine density). 3–10 segments were sampled per animal, and the average spine head diameter and the spine density were calculated for each segment. Data for each variable was then expressed as number of spine segments/number of animals. All analyses were performed under experimenter-blinded conditions.</p></sec><sec id="s4-13"><title>Electrophysiology</title><p>All acute-slice electrophysiological experiments were performed in SC and <italic>Npas4</italic> shRNA<sup>PFC</sup> mice at 12–14 weeks old. Acute coronal slices (300 μm thickness) containing mPFC were prepared in a semi-frozen 300 mOsM dissection solution containing (in mM): 100.0 choline chloride, 2.5 KCl, 1.25 Na<sub>2</sub>H<sub>2</sub>PO<sub>4</sub>, 25.0 NaHCO<sub>3</sub>, 25.0 D-glucose, 3.1 Na-pyruvate, 9.0 Na-ascorbate, 7.0 MgCl<sub>2</sub>, 0.5 CaCl<sub>2</sub> and 5.0 kynurenic acid (pH 7.4) and was continually equilibrated with 95% O<sub>2</sub> and 5% CO<sub>2</sub> prior to and during the slicing procedure. Slices were transferred to a 315 mOsM normal artificial cerebrospinal fluid (ACSF) solution containing (in mM): 127.0 NaCl, 2.5 KCl, 1.2 Na<sub>2</sub>H<sub>2</sub>PO4, 24.0 NaHCO<sub>3</sub>, 11.0 D-glucose, 1.2 MgCl<sub>2</sub>, 2.4 CaCl<sub>2</sub>, and 0.4 Na-ascorbate (pH 7.4) to recover at 37°C for 30 min, and then transferred to room temperature ACSF for an additional 30 min prior to recording.</p><p>mPFC pyramidal neurons of layer 5 were visualized with infrared differential interference contrast optics (DIC/infrared optics) and identified by their location, apical dendrites, and spiking patterns in response to depolarizing current injection and AAV2-mediated SC shRNA or <italic>Npas4</italic> shRNA expression cells were identified by expression of GFP. Unless stated otherwise, all electrophysiological experiments were performed in whole-cell voltage-clamp mode at –70 mV using borosilicate pipettes (4–6 MΩ) made on NARISHIGE puller (NARISHIGE, PG10) from borosilicate tubing (Sutter Instruments) and filled by an internal solution containing (in mM): 140.0 CsMetSO<sub>4</sub>, 5.0 KCl, 1.0 MgCl<sub>2</sub>, 0.2 EGTA, 11 HEPES, 2 NaATP, 0.2 Na<sub>2</sub>GTP (pH 7.2; 290–295 mOsm).</p><p>The AMPA-receptor-mediated mEPSCs were recorded in the presence of 100 μM picrotoxin (GABAARs antagonist, Sigma-Aldrich) and TTX (sodium channels blocker, Sigma-Aldrich). Data were recorded in a series of 10 traces (sweeps), 10 s each. At the beginning of each sweep, a depolarizing step (4 mV for 100ms) was generated to monitor series (10–40 MΩ) and input resistance (&gt;400 MΩ). To analyze data, synaptic events were detected via custom parameters in MiniAnalysis software (Synaptosoft, Decatur, GA) and subsequently confirmed by the observer blinded to the experimental conditions. Data were measured until 700 events in a series were analyzed, or until the maximal duration of the series.</p><p>Paired EPSC for PPR measurements were generated at –70 mV with the inter-stimulus interval of 50 ms at frequency of 0.05 Hz – 3 stimulus in 1 min. The peak amplitude of the second EPSC (P2) was divided by the peak of the first amplitude (P1) to generate the PPR (P2/P1).</p><p>All data (recordings) were acquired and analyzed by amplifier AXOPATCH 200B (Axon Instruments), digitizer BNC2090 (National instruments), and software AxoGraph v1.7.0, Clampfit v8.0 (pClamp, Molecular Devices), and MiniAnalysis Program v6.0.9 (Synaptosoft). Data were filtered at 2 kHz via AXOPATCH 200B amplifier (Axon Instruments) and digitized at 20 kHz via AxoGraph v1.7.0.</p></sec><sec id="s4-14"><title>RNA-seq and bioinformatic analysis</title><p>Total RNA was isolated from AAV2-mediated eGFP-positive mPFC slices using the QIAGEN RNA purification kit, as described above. Sequencing was performed by BGI genomics using PolyA mRNA isolation, directional RNA-seq library preparation, and a BIGSeq-500 sequencer. Reads were aligned to the mouse mm10 reference genome using STAR (v2.7.1a) (<xref ref-type="bibr" rid="bib21">Dobin et al., 2013</xref>). Only uniquely mapped reads were retained for further analyses. Quality control metrics were assessed by Picard tool (RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_006525">SCR_006525</ext-link>) (<ext-link ext-link-type="uri" xlink:href="http://broadinstitute.github.io/picard/">http://broadinstitute.github.io/picard/</ext-link>). Gencode annotation for mm10 (version M21) was used as reference alignment annotation and downstream quantification. Gene-level expression was calculated using HTseq (v0.9.1) (<xref ref-type="bibr" rid="bib2">Anders et al., 2015</xref>) using the intersection-strict mode by exon. Counts were calculated based on protein-coding genes from the annotation file.</p></sec><sec id="s4-15"><title>Differential gene expression</title><p>Counts were normalized using counts per million reads (CPM). Genes with no reads were removed. Differential expression analysis was performed in R using linear modeling as following: lm(gene expression ~ Treatment + Batch). We estimated log2 fold changes and p-values. p-Values were adjusted for multiple comparisons using a Benjamini–Hochberg correction (FDR). Differentially expressed genes were analyzed at FDR &lt;0.05. Mouse Gene IDs were translated into Human Gene IDs using the biomaRt package (v2.46.0) in R (<xref ref-type="bibr" rid="bib24">Durinck et al., 2009</xref>).</p></sec><sec id="s4-16"><title>Gene ontology analyses</title><p>The functional annotation of differentially expressed and co-expressed genes was performed using GOstats (<xref ref-type="bibr" rid="bib25">Falcon and Gentleman, 2007</xref>). A Benjamini–Hochberg FDR (FDR &lt;0.05) was applied as a multiple comparison adjustment.</p></sec><sec id="s4-17"><title>Gene set enrichment</title><p>Gene set enrichment was performed in R using Fisher’s exact test with the following parameters: alternative = ‘greater,’ confidence level = 0.95. We reported odds ratio (OR) and Benjamini–Hochberg adjusted p-values (FDR).</p></sec><sec id="s4-18"><title>Statistics</title><p>One-way, two-way, and three-way analyses of variance (ANOVAs) with or without repeated-measures (RM) were used, followed by Bonferroni or Tukey post hoc tests when a significant interaction was revealed, to analyze mRNA expression, number of NPAS4 (+) cells, NPAS4 protein expression in each cell, percentage of CaMKIIα(+) cells, social interaction, social aversion, sucrose preference, elevated plus maze, sucrose self-administration acquisition and discrimination, dendritic spine morphometric data, and breakpoint in the progressive ratio test. All statistics were performed using GraphPad Prism, except SPSS software was used to handle complex datasets (e.g., three-way ANOVAs). Statistical outliers were detected using a Grubbs test and excluded from analysis. All data are presented as the mean ± SEM. Significance was shown as *p&lt;0.05, **p&lt;0.01, ***p&lt;0.001, ****p&lt;0.0001, and nonsignificant values were either not noted or shown as n.s.</p></sec></sec></body><back><sec sec-type="additional-information" id="s5"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn><fn fn-type="COI-statement" id="conf2"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Data curation, Formal analysis, Validation, Investigation, Methodology, Writing - original draft, Writing - review and editing</p></fn><fn fn-type="con" id="con2"><p>Data curation, Investigation, Methodology</p></fn><fn fn-type="con" id="con3"><p>Data curation, Formal analysis, conducted the electrophysiology recording experiments and analyzed the data for Figure 4C-4H in the revision</p></fn><fn fn-type="con" id="con4"><p>Data curation</p></fn><fn fn-type="con" id="con5"><p>Data curation, Methodology</p></fn><fn fn-type="con" id="con6"><p>Data curation, Investigation</p></fn><fn fn-type="con" id="con7"><p>Data curation, Investigation</p></fn><fn fn-type="con" id="con8"><p>Data curation, conducted the single nuclei RNA-seq sample preparations for Figure 1A-1D in the revision</p></fn><fn fn-type="con" id="con9"><p>Data curation</p></fn><fn fn-type="con" id="con10"><p>Data curation, conducted an immunohistochemistry experiment and analyzed the data for Figure 1H in the revision</p></fn><fn fn-type="con" id="con11"><p>Data curation, conducted the single nuclei RNA-seq sample preparations for Figure 1A-1D in the revision</p></fn><fn fn-type="con" id="con12"><p>Data curation, Investigation, Methodology</p></fn><fn fn-type="con" id="con13"><p>Conceptualization, Formal analysis, Supervision, Funding acquisition, Writing - original draft, Project administration, Writing - review and editing</p></fn><fn fn-type="con" id="con14"><p>Conceptualization, Resources, Data curation, Formal analysis, Supervision, Funding acquisition, Validation, Investigation, Visualization, Methodology, Writing - original draft, Project administration, Writing - review and editing</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>All experimental procedures were in accordance with Institutional Animal Care and Use (IACUC) guidelines and approved protocols #01156 of the Medical University of South Carolina.</p></fn></fn-group></sec><sec sec-type="supplementary-material" id="s6"><title>Additional files</title><supplementary-material id="supp1"><label>Supplementary file 1.</label><caption><title>RNA-seq data Related to <xref ref-type="fig" rid="fig5">Figure 5</xref>.</title></caption><media xlink:href="elife-75631-supp1-v1.xlsx" mimetype="application" mime-subtype="xlsx"/></supplementary-material><supplementary-material id="transrepform"><label>Transparent reporting form</label><media xlink:href="elife-75631-transrepform1-v1.pdf" mimetype="application" mime-subtype="pdf"/></supplementary-material><supplementary-material id="sdata1"><label>Source data 1.</label><caption><title>Detailed statistics information related to <xref ref-type="fig" rid="fig1">Figures 1</xref>—<xref ref-type="fig" rid="fig5">5</xref> and figure supplements.</title></caption><media xlink:href="elife-75631-data1-v1.xlsx" mimetype="application" mime-subtype="xlsx"/></supplementary-material></sec><sec sec-type="data-availability" id="s7"><title>Data availability</title><p>Sequencing data have been deposited in GEO under accession codes GSE165586. The data access is limited until the finding is accepted for publication.</p><p>The following dataset was generated:</p><p><element-citation publication-type="data" specific-use="isSupplementedBy" id="dataset1"><person-group person-group-type="author"><name><surname>Taniguchi</surname><given-names>M</given-names></name><name><surname>Hughes</surname><given-names>B</given-names></name><name><surname>Cowan</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2021">2021</year><data-title>RNA sequencing approaches to identify the differential expression gene in the mPFC with AAV-mediated Npas4 shRNA expression</data-title><source>NCBI Gene Expression Omnibus</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE165586">GSE165586</pub-id></element-citation></p><p>The following previously published datasets were used:</p><p><element-citation publication-type="data" specific-use="references" id="dataset2"><person-group person-group-type="author"><name><surname>Labonte</surname><given-names>B</given-names></name><name><surname>Engmann</surname><given-names>O</given-names></name><name><surname>Purushothaman</surname><given-names>I</given-names></name><name><surname>Ménard</surname><given-names>C</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Tan</surname><given-names>C</given-names></name><name><surname>Scarpa</surname><given-names>JR</given-names></name><name><surname>Moy</surname><given-names>G</given-names></name><name><surname>Loh</surname><given-names>YE</given-names></name><name><surname>Cahill</surname><given-names>M</given-names></name><name><surname>Lorsch</surname><given-names>ZS</given-names></name><name><surname>Hamilton</surname><given-names>PJ</given-names></name><name><surname>Calipari</surname><given-names>ES</given-names></name><name><surname>Hodes</surname><given-names>GE</given-names></name><name><surname>Issler</surname><given-names>O</given-names></name><name><surname>Kronman</surname><given-names>H</given-names></name><name><surname>Pfau</surname><given-names>M</given-names></name><name><surname>Obradovic</surname><given-names>A</given-names></name><name><surname>Dong</surname><given-names>Y</given-names></name><name><surname>Neve</surname><given-names>RL</given-names></name><name><surname>Russo</surname><given-names>S</given-names></name><name><surname>Kazarskis</surname><given-names>A</given-names></name><name><surname>Tamminga</surname><given-names>C</given-names></name><name><surname>Mechawar</surname><given-names>N</given-names></name><name><surname>Turecki</surname><given-names>G</given-names></name><name><surname>Zhang</surname><given-names>B</given-names></name><name><surname>Shen</surname><given-names>L</given-names></name><name><surname>Nestler</surname><given-names>EJ</given-names></name></person-group><year iso-8601-date="2017">2017</year><data-title>Sex-specific Transcriptional Signatures in Human Depression</data-title><source>NCBI Gene Expression Omnibus</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE102556">GSE102556</pub-id></element-citation></p><p><element-citation publication-type="data" specific-use="references" id="dataset3"><person-group person-group-type="author"><name><surname>Brigidi</surname><given-names>GS</given-names></name><name><surname>Hayes</surname><given-names>MGB</given-names></name><name><surname>Delos Santos</surname><given-names>NP</given-names></name><name><surname>Hartzell</surname><given-names>AL</given-names></name><name><surname>Texari</surname><given-names>L</given-names></name><name><surname>Lin</surname><given-names>PA</given-names></name><name><surname>Bartlett</surname><given-names>A</given-names></name><name><surname>Ecker</surname><given-names>JR</given-names></name><name><surname>Benner</surname><given-names>C</given-names></name><name><surname>Heinz</surname><given-names>S</given-names></name><name><surname>Bloodgood</surname><given-names>BL</given-names></name></person-group><year iso-8601-date="2019">2019</year><data-title>Characterization of Npas4 and heterodimer DNA binding in stimulated and silenced rat neurons</data-title><source>NCBI Gene Expression Omnibus</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE127793">GSE127793</pub-id></element-citation></p><p><element-citation publication-type="data" specific-use="references" id="dataset4"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>TK</given-names></name><name><surname>Hemberg</surname><given-names>M</given-names></name><name><surname>Gray</surname><given-names>JM</given-names></name><name><surname>Costa</surname><given-names>AM</given-names></name><name><surname>Bear</surname><given-names>DM</given-names></name><name><surname>Wu</surname><given-names>J</given-names></name><name><surname>Harmin</surname><given-names>DA</given-names></name><name><surname>Laptewicz</surname><given-names>M</given-names></name><name><surname>Barbara-Haley</surname><given-names>K</given-names></name><name><surname>Kuersten</surname><given-names>S</given-names></name><name><surname>Markenscoff-Papadimitriou</surname><given-names>E</given-names></name><name><surname>Kuhl</surname><given-names>D</given-names></name><name><surname>Bito</surname><given-names>H</given-names></name><name><surname>Worley</surname><given-names>PF</given-names></name><name><surname>Kreiman</surname><given-names>G</given-names></name><name><surname>Greenberg</surname><given-names>ME</given-names></name></person-group><year iso-8601-date="2010">2010</year><data-title>Widespread transcription at neuronal activity-regulated enhancers</data-title><source>NCBI Gene Expression Omnibus</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE21161">GSE21161</pub-id></element-citation></p></sec><ack id="ack"><title>Acknowledgements</title><p>The authors thank Yingxi Lin, Rachel Penrod, Laura Smith, Yuhong Guo, Ben Zirlin, and Sara Pilling in the Taniguchi and Cowan lab for technical assistance, comments on the manuscript, and helpful discussions. BWH was supported by an NIH predoctoral fellowship (F31 DA048557 and T32 DA07288). BMS was supported by an NIH postdoctoral fellowship (F32 DA050427). MT was supported by a NARSAD Young Investigator Award from the Brain &amp; Behavior Research Foundation (Grant #22765). This work was supported by grants from the NIH (UL1 TR001450 to MT, R01 DA032708 to CWC, and DA046373 to CWC and MT).</p></ack><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="book"><person-group person-group-type="author"><collab>American Psychiatric Association</collab></person-group><year iso-8601-date="2013">2013</year><source>Diagnostic and Statistical Manual of Mental Disorders</source><publisher-name>American Psychiatric Pub</publisher-name><pub-id pub-id-type="doi">10.1176/appi.books.9780890425596</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anders</surname><given-names>S</given-names></name><name><surname>Pyl</surname><given-names>PT</given-names></name><name><surname>Huber</surname><given-names>W</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>HTSeq -- a python framework to work with high-throughput sequencing data</article-title><source>Bioinformatics</source><volume>31</volume><fpage>166</fpage><lpage>169</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btu638</pub-id><pub-id pub-id-type="pmid">25260700</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arnsten</surname><given-names>AFT</given-names></name><name><surname>Raskind</surname><given-names>MA</given-names></name><name><surname>Taylor</surname><given-names>FB</given-names></name><name><surname>Connor</surname><given-names>DF</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>The effects of stress exposure on prefrontal cortex: translating basic research into successful treatments for post-traumatic stress disorder</article-title><source>Neurobiology of Stress</source><volume>1</volume><fpage>89</fpage><lpage>99</lpage><pub-id pub-id-type="doi">10.1016/j.ynstr.2014.10.002</pub-id><pub-id pub-id-type="pmid">25436222</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bagot</surname><given-names>RC</given-names></name><name><surname>Cates</surname><given-names>HM</given-names></name><name><surname>Purushothaman</surname><given-names>I</given-names></name><name><surname>Lorsch</surname><given-names>ZS</given-names></name><name><surname>Walker</surname><given-names>DM</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Huang</surname><given-names>X</given-names></name><name><surname>Schlüter</surname><given-names>OM</given-names></name><name><surname>Maze</surname><given-names>I</given-names></name><name><surname>Peña</surname><given-names>CJ</given-names></name><name><surname>Heller</surname><given-names>EA</given-names></name><name><surname>Issler</surname><given-names>O</given-names></name><name><surname>Wang</surname><given-names>M</given-names></name><name><surname>Song</surname><given-names>W-M</given-names></name><name><surname>Stein</surname><given-names>JL</given-names></name><name><surname>Liu</surname><given-names>X</given-names></name><name><surname>Doyle</surname><given-names>MA</given-names></name><name><surname>Scobie</surname><given-names>KN</given-names></name><name><surname>Sun</surname><given-names>HS</given-names></name><name><surname>Neve</surname><given-names>RL</given-names></name><name><surname>Geschwind</surname><given-names>D</given-names></name><name><surname>Dong</surname><given-names>Y</given-names></name><name><surname>Shen</surname><given-names>L</given-names></name><name><surname>Zhang</surname><given-names>B</given-names></name><name><surname>Nestler</surname><given-names>EJ</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Circuit-wide transcriptional profiling reveals brain region-specific gene networks regulating depression susceptibility</article-title><source>Neuron</source><volume>90</volume><fpage>969</fpage><lpage>983</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2016.04.015</pub-id><pub-id pub-id-type="pmid">27181059</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berton</surname><given-names>O</given-names></name><name><surname>McClung</surname><given-names>CA</given-names></name><name><surname>Dileone</surname><given-names>RJ</given-names></name><name><surname>Krishnan</surname><given-names>V</given-names></name><name><surname>Renthal</surname><given-names>W</given-names></name><name><surname>Russo</surname><given-names>SJ</given-names></name><name><surname>Graham</surname><given-names>D</given-names></name><name><surname>Tsankova</surname><given-names>NM</given-names></name><name><surname>Bolanos</surname><given-names>CA</given-names></name><name><surname>Rios</surname><given-names>M</given-names></name><name><surname>Monteggia</surname><given-names>LM</given-names></name><name><surname>Self</surname><given-names>DW</given-names></name><name><surname>Nestler</surname><given-names>EJ</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Essential role of BDNF in the mesolimbic dopamine pathway in social defeat stress</article-title><source>Science</source><volume>311</volume><fpage>864</fpage><lpage>868</lpage><pub-id pub-id-type="doi">10.1126/science.1120972</pub-id><pub-id pub-id-type="pmid">16469931</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bloodgood</surname><given-names>BL</given-names></name><name><surname>Sharma</surname><given-names>N</given-names></name><name><surname>Browne</surname><given-names>HA</given-names></name><name><surname>Trepman</surname><given-names>AZ</given-names></name><name><surname>Greenberg</surname><given-names>ME</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>The activity-dependent transcription factor NPAS4 regulates domain-specific inhibition</article-title><source>Nature</source><volume>503</volume><fpage>121</fpage><lpage>125</lpage><pub-id pub-id-type="doi">10.1038/nature12743</pub-id><pub-id pub-id-type="pmid">24201284</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brigidi</surname><given-names>GS</given-names></name><name><surname>Hayes</surname><given-names>MGB</given-names></name><name><surname>Delos Santos</surname><given-names>NP</given-names></name><name><surname>Hartzell</surname><given-names>AL</given-names></name><name><surname>Texari</surname><given-names>L</given-names></name><name><surname>Lin</surname><given-names>P-A</given-names></name><name><surname>Bartlett</surname><given-names>A</given-names></name><name><surname>Ecker</surname><given-names>JR</given-names></name><name><surname>Benner</surname><given-names>C</given-names></name><name><surname>Heinz</surname><given-names>S</given-names></name><name><surname>Bloodgood</surname><given-names>BL</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Genomic decoding of neuronal depolarization by stimulus-specific NPAS4 heterodimers</article-title><source>Cell</source><volume>179</volume><fpage>373</fpage><lpage>391</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2019.09.004</pub-id><pub-id pub-id-type="pmid">31585079</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brown</surname><given-names>SM</given-names></name><name><surname>Henning</surname><given-names>S</given-names></name><name><surname>Wellman</surname><given-names>CL</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Mild, short-term stress alters dendritic morphology in rat medial prefrontal cortex</article-title><source>Cerebral Cortex</source><volume>15</volume><fpage>1714</fpage><lpage>1722</lpage><pub-id pub-id-type="doi">10.1093/cercor/bhi048</pub-id><pub-id pub-id-type="pmid">15703248</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Capuzzo</surname><given-names>G</given-names></name><name><surname>Floresco</surname><given-names>SB</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Prelimbic and infralimbic prefrontal regulation of active and inhibitory avoidance and reward-seeking</article-title><source>The Journal of Neuroscience</source><volume>40</volume><fpage>4773</fpage><lpage>4787</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.0414-20.2020</pub-id><pub-id pub-id-type="pmid">32393535</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cerqueira</surname><given-names>JJ</given-names></name><name><surname>Taipa</surname><given-names>R</given-names></name><name><surname>Uylings</surname><given-names>HBM</given-names></name><name><surname>Almeida</surname><given-names>OFX</given-names></name><name><surname>Sousa</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Specific configuration of dendritic degeneration in pyramidal neurons of the medial prefrontal cortex induced by differing corticosteroid regimens</article-title><source>Cerebral Cortex</source><volume>17</volume><fpage>1998</fpage><lpage>2006</lpage><pub-id pub-id-type="doi">10.1093/cercor/bhl108</pub-id><pub-id pub-id-type="pmid">17082516</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>C</given-names></name><name><surname>Takahashi</surname><given-names>T</given-names></name><name><surname>Nakagawa</surname><given-names>S</given-names></name><name><surname>Inoue</surname><given-names>T</given-names></name><name><surname>Kusumi</surname><given-names>I</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Reinforcement learning in depression: a review of computational research</article-title><source>Neuroscience and Biobehavioral Reviews</source><volume>55</volume><fpage>247</fpage><lpage>267</lpage><pub-id pub-id-type="doi">10.1016/j.neubiorev.2015.05.005</pub-id><pub-id pub-id-type="pmid">25979140</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Christoffel</surname><given-names>DJ</given-names></name><name><surname>Golden</surname><given-names>SA</given-names></name><name><surname>Russo</surname><given-names>SJ</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Structural and synaptic plasticity in stress-related disorders</article-title><source>Reviews in the Neurosciences</source><volume>22</volume><fpage>535</fpage><lpage>549</lpage><pub-id pub-id-type="doi">10.1515/RNS.2011.044</pub-id><pub-id pub-id-type="pmid">21967517</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Colyn</surname><given-names>L</given-names></name><name><surname>Venzala</surname><given-names>E</given-names></name><name><surname>Marco</surname><given-names>S</given-names></name><name><surname>Perez-Otaño</surname><given-names>I</given-names></name><name><surname>Tordera</surname><given-names>RM</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Chronic social defeat stress induces sustained synaptic structural changes in the prefrontal cortex and amygdala</article-title><source>Behavioural Brain Research</source><volume>373</volume><elocation-id>112079</elocation-id><pub-id pub-id-type="doi">10.1016/j.bbr.2019.112079</pub-id><pub-id pub-id-type="pmid">31301411</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cook</surname><given-names>SC</given-names></name><name><surname>Wellman</surname><given-names>CL</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Chronic stress alters dendritic morphology in rat medial prefrontal cortex</article-title><source>Journal of Neurobiology</source><volume>60</volume><fpage>236</fpage><lpage>248</lpage><pub-id pub-id-type="doi">10.1002/neu.20025</pub-id><pub-id pub-id-type="pmid">15266654</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Covington</surname><given-names>HE</given-names></name><name><surname>Kikusui</surname><given-names>T</given-names></name><name><surname>Goodhue</surname><given-names>J</given-names></name><name><surname>Nikulina</surname><given-names>EM</given-names></name><name><surname>Hammer</surname><given-names>RP</given-names></name><name><surname>Miczek</surname><given-names>KA</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Brief social defeat stress: long lasting effects on cocaine taking during a binge and zif268 mrna expression in the amygdala and prefrontal cortex</article-title><source>Neuropsychopharmacology</source><volume>30</volume><fpage>310</fpage><lpage>321</lpage><pub-id pub-id-type="doi">10.1038/sj.npp.1300587</pub-id><pub-id pub-id-type="pmid">15496936</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Covington</surname><given-names>HE</given-names></name><name><surname>Maze</surname><given-names>I</given-names></name><name><surname>LaPlant</surname><given-names>QC</given-names></name><name><surname>Vialou</surname><given-names>VF</given-names></name><name><surname>Ohnishi</surname><given-names>YN</given-names></name><name><surname>Berton</surname><given-names>O</given-names></name><name><surname>Fass</surname><given-names>DM</given-names></name><name><surname>Renthal</surname><given-names>W</given-names></name><name><surname>Rush</surname><given-names>AJ</given-names></name><name><surname>Wu</surname><given-names>EY</given-names></name><name><surname>Ghose</surname><given-names>S</given-names></name><name><surname>Krishnan</surname><given-names>V</given-names></name><name><surname>Russo</surname><given-names>SJ</given-names></name><name><surname>Tamminga</surname><given-names>C</given-names></name><name><surname>Haggarty</surname><given-names>SJ</given-names></name><name><surname>Nestler</surname><given-names>EJ</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Antidepressant actions of histone deacetylase inhibitors</article-title><source>The Journal of Neuroscience</source><volume>29</volume><fpage>11451</fpage><lpage>11460</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.1758-09.2009</pub-id><pub-id pub-id-type="pmid">19759294</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Covington</surname><given-names>HE</given-names></name><name><surname>Lobo</surname><given-names>MK</given-names></name><name><surname>Maze</surname><given-names>I</given-names></name><name><surname>Vialou</surname><given-names>V</given-names></name><name><surname>Hyman</surname><given-names>JM</given-names></name><name><surname>Zaman</surname><given-names>S</given-names></name><name><surname>LaPlant</surname><given-names>Q</given-names></name><name><surname>Mouzon</surname><given-names>E</given-names></name><name><surname>Ghose</surname><given-names>S</given-names></name><name><surname>Tamminga</surname><given-names>CA</given-names></name><name><surname>Neve</surname><given-names>RL</given-names></name><name><surname>Deisseroth</surname><given-names>K</given-names></name><name><surname>Nestler</surname><given-names>EJ</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Antidepressant effect of optogenetic stimulation of the medial prefrontal cortex</article-title><source>The Journal of Neuroscience</source><volume>30</volume><fpage>16082</fpage><lpage>16090</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.1731-10.2010</pub-id><pub-id pub-id-type="pmid">21123555</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dantzer</surname><given-names>R</given-names></name><name><surname>Cohen</surname><given-names>S</given-names></name><name><surname>Russo</surname><given-names>SJ</given-names></name><name><surname>Dinan</surname><given-names>TG</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Resilience and immunity</article-title><source>Brain, Behavior, and Immunity</source><volume>74</volume><fpage>28</fpage><lpage>42</lpage><pub-id pub-id-type="doi">10.1016/j.bbi.2018.08.010</pub-id><pub-id pub-id-type="pmid">30102966</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Darby</surname><given-names>MM</given-names></name><name><surname>Yolken</surname><given-names>RH</given-names></name><name><surname>Sabunciyan</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Consistently altered expression of gene sets in postmortem brains of individuals with major psychiatric disorders</article-title><source>Translational Psychiatry</source><volume>6</volume><elocation-id>e890</elocation-id><pub-id pub-id-type="doi">10.1038/tp.2016.173</pub-id><pub-id pub-id-type="pmid">27622934</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Der-Avakian</surname><given-names>A</given-names></name><name><surname>Markou</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>The neurobiology of anhedonia and other reward-related deficits</article-title><source>Trends in Neurosciences</source><volume>35</volume><fpage>68</fpage><lpage>77</lpage><pub-id pub-id-type="doi">10.1016/j.tins.2011.11.005</pub-id><pub-id pub-id-type="pmid">22177980</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dobin</surname><given-names>A</given-names></name><name><surname>Davis</surname><given-names>CA</given-names></name><name><surname>Schlesinger</surname><given-names>F</given-names></name><name><surname>Drenkow</surname><given-names>J</given-names></name><name><surname>Zaleski</surname><given-names>C</given-names></name><name><surname>Jha</surname><given-names>S</given-names></name><name><surname>Batut</surname><given-names>P</given-names></name><name><surname>Chaisson</surname><given-names>M</given-names></name><name><surname>Gingeras</surname><given-names>TR</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Star: ultrafast universal RNA-seq aligner</article-title><source>Bioinformatics</source><volume>29</volume><fpage>15</fpage><lpage>21</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/bts635</pub-id><pub-id pub-id-type="pmid">23104886</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Duman</surname><given-names>CH</given-names></name><name><surname>Duman</surname><given-names>RS</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Spine synapse remodeling in the pathophysiology and treatment of depression</article-title><source>Neuroscience Letters</source><volume>601</volume><fpage>20</fpage><lpage>29</lpage><pub-id pub-id-type="doi">10.1016/j.neulet.2015.01.022</pub-id><pub-id pub-id-type="pmid">25582786</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Duman</surname><given-names>RS</given-names></name><name><surname>Aghajanian</surname><given-names>GK</given-names></name><name><surname>Sanacora</surname><given-names>G</given-names></name><name><surname>Krystal</surname><given-names>JH</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Synaptic plasticity and depression: new insights from stress and rapid-acting antidepressants</article-title><source>Nature Medicine</source><volume>22</volume><fpage>238</fpage><lpage>249</lpage><pub-id pub-id-type="doi">10.1038/nm.4050</pub-id><pub-id pub-id-type="pmid">26937618</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Durinck</surname><given-names>S</given-names></name><name><surname>Spellman</surname><given-names>PT</given-names></name><name><surname>Birney</surname><given-names>E</given-names></name><name><surname>Huber</surname><given-names>W</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Mapping identifiers for the integration of genomic datasets with the R/bioconductor package biomart</article-title><source>Nature Protocols</source><volume>4</volume><fpage>1184</fpage><lpage>1191</lpage><pub-id pub-id-type="doi">10.1038/nprot.2009.97</pub-id><pub-id pub-id-type="pmid">19617889</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Falcon</surname><given-names>S</given-names></name><name><surname>Gentleman</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Using gostats to test gene lists for go term association</article-title><source>Bioinformatics</source><volume>23</volume><fpage>257</fpage><lpage>258</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btl567</pub-id><pub-id pub-id-type="pmid">17098774</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Forrest</surname><given-names>MP</given-names></name><name><surname>Parnell</surname><given-names>E</given-names></name><name><surname>Penzes</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Dendritic structural plasticity and neuropsychiatric disease</article-title><source>Nature Reviews. Neuroscience</source><volume>19</volume><fpage>215</fpage><lpage>234</lpage><pub-id pub-id-type="doi">10.1038/nrn.2018.16</pub-id><pub-id pub-id-type="pmid">29545546</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Frankish</surname><given-names>A</given-names></name><name><surname>Diekhans</surname><given-names>M</given-names></name><name><surname>Jungreis</surname><given-names>I</given-names></name><name><surname>Lagarde</surname><given-names>J</given-names></name><name><surname>Loveland</surname><given-names>JE</given-names></name><name><surname>Mudge</surname><given-names>JM</given-names></name><name><surname>Sisu</surname><given-names>C</given-names></name><name><surname>Wright</surname><given-names>JC</given-names></name><name><surname>Armstrong</surname><given-names>J</given-names></name><name><surname>Barnes</surname><given-names>I</given-names></name><name><surname>Berry</surname><given-names>A</given-names></name><name><surname>Bignell</surname><given-names>A</given-names></name><name><surname>Boix</surname><given-names>C</given-names></name><name><surname>Carbonell Sala</surname><given-names>S</given-names></name><name><surname>Cunningham</surname><given-names>F</given-names></name><name><surname>Di Domenico</surname><given-names>T</given-names></name><name><surname>Donaldson</surname><given-names>S</given-names></name><name><surname>Fiddes</surname><given-names>IT</given-names></name><name><surname>García Girón</surname><given-names>C</given-names></name><name><surname>Gonzalez</surname><given-names>JM</given-names></name><name><surname>Grego</surname><given-names>T</given-names></name><name><surname>Hardy</surname><given-names>M</given-names></name><name><surname>Hourlier</surname><given-names>T</given-names></name><name><surname>Howe</surname><given-names>KL</given-names></name><name><surname>Hunt</surname><given-names>T</given-names></name><name><surname>Izuogu</surname><given-names>OG</given-names></name><name><surname>Johnson</surname><given-names>R</given-names></name><name><surname>Martin</surname><given-names>FJ</given-names></name><name><surname>Martínez</surname><given-names>L</given-names></name><name><surname>Mohanan</surname><given-names>S</given-names></name><name><surname>Muir</surname><given-names>P</given-names></name><name><surname>Navarro</surname><given-names>FCP</given-names></name><name><surname>Parker</surname><given-names>A</given-names></name><name><surname>Pei</surname><given-names>B</given-names></name><name><surname>Pozo</surname><given-names>F</given-names></name><name><surname>Riera</surname><given-names>FC</given-names></name><name><surname>Ruffier</surname><given-names>M</given-names></name><name><surname>Schmitt</surname><given-names>BM</given-names></name><name><surname>Stapleton</surname><given-names>E</given-names></name><name><surname>Suner</surname><given-names>M-M</given-names></name><name><surname>Sycheva</surname><given-names>I</given-names></name><name><surname>Uszczynska-Ratajczak</surname><given-names>B</given-names></name><name><surname>Wolf</surname><given-names>MY</given-names></name><name><surname>Xu</surname><given-names>J</given-names></name><name><surname>Yang</surname><given-names>YT</given-names></name><name><surname>Yates</surname><given-names>A</given-names></name><name><surname>Zerbino</surname><given-names>D</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Choudhary</surname><given-names>JS</given-names></name><name><surname>Gerstein</surname><given-names>M</given-names></name><name><surname>Guigó</surname><given-names>R</given-names></name><name><surname>Hubbard</surname><given-names>TJP</given-names></name><name><surname>Kellis</surname><given-names>M</given-names></name><name><surname>Paten</surname><given-names>B</given-names></name><name><surname>Tress</surname><given-names>ML</given-names></name><name><surname>Flicek</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>GENCODE 2021</article-title><source>Nucleic Acids Research</source><volume>49</volume><fpage>D916</fpage><lpage>D923</lpage><pub-id pub-id-type="doi">10.1093/nar/gkaa1087</pub-id><pub-id pub-id-type="pmid">33270111</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Furukawa-Hibi</surname><given-names>Y</given-names></name><name><surname>Yun</surname><given-names>J</given-names></name><name><surname>Nagai</surname><given-names>T</given-names></name><name><surname>Yamada</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Transcriptional suppression of the neuronal PAS domain 4 (npas4) gene by stress via the binding of agonist-bound glucocorticoid receptor to its promoter</article-title><source>Journal of Neurochemistry</source><volume>123</volume><fpage>866</fpage><lpage>875</lpage><pub-id pub-id-type="doi">10.1111/jnc.12034</pub-id><pub-id pub-id-type="pmid">23020797</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Galynker</surname><given-names>II</given-names></name><name><surname>Cai</surname><given-names>J</given-names></name><name><surname>Ongseng</surname><given-names>F</given-names></name><name><surname>Finestone</surname><given-names>H</given-names></name><name><surname>Dutta</surname><given-names>E</given-names></name><name><surname>Serseni</surname><given-names>D</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>Hypofrontality and negative symptoms in major depressive disorder</article-title><source>Journal of Nuclear Medicine</source><volume>39</volume><fpage>608</fpage><lpage>612</lpage><pub-id pub-id-type="pmid">9544664</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gandal</surname><given-names>MJ</given-names></name><name><surname>Zhang</surname><given-names>P</given-names></name><name><surname>Hadjimichael</surname><given-names>E</given-names></name><name><surname>Walker</surname><given-names>RL</given-names></name><name><surname>Chen</surname><given-names>C</given-names></name><name><surname>Liu</surname><given-names>S</given-names></name><name><surname>Won</surname><given-names>H</given-names></name><name><surname>van Bakel</surname><given-names>H</given-names></name><name><surname>Varghese</surname><given-names>M</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Shieh</surname><given-names>AW</given-names></name><name><surname>Haney</surname><given-names>J</given-names></name><name><surname>Parhami</surname><given-names>S</given-names></name><name><surname>Belmont</surname><given-names>J</given-names></name><name><surname>Kim</surname><given-names>M</given-names></name><name><surname>Moran Losada</surname><given-names>P</given-names></name><name><surname>Khan</surname><given-names>Z</given-names></name><name><surname>Mleczko</surname><given-names>J</given-names></name><name><surname>Xia</surname><given-names>Y</given-names></name><name><surname>Dai</surname><given-names>R</given-names></name><name><surname>Wang</surname><given-names>D</given-names></name><name><surname>Yang</surname><given-names>YT</given-names></name><name><surname>Xu</surname><given-names>M</given-names></name><name><surname>Fish</surname><given-names>K</given-names></name><name><surname>Hof</surname><given-names>PR</given-names></name><name><surname>Warrell</surname><given-names>J</given-names></name><name><surname>Fitzgerald</surname><given-names>D</given-names></name><name><surname>White</surname><given-names>K</given-names></name><name><surname>Jaffe</surname><given-names>AE</given-names></name><collab>PsychENCODE Consortium</collab><name><surname>Peters</surname><given-names>MA</given-names></name><name><surname>Gerstein</surname><given-names>M</given-names></name><name><surname>Liu</surname><given-names>C</given-names></name><name><surname>Iakoucheva</surname><given-names>LM</given-names></name><name><surname>Pinto</surname><given-names>D</given-names></name><name><surname>Geschwind</surname><given-names>DH</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Transcriptome-Wide isoform-level dysregulation in ASD, schizophrenia, and bipolar disorder</article-title><source>Science</source><volume>362</volume><elocation-id>eaat8127</elocation-id><pub-id pub-id-type="doi">10.1126/science.aat8127</pub-id><pub-id pub-id-type="pmid">30545856</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gerhard</surname><given-names>DM</given-names></name><name><surname>Pothula</surname><given-names>S</given-names></name><name><surname>Liu</surname><given-names>R-J</given-names></name><name><surname>Wu</surname><given-names>M</given-names></name><name><surname>Li</surname><given-names>X-Y</given-names></name><name><surname>Girgenti</surname><given-names>MJ</given-names></name><name><surname>Taylor</surname><given-names>SR</given-names></name><name><surname>Duman</surname><given-names>CH</given-names></name><name><surname>Delpire</surname><given-names>E</given-names></name><name><surname>Picciotto</surname><given-names>M</given-names></name><name><surname>Wohleb</surname><given-names>ES</given-names></name><name><surname>Duman</surname><given-names>RS</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Gaba interneurons are the cellular trigger for ketamine’s rapid antidepressant actions</article-title><source>The Journal of Clinical Investigation</source><volume>130</volume><fpage>1336</fpage><lpage>1349</lpage><pub-id pub-id-type="doi">10.1172/JCI130808</pub-id><pub-id pub-id-type="pmid">31743111</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Glausier</surname><given-names>JR</given-names></name><name><surname>Lewis</surname><given-names>DA</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Dendritic spine pathology in schizophrenia</article-title><source>Neuroscience</source><volume>251</volume><fpage>90</fpage><lpage>107</lpage><pub-id pub-id-type="doi">10.1016/j.neuroscience.2012.04.044</pub-id><pub-id pub-id-type="pmid">22546337</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Golden</surname><given-names>SA</given-names></name><name><surname>Covington</surname><given-names>HE</given-names></name><name><surname>Berton</surname><given-names>O</given-names></name><name><surname>Russo</surname><given-names>SJ</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>A standardized protocol for repeated social defeat stress in mice</article-title><source>Nature Protocols</source><volume>6</volume><fpage>1183</fpage><lpage>1191</lpage><pub-id pub-id-type="doi">10.1038/nprot.2011.361</pub-id><pub-id pub-id-type="pmid">21799487</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goldwater</surname><given-names>DS</given-names></name><name><surname>Pavlides</surname><given-names>C</given-names></name><name><surname>Hunter</surname><given-names>RG</given-names></name><name><surname>Bloss</surname><given-names>EB</given-names></name><name><surname>Hof</surname><given-names>PR</given-names></name><name><surname>McEwen</surname><given-names>BS</given-names></name><name><surname>Morrison</surname><given-names>JH</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Structural and functional alterations to rat medial prefrontal cortex following chronic restraint stress and recovery</article-title><source>Neuroscience</source><volume>164</volume><fpage>798</fpage><lpage>808</lpage><pub-id pub-id-type="doi">10.1016/j.neuroscience.2009.08.053</pub-id><pub-id pub-id-type="pmid">19723561</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gong</surname><given-names>L</given-names></name><name><surname>Yin</surname><given-names>Y</given-names></name><name><surname>He</surname><given-names>C</given-names></name><name><surname>Ye</surname><given-names>Q</given-names></name><name><surname>Bai</surname><given-names>F</given-names></name><name><surname>Yuan</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>H</given-names></name><name><surname>Lv</surname><given-names>L</given-names></name><name><surname>Zhang</surname><given-names>H</given-names></name><name><surname>Xie</surname><given-names>C</given-names></name><name><surname>Zhang</surname><given-names>Z</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Disrupted reward circuits is associated with cognitive deficits and depression severity in major depressive disorder</article-title><source>Journal of Psychiatric Research</source><volume>84</volume><fpage>9</fpage><lpage>17</lpage><pub-id pub-id-type="doi">10.1016/j.jpsychires.2016.09.016</pub-id><pub-id pub-id-type="pmid">27673704</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gong</surname><given-names>L</given-names></name><name><surname>He</surname><given-names>C</given-names></name><name><surname>Zhang</surname><given-names>H</given-names></name><name><surname>Zhang</surname><given-names>H</given-names></name><name><surname>Zhang</surname><given-names>Z</given-names></name><name><surname>Xie</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Disrupted reward and cognitive control networks contribute to anhedonia in depression</article-title><source>Journal of Psychiatric Research</source><volume>103</volume><fpage>61</fpage><lpage>68</lpage><pub-id pub-id-type="doi">10.1016/j.jpsychires.2018.05.010</pub-id><pub-id pub-id-type="pmid">29783076</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Han</surname><given-names>MH</given-names></name><name><surname>Nestler</surname><given-names>EJ</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Neural substrates of depression and resilience</article-title><source>Neurotherapeutics</source><volume>14</volume><fpage>677</fpage><lpage>686</lpage><pub-id pub-id-type="doi">10.1007/s13311-017-0527-x</pub-id><pub-id pub-id-type="pmid">28397115</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hare</surname><given-names>BD</given-names></name><name><surname>Duman</surname><given-names>RS</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Prefrontal cortex circuits in depression and anxiety: contribution of discrete neuronal populations and target regions</article-title><source>Molecular Psychiatry</source><volume>25</volume><fpage>2742</fpage><lpage>2758</lpage><pub-id pub-id-type="doi">10.1038/s41380-020-0685-9</pub-id><pub-id pub-id-type="pmid">32086434</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hartzell</surname><given-names>AL</given-names></name><name><surname>Martyniuk</surname><given-names>KM</given-names></name><name><surname>Brigidi</surname><given-names>GS</given-names></name><name><surname>Heinz</surname><given-names>DA</given-names></name><name><surname>Djaja</surname><given-names>NA</given-names></name><name><surname>Payne</surname><given-names>A</given-names></name><name><surname>Bloodgood</surname><given-names>BL</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Npas4 recruits CCK basket cell synapses and enhances cannabinoid-sensitive inhibition in the mouse hippocampus</article-title><source>eLife</source><volume>7</volume><elocation-id>e35927</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.35927</pub-id><pub-id pub-id-type="pmid">30052197</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heinz</surname><given-names>S</given-names></name><name><surname>Benner</surname><given-names>C</given-names></name><name><surname>Spann</surname><given-names>N</given-names></name><name><surname>Bertolino</surname><given-names>E</given-names></name><name><surname>Lin</surname><given-names>YC</given-names></name><name><surname>Laslo</surname><given-names>P</given-names></name><name><surname>Cheng</surname><given-names>JX</given-names></name><name><surname>Murre</surname><given-names>C</given-names></name><name><surname>Singh</surname><given-names>H</given-names></name><name><surname>Glass</surname><given-names>CK</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities</article-title><source>Molecular Cell</source><volume>38</volume><fpage>576</fpage><lpage>589</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2010.05.004</pub-id><pub-id pub-id-type="pmid">20513432</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Henriques</surname><given-names>JB</given-names></name><name><surname>Davidson</surname><given-names>RJ</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Decreased responsiveness to reward in depression</article-title><source>Cognition &amp; Emotion</source><volume>14</volume><fpage>711</fpage><lpage>724</lpage><pub-id pub-id-type="doi">10.1080/02699930050117684</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heshmati</surname><given-names>M</given-names></name><name><surname>Russo</surname><given-names>SJ</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Anhedonia and the brain reward circuitry in depression</article-title><source>Current Behavioral Neuroscience Reports</source><volume>2</volume><fpage>146</fpage><lpage>153</lpage><pub-id pub-id-type="doi">10.1007/s40473-015-0044-3</pub-id><pub-id pub-id-type="pmid">26525751</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heslin</surname><given-names>K</given-names></name><name><surname>Coutellier</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Npas4 deficiency and prenatal stress interact to affect social recognition in mice</article-title><source>Genes, Brain, and Behavior</source><volume>17</volume><elocation-id>e12448</elocation-id><pub-id pub-id-type="doi">10.1111/gbb.12448</pub-id><pub-id pub-id-type="pmid">29227584</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Holmes</surname><given-names>A</given-names></name><name><surname>Wellman</surname><given-names>CL</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Stress-Induced prefrontal reorganization and executive dysfunction in rodents</article-title><source>Neuroscience and Biobehavioral Reviews</source><volume>33</volume><fpage>773</fpage><lpage>783</lpage><pub-id pub-id-type="doi">10.1016/j.neubiorev.2008.11.005</pub-id><pub-id pub-id-type="pmid">19111570</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Holmes</surname><given-names>SE</given-names></name><name><surname>Scheinost</surname><given-names>D</given-names></name><name><surname>Finnema</surname><given-names>SJ</given-names></name><name><surname>Naganawa</surname><given-names>M</given-names></name><name><surname>Davis</surname><given-names>MT</given-names></name><name><surname>DellaGioia</surname><given-names>N</given-names></name><name><surname>Nabulsi</surname><given-names>N</given-names></name><name><surname>Matuskey</surname><given-names>D</given-names></name><name><surname>Angarita</surname><given-names>GA</given-names></name><name><surname>Pietrzak</surname><given-names>RH</given-names></name><name><surname>Duman</surname><given-names>RS</given-names></name><name><surname>Sanacora</surname><given-names>G</given-names></name><name><surname>Krystal</surname><given-names>JH</given-names></name><name><surname>Carson</surname><given-names>RE</given-names></name><name><surname>Esterlis</surname><given-names>I</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Lower synaptic density is associated with depression severity and network alterations</article-title><source>Nature Communications</source><volume>10</volume><elocation-id>1529</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-019-09562-7</pub-id><pub-id pub-id-type="pmid">30948709</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hori</surname><given-names>H</given-names></name><name><surname>Nakamura</surname><given-names>S</given-names></name><name><surname>Yoshida</surname><given-names>F</given-names></name><name><surname>Teraishi</surname><given-names>T</given-names></name><name><surname>Sasayama</surname><given-names>D</given-names></name><name><surname>Ota</surname><given-names>M</given-names></name><name><surname>Hattori</surname><given-names>K</given-names></name><name><surname>Kim</surname><given-names>Y</given-names></name><name><surname>Higuchi</surname><given-names>T</given-names></name><name><surname>Kunugi</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Integrated profiling of phenotype and blood transcriptome for stress vulnerability and depression</article-title><source>Journal of Psychiatric Research</source><volume>104</volume><fpage>202</fpage><lpage>210</lpage><pub-id pub-id-type="doi">10.1016/j.jpsychires.2018.08.010</pub-id><pub-id pub-id-type="pmid">30103068</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jaehne</surname><given-names>EJ</given-names></name><name><surname>Klarić</surname><given-names>TS</given-names></name><name><surname>Koblar</surname><given-names>SA</given-names></name><name><surname>Baune</surname><given-names>BT</given-names></name><name><surname>Lewis</surname><given-names>MD</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Effects of NPAS4 deficiency on anxiety, depression-like, cognition and sociability behaviour</article-title><source>Behavioural Brain Research</source><volume>281</volume><fpage>276</fpage><lpage>282</lpage><pub-id pub-id-type="doi">10.1016/j.bbr.2014.12.044</pub-id><pub-id pub-id-type="pmid">25549857</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>T-K</given-names></name><name><surname>Hemberg</surname><given-names>M</given-names></name><name><surname>Gray</surname><given-names>JM</given-names></name><name><surname>Costa</surname><given-names>AM</given-names></name><name><surname>Bear</surname><given-names>DM</given-names></name><name><surname>Wu</surname><given-names>J</given-names></name><name><surname>Harmin</surname><given-names>DA</given-names></name><name><surname>Laptewicz</surname><given-names>M</given-names></name><name><surname>Barbara-Haley</surname><given-names>K</given-names></name><name><surname>Kuersten</surname><given-names>S</given-names></name><name><surname>Markenscoff-Papadimitriou</surname><given-names>E</given-names></name><name><surname>Kuhl</surname><given-names>D</given-names></name><name><surname>Bito</surname><given-names>H</given-names></name><name><surname>Worley</surname><given-names>PF</given-names></name><name><surname>Kreiman</surname><given-names>G</given-names></name><name><surname>Greenberg</surname><given-names>ME</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Widespread transcription at neuronal activity-regulated enhancers</article-title><source>Nature</source><volume>465</volume><fpage>182</fpage><lpage>187</lpage><pub-id pub-id-type="doi">10.1038/nature09033</pub-id><pub-id pub-id-type="pmid">20393465</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Konopaske</surname><given-names>GT</given-names></name><name><surname>Lange</surname><given-names>N</given-names></name><name><surname>Coyle</surname><given-names>JT</given-names></name><name><surname>Benes</surname><given-names>FM</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Prefrontal cortical dendritic spine pathology in schizophrenia and bipolar disorder</article-title><source>JAMA Psychiatry</source><volume>71</volume><fpage>1323</fpage><lpage>1331</lpage><pub-id pub-id-type="doi">10.1001/jamapsychiatry.2014.1582</pub-id><pub-id pub-id-type="pmid">25271938</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krishnan</surname><given-names>V</given-names></name><name><surname>Han</surname><given-names>M-H</given-names></name><name><surname>Graham</surname><given-names>DL</given-names></name><name><surname>Berton</surname><given-names>O</given-names></name><name><surname>Renthal</surname><given-names>W</given-names></name><name><surname>Russo</surname><given-names>SJ</given-names></name><name><surname>Laplant</surname><given-names>Q</given-names></name><name><surname>Graham</surname><given-names>A</given-names></name><name><surname>Lutter</surname><given-names>M</given-names></name><name><surname>Lagace</surname><given-names>DC</given-names></name><name><surname>Ghose</surname><given-names>S</given-names></name><name><surname>Reister</surname><given-names>R</given-names></name><name><surname>Tannous</surname><given-names>P</given-names></name><name><surname>Green</surname><given-names>TA</given-names></name><name><surname>Neve</surname><given-names>RL</given-names></name><name><surname>Chakravarty</surname><given-names>S</given-names></name><name><surname>Kumar</surname><given-names>A</given-names></name><name><surname>Eisch</surname><given-names>AJ</given-names></name><name><surname>Self</surname><given-names>DW</given-names></name><name><surname>Lee</surname><given-names>FS</given-names></name><name><surname>Tamminga</surname><given-names>CA</given-names></name><name><surname>Cooper</surname><given-names>DC</given-names></name><name><surname>Gershenfeld</surname><given-names>HK</given-names></name><name><surname>Nestler</surname><given-names>EJ</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Molecular adaptations underlying susceptibility and resistance to social defeat in brain reward regions</article-title><source>Cell</source><volume>131</volume><fpage>391</fpage><lpage>404</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2007.09.018</pub-id><pub-id pub-id-type="pmid">17956738</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krishnan</surname><given-names>V</given-names></name><name><surname>Nestler</surname><given-names>EJ</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>The molecular neurobiology of depression</article-title><source>Nature</source><volume>455</volume><fpage>894</fpage><lpage>902</lpage><pub-id pub-id-type="doi">10.1038/nature07455</pub-id><pub-id pub-id-type="pmid">18923511</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krishnan</surname><given-names>V</given-names></name><name><surname>Nestler</surname><given-names>EJ</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Animal models of depression: molecular perspectives</article-title><source>Current Topics in Behavioral Neurosciences</source><volume>7</volume><fpage>121</fpage><lpage>147</lpage><pub-id pub-id-type="doi">10.1007/7854_2010_108</pub-id><pub-id pub-id-type="pmid">21225412</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuang</surname><given-names>X-J</given-names></name><name><surname>Zhang</surname><given-names>C-Y</given-names></name><name><surname>Yan</surname><given-names>B-Y</given-names></name><name><surname>Cai</surname><given-names>W-Z</given-names></name><name><surname>Lu</surname><given-names>C-L</given-names></name><name><surname>Xie</surname><given-names>L-J</given-names></name><name><surname>Li</surname><given-names>S-J</given-names></name><name><surname>Kong</surname><given-names>P-L</given-names></name><name><surname>Fan</surname><given-names>J</given-names></name><name><surname>Pan</surname><given-names>S-M</given-names></name><name><surname>Guo</surname><given-names>T</given-names></name><name><surname>Cao</surname><given-names>X</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>P2X2 receptors in pyramidal neurons are critical for regulating vulnerability to chronic stress</article-title><source>Theranostics</source><volume>12</volume><fpage>3703</fpage><lpage>3718</lpage><pub-id pub-id-type="doi">10.7150/thno.72144</pub-id><pub-id pub-id-type="pmid">35664080</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Labonté</surname><given-names>B</given-names></name><name><surname>Engmann</surname><given-names>O</given-names></name><name><surname>Purushothaman</surname><given-names>I</given-names></name><name><surname>Menard</surname><given-names>C</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Tan</surname><given-names>C</given-names></name><name><surname>Scarpa</surname><given-names>JR</given-names></name><name><surname>Moy</surname><given-names>G</given-names></name><name><surname>Loh</surname><given-names>Y-HE</given-names></name><name><surname>Cahill</surname><given-names>M</given-names></name><name><surname>Lorsch</surname><given-names>ZS</given-names></name><name><surname>Hamilton</surname><given-names>PJ</given-names></name><name><surname>Calipari</surname><given-names>ES</given-names></name><name><surname>Hodes</surname><given-names>GE</given-names></name><name><surname>Issler</surname><given-names>O</given-names></name><name><surname>Kronman</surname><given-names>H</given-names></name><name><surname>Pfau</surname><given-names>M</given-names></name><name><surname>Obradovic</surname><given-names>ALJ</given-names></name><name><surname>Dong</surname><given-names>Y</given-names></name><name><surname>Neve</surname><given-names>RL</given-names></name><name><surname>Russo</surname><given-names>S</given-names></name><name><surname>Kazarskis</surname><given-names>A</given-names></name><name><surname>Tamminga</surname><given-names>C</given-names></name><name><surname>Mechawar</surname><given-names>N</given-names></name><name><surname>Turecki</surname><given-names>G</given-names></name><name><surname>Zhang</surname><given-names>B</given-names></name><name><surname>Shen</surname><given-names>L</given-names></name><name><surname>Nestler</surname><given-names>EJ</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Sex-Specific transcriptional signatures in human depression</article-title><source>Nature Medicine</source><volume>23</volume><fpage>1102</fpage><lpage>1111</lpage><pub-id pub-id-type="doi">10.1038/nm.4386</pub-id><pub-id pub-id-type="pmid">28825715</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lewis</surname><given-names>DA</given-names></name><name><surname>González-Burgos</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Neuroplasticity of neocortical circuits in schizophrenia</article-title><source>Neuropsychopharmacology</source><volume>33</volume><fpage>141</fpage><lpage>165</lpage><pub-id pub-id-type="doi">10.1038/sj.npp.1301563</pub-id><pub-id pub-id-type="pmid">17805309</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>CT</given-names></name><name><surname>Su</surname><given-names>TP</given-names></name><name><surname>Wang</surname><given-names>SJ</given-names></name><name><surname>Tu</surname><given-names>PC</given-names></name><name><surname>Hsieh</surname><given-names>JC</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Prefrontal glucose metabolism in medication-resistant major depression</article-title><source>The British Journal of Psychiatry</source><volume>206</volume><fpage>316</fpage><lpage>323</lpage><pub-id pub-id-type="doi">10.1192/bjp.bp.113.140434</pub-id><pub-id pub-id-type="pmid">25657357</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>Y</given-names></name><name><surname>Bloodgood</surname><given-names>BL</given-names></name><name><surname>Hauser</surname><given-names>JL</given-names></name><name><surname>Lapan</surname><given-names>AD</given-names></name><name><surname>Koon</surname><given-names>AC</given-names></name><name><surname>Kim</surname><given-names>T-K</given-names></name><name><surname>Hu</surname><given-names>LS</given-names></name><name><surname>Malik</surname><given-names>AN</given-names></name><name><surname>Greenberg</surname><given-names>ME</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Activity-Dependent regulation of inhibitory synapse development by NPAS4</article-title><source>Nature</source><volume>455</volume><fpage>1198</fpage><lpage>1204</lpage><pub-id pub-id-type="doi">10.1038/nature07319</pub-id><pub-id pub-id-type="pmid">18815592</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Linley</surname><given-names>PA</given-names></name><name><surname>Joseph</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Positive change following trauma and adversity: a review</article-title><source>Journal of Traumatic Stress</source><volume>17</volume><fpage>11</fpage><lpage>21</lpage><pub-id pub-id-type="doi">10.1023/B:JOTS.0000014671.27856.7e</pub-id><pub-id pub-id-type="pmid">15027788</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liston</surname><given-names>C</given-names></name><name><surname>Miller</surname><given-names>MM</given-names></name><name><surname>Goldwater</surname><given-names>DS</given-names></name><name><surname>Radley</surname><given-names>JJ</given-names></name><name><surname>Rocher</surname><given-names>AB</given-names></name><name><surname>Hof</surname><given-names>PR</given-names></name><name><surname>Morrison</surname><given-names>JH</given-names></name><name><surname>McEwen</surname><given-names>BS</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Stress-Induced alterations in prefrontal cortical dendritic morphology predict selective impairments in perceptual attentional set-shifting</article-title><source>The Journal of Neuroscience</source><volume>26</volume><fpage>7870</fpage><lpage>7874</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.1184-06.2006</pub-id><pub-id pub-id-type="pmid">16870732</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Llorca</surname><given-names>P</given-names></name><name><surname>Gourion</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Management of anhedonia and depressive symptoms in depressed outpatients: benefit for functioning</article-title><source>European Psychiatry</source><volume>30</volume><elocation-id>364</elocation-id><pub-id pub-id-type="doi">10.1016/S0924-9338(15)31881-2</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matsuo</surname><given-names>K</given-names></name><name><surname>Kato</surname><given-names>T</given-names></name><name><surname>Fukuda</surname><given-names>M</given-names></name><name><surname>Kato</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Alteration of hemoglobin oxygenation in the frontal region in elderly depressed patients as measured by near-infrared spectroscopy</article-title><source>The Journal of Neuropsychiatry and Clinical Neurosciences</source><volume>12</volume><fpage>465</fpage><lpage>471</lpage><pub-id pub-id-type="doi">10.1176/jnp.12.4.465</pub-id><pub-id pub-id-type="pmid">11083163</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maya-Vetencourt</surname><given-names>JF</given-names></name><name><surname>Tiraboschi</surname><given-names>E</given-names></name><name><surname>Greco</surname><given-names>D</given-names></name><name><surname>Restani</surname><given-names>L</given-names></name><name><surname>Cerri</surname><given-names>C</given-names></name><name><surname>Auvinen</surname><given-names>P</given-names></name><name><surname>Maffei</surname><given-names>L</given-names></name><name><surname>Castrén</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Experience-dependent expression of NPAS4 regulates plasticity in adult visual cortex</article-title><source>The Journal of Physiology</source><volume>590</volume><fpage>4777</fpage><lpage>4787</lpage><pub-id pub-id-type="doi">10.1113/jphysiol.2012.234237</pub-id><pub-id pub-id-type="pmid">22674715</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mayanagi</surname><given-names>T</given-names></name><name><surname>Sobue</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Social stress-induced postsynaptic hyporesponsiveness in glutamatergic synapses is mediated by PSD-zip70-rap2 pathway and relates to anxiety-like behaviors</article-title><source>Frontiers in Cellular Neuroscience</source><volume>13</volume><elocation-id>564</elocation-id><pub-id pub-id-type="doi">10.3389/fncel.2019.00564</pub-id><pub-id pub-id-type="pmid">31969804</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McKlveen</surname><given-names>JM</given-names></name><name><surname>Myers</surname><given-names>B</given-names></name><name><surname>Flak</surname><given-names>JN</given-names></name><name><surname>Bundzikova</surname><given-names>J</given-names></name><name><surname>Solomon</surname><given-names>MB</given-names></name><name><surname>Seroogy</surname><given-names>KB</given-names></name><name><surname>Herman</surname><given-names>JP</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Role of prefrontal cortex glucocorticoid receptors in stress and emotion</article-title><source>Biological Psychiatry</source><volume>74</volume><fpage>672</fpage><lpage>679</lpage><pub-id pub-id-type="doi">10.1016/j.biopsych.2013.03.024</pub-id><pub-id pub-id-type="pmid">23683655</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moda-Sava</surname><given-names>RN</given-names></name><name><surname>Murdock</surname><given-names>MH</given-names></name><name><surname>Parekh</surname><given-names>PK</given-names></name><name><surname>Fetcho</surname><given-names>RN</given-names></name><name><surname>Huang</surname><given-names>BS</given-names></name><name><surname>Huynh</surname><given-names>TN</given-names></name><name><surname>Witztum</surname><given-names>J</given-names></name><name><surname>Shaver</surname><given-names>DC</given-names></name><name><surname>Rosenthal</surname><given-names>DL</given-names></name><name><surname>Alway</surname><given-names>EJ</given-names></name><name><surname>Lopez</surname><given-names>K</given-names></name><name><surname>Meng</surname><given-names>Y</given-names></name><name><surname>Nellissen</surname><given-names>L</given-names></name><name><surname>Grosenick</surname><given-names>L</given-names></name><name><surname>Milner</surname><given-names>TA</given-names></name><name><surname>Deisseroth</surname><given-names>K</given-names></name><name><surname>Bito</surname><given-names>H</given-names></name><name><surname>Kasai</surname><given-names>H</given-names></name><name><surname>Liston</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Sustained rescue of prefrontal circuit dysfunction by antidepressant-induced spine formation</article-title><source>Science</source><volume>364</volume><elocation-id>eaat8078</elocation-id><pub-id pub-id-type="doi">10.1126/science.aat8078</pub-id><pub-id pub-id-type="pmid">30975859</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moyer</surname><given-names>CE</given-names></name><name><surname>Shelton</surname><given-names>MA</given-names></name><name><surname>Sweet</surname><given-names>RA</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Dendritic spine alterations in schizophrenia</article-title><source>Neuroscience Letters</source><volume>601</volume><fpage>46</fpage><lpage>53</lpage><pub-id pub-id-type="doi">10.1016/j.neulet.2014.11.042</pub-id><pub-id pub-id-type="pmid">25478958</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ota</surname><given-names>KT</given-names></name><name><surname>Duman</surname><given-names>RS</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Environmental and pharmacological modulations of cellular plasticity: role in the pathophysiology and treatment of depression</article-title><source>Neurobiology of Disease</source><volume>57</volume><fpage>28</fpage><lpage>37</lpage><pub-id pub-id-type="doi">10.1016/j.nbd.2012.05.022</pub-id><pub-id pub-id-type="pmid">22691453</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pechtel</surname><given-names>P</given-names></name><name><surname>Dutra</surname><given-names>SJ</given-names></name><name><surname>Goetz</surname><given-names>EL</given-names></name><name><surname>Pizzagalli</surname><given-names>DA</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Blunted reward responsiveness in remitted depression</article-title><source>Journal of Psychiatric Research</source><volume>47</volume><fpage>1864</fpage><lpage>1869</lpage><pub-id pub-id-type="doi">10.1016/j.jpsychires.2013.08.011</pub-id><pub-id pub-id-type="pmid">24064208</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Penrod</surname><given-names>RD</given-names></name><name><surname>Kumar</surname><given-names>J</given-names></name><name><surname>Smith</surname><given-names>LN</given-names></name><name><surname>McCalley</surname><given-names>D</given-names></name><name><surname>Nentwig</surname><given-names>TB</given-names></name><name><surname>Hughes</surname><given-names>BW</given-names></name><name><surname>Barry</surname><given-names>GM</given-names></name><name><surname>Glover</surname><given-names>K</given-names></name><name><surname>Taniguchi</surname><given-names>M</given-names></name><name><surname>Cowan</surname><given-names>CW</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Activity-regulated cytoskeleton-associated protein (arc/arg3.1) regulates anxiety- and novelty-related behaviors</article-title><source>Genes, Brain, and Behavior</source><volume>18</volume><elocation-id>e12561</elocation-id><pub-id pub-id-type="doi">10.1111/gbb.12561</pub-id><pub-id pub-id-type="pmid">30761730</pub-id></element-citation></ref><ref id="bib70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pizzagalli</surname><given-names>DA</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Depression, stress, and anhedonia: toward a synthesis and integrated model</article-title><source>Annual Review of Clinical Psychology</source><volume>10</volume><fpage>393</fpage><lpage>423</lpage><pub-id pub-id-type="doi">10.1146/annurev-clinpsy-050212-185606</pub-id><pub-id pub-id-type="pmid">24471371</pub-id></element-citation></ref><ref id="bib71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ploski</surname><given-names>JE</given-names></name><name><surname>Monsey</surname><given-names>MS</given-names></name><name><surname>Nguyen</surname><given-names>T</given-names></name><name><surname>DiLeone</surname><given-names>RJ</given-names></name><name><surname>Schafe</surname><given-names>GE</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>The neuronal PAS domain protein 4 (npas4) is required for new and reactivated fear memories</article-title><source>PLOS ONE</source><volume>6</volume><elocation-id>e23760</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0023760</pub-id><pub-id pub-id-type="pmid">21887312</pub-id></element-citation></ref><ref id="bib72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Porcelli</surname><given-names>AJ</given-names></name><name><surname>Delgado</surname><given-names>MR</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Stress and decision making: effects on valuation, learning, and risk-taking</article-title><source>Current Opinion in Behavioral Sciences</source><volume>14</volume><fpage>33</fpage><lpage>39</lpage><pub-id pub-id-type="doi">10.1016/j.cobeha.2016.11.015</pub-id><pub-id pub-id-type="pmid">28044144</pub-id></element-citation></ref><ref id="bib73"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qiao</surname><given-names>H</given-names></name><name><surname>Li</surname><given-names>MX</given-names></name><name><surname>Xu</surname><given-names>C</given-names></name><name><surname>Chen</surname><given-names>HB</given-names></name><name><surname>An</surname><given-names>SC</given-names></name><name><surname>Ma</surname><given-names>XM</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Dendritic spines in depression: what we learned from animal models</article-title><source>Neural Plasticity</source><volume>2016</volume><elocation-id>8056370</elocation-id><pub-id pub-id-type="doi">10.1155/2016/8056370</pub-id><pub-id pub-id-type="pmid">26881133</pub-id></element-citation></ref><ref id="bib74"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qu</surname><given-names>Y</given-names></name><name><surname>Yang</surname><given-names>C</given-names></name><name><surname>Ren</surname><given-names>Q</given-names></name><name><surname>Ma</surname><given-names>M</given-names></name><name><surname>Dong</surname><given-names>C</given-names></name><name><surname>Hashimoto</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Regional differences in dendritic spine density confer resilience to chronic social defeat stress</article-title><source>Acta Neuropsychiatrica</source><volume>30</volume><fpage>117</fpage><lpage>122</lpage><pub-id pub-id-type="doi">10.1017/neu.2017.16</pub-id><pub-id pub-id-type="pmid">28566105</pub-id></element-citation></ref><ref id="bib75"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Radley</surname><given-names>JJ</given-names></name><name><surname>Sisti</surname><given-names>HM</given-names></name><name><surname>Hao</surname><given-names>J</given-names></name><name><surname>Rocher</surname><given-names>AB</given-names></name><name><surname>McCall</surname><given-names>T</given-names></name><name><surname>Hof</surname><given-names>PR</given-names></name><name><surname>McEwen</surname><given-names>BS</given-names></name><name><surname>Morrison</surname><given-names>JH</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Chronic behavioral stress induces apical dendritic reorganization in pyramidal neurons of the medial prefrontal cortex</article-title><source>Neuroscience</source><volume>125</volume><fpage>1</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1016/j.neuroscience.2004.01.006</pub-id><pub-id pub-id-type="pmid">15051139</pub-id></element-citation></ref><ref id="bib76"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Radley</surname><given-names>JJ</given-names></name><name><surname>Rocher</surname><given-names>AB</given-names></name><name><surname>Janssen</surname><given-names>WGM</given-names></name><name><surname>Hof</surname><given-names>PR</given-names></name><name><surname>McEwen</surname><given-names>BS</given-names></name><name><surname>Morrison</surname><given-names>JH</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Reversibility of apical dendritic retraction in the rat medial prefrontal cortex following repeated stress</article-title><source>Experimental Neurology</source><volume>196</volume><fpage>199</fpage><lpage>203</lpage><pub-id pub-id-type="doi">10.1016/j.expneurol.2005.07.008</pub-id><pub-id pub-id-type="pmid">16095592</pub-id></element-citation></ref><ref id="bib77"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Radley</surname><given-names>JJ</given-names></name><name><surname>Arias</surname><given-names>CM</given-names></name><name><surname>Sawchenko</surname><given-names>PE</given-names></name></person-group><year iso-8601-date="2006">2006a</year><article-title>Regional differentiation of the medial prefrontal cortex in regulating adaptive responses to acute emotional stress</article-title><source>The Journal of Neuroscience</source><volume>26</volume><fpage>12967</fpage><lpage>12976</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.4297-06.2006</pub-id><pub-id pub-id-type="pmid">17167086</pub-id></element-citation></ref><ref id="bib78"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Radley</surname><given-names>JJ</given-names></name><name><surname>Rocher</surname><given-names>AB</given-names></name><name><surname>Miller</surname><given-names>M</given-names></name><name><surname>Janssen</surname><given-names>WGM</given-names></name><name><surname>Liston</surname><given-names>C</given-names></name><name><surname>Hof</surname><given-names>PR</given-names></name><name><surname>McEwen</surname><given-names>BS</given-names></name><name><surname>Morrison</surname><given-names>JH</given-names></name></person-group><year iso-8601-date="2006">2006b</year><article-title>Repeated stress induces dendritic spine loss in the rat medial prefrontal cortex</article-title><source>Cerebral Cortex</source><volume>16</volume><fpage>313</fpage><lpage>320</lpage><pub-id pub-id-type="doi">10.1093/cercor/bhi104</pub-id><pub-id pub-id-type="pmid">15901656</pub-id></element-citation></ref><ref id="bib79"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ramamoorthi</surname><given-names>K</given-names></name><name><surname>Fropf</surname><given-names>R</given-names></name><name><surname>Belfort</surname><given-names>GM</given-names></name><name><surname>Fitzmaurice</surname><given-names>HL</given-names></name><name><surname>McKinney</surname><given-names>RM</given-names></name><name><surname>Neve</surname><given-names>RL</given-names></name><name><surname>Otto</surname><given-names>T</given-names></name><name><surname>Lin</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Npas4 regulates a transcriptional program in CA3 required for contextual memory formation</article-title><source>Science</source><volume>334</volume><fpage>1669</fpage><lpage>1675</lpage><pub-id pub-id-type="doi">10.1126/science.1208049</pub-id><pub-id pub-id-type="pmid">22194569</pub-id></element-citation></ref><ref id="bib80"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rehm</surname><given-names>J</given-names></name><name><surname>Shield</surname><given-names>KD</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Global burden of disease and the impact of mental and addictive disorders</article-title><source>Current Psychiatry Reports</source><volume>21</volume><elocation-id>10</elocation-id><pub-id pub-id-type="doi">10.1007/s11920-019-0997-0</pub-id><pub-id pub-id-type="pmid">30729322</pub-id></element-citation></ref><ref id="bib81"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Riaz</surname><given-names>S</given-names></name><name><surname>Puveendrakumaran</surname><given-names>P</given-names></name><name><surname>Khan</surname><given-names>D</given-names></name><name><surname>Yoon</surname><given-names>S</given-names></name><name><surname>Hamel</surname><given-names>L</given-names></name><name><surname>Ito</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Prelimbic and infralimbic cortical inactivations attenuate contextually driven discriminative responding for reward</article-title><source>Scientific Reports</source><volume>9</volume><elocation-id>3982</elocation-id><pub-id pub-id-type="doi">10.1038/s41598-019-40532-7</pub-id><pub-id pub-id-type="pmid">30850668</pub-id></element-citation></ref><ref id="bib82"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Savell</surname><given-names>KE</given-names></name><name><surname>Tuscher</surname><given-names>JJ</given-names></name><name><surname>Zipperly</surname><given-names>ME</given-names></name><name><surname>Duke</surname><given-names>CG</given-names></name><name><surname>Phillips</surname><given-names>RA</given-names></name><name><surname>Bauman</surname><given-names>AJ</given-names></name><name><surname>Thukral</surname><given-names>S</given-names></name><name><surname>Sultan</surname><given-names>FA</given-names></name><name><surname>Goska</surname><given-names>NA</given-names></name><name><surname>Ianov</surname><given-names>L</given-names></name><name><surname>Day</surname><given-names>JJ</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>A dopamine-induced gene expression signature regulates neuronal function and cocaine response</article-title><source>Science Advances</source><volume>6</volume><elocation-id>eaba4221</elocation-id><pub-id pub-id-type="doi">10.1126/sciadv.aba4221</pub-id><pub-id pub-id-type="pmid">32637607</pub-id></element-citation></ref><ref id="bib83"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sharma</surname><given-names>N</given-names></name><name><surname>Pollina</surname><given-names>EA</given-names></name><name><surname>Nagy</surname><given-names>MA</given-names></name><name><surname>Yap</surname><given-names>E-L</given-names></name><name><surname>DiBiase</surname><given-names>FA</given-names></name><name><surname>Hrvatin</surname><given-names>S</given-names></name><name><surname>Hu</surname><given-names>L</given-names></name><name><surname>Lin</surname><given-names>C</given-names></name><name><surname>Greenberg</surname><given-names>ME</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Arnt2 tunes activity-dependent gene expression through ncor2-mediated repression and NPAS4-mediated activation</article-title><source>Neuron</source><volume>102</volume><fpage>390</fpage><lpage>406</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2019.02.007</pub-id><pub-id pub-id-type="pmid">30846309</pub-id></element-citation></ref><ref id="bib84"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shepard</surname><given-names>R</given-names></name><name><surname>Heslin</surname><given-names>K</given-names></name><name><surname>Hagerdorn</surname><given-names>P</given-names></name><name><surname>Coutellier</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Downregulation of NPAS4 in parvalbumin interneurons and cognitive deficits after neonatal NMDA receptor blockade: relevance for schizophrenia</article-title><source>Translational Psychiatry</source><volume>9</volume><elocation-id>99</elocation-id><pub-id pub-id-type="doi">10.1038/s41398-019-0436-3</pub-id><pub-id pub-id-type="pmid">30792384</pub-id></element-citation></ref><ref id="bib85"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shu</surname><given-names>Y</given-names></name><name><surname>Xu</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Chronic social defeat stress modulates dendritic spines structural plasticity in adult mouse frontal association cortex</article-title><source>Neural Plasticity</source><volume>2017</volume><elocation-id>6207873</elocation-id><pub-id pub-id-type="doi">10.1155/2017/6207873</pub-id><pub-id pub-id-type="pmid">28197343</pub-id></element-citation></ref><ref id="bib86"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Siemsen</surname><given-names>BM</given-names></name><name><surname>Giannotti</surname><given-names>G</given-names></name><name><surname>McFaddin</surname><given-names>JA</given-names></name><name><surname>Scofield</surname><given-names>MD</given-names></name><name><surname>McGinty</surname><given-names>JF</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Biphasic effect of abstinence duration following cocaine self-administration on spine morphology and plasticity-related proteins in prelimbic cortical neurons projecting to the nucleus accumbens core</article-title><source>Brain Structure &amp; Function</source><volume>224</volume><fpage>741</fpage><lpage>758</lpage><pub-id pub-id-type="doi">10.1007/s00429-018-1805-z</pub-id><pub-id pub-id-type="pmid">30498893</pub-id></element-citation></ref><ref id="bib87"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sim</surname><given-names>S</given-names></name><name><surname>Antolin</surname><given-names>S</given-names></name><name><surname>Lin</surname><given-names>CW</given-names></name><name><surname>Lin</surname><given-names>Y</given-names></name><name><surname>Lois</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Increased cell-intrinsic excitability induces synaptic changes in new neurons in the adult dentate gyrus that require NPAS4</article-title><source>The Journal of Neuroscience</source><volume>33</volume><fpage>7928</fpage><lpage>7940</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.1571-12.2013</pub-id><pub-id pub-id-type="pmid">23637184</pub-id></element-citation></ref><ref id="bib88"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spiegel</surname><given-names>I</given-names></name><name><surname>Mardinly</surname><given-names>AR</given-names></name><name><surname>Gabel</surname><given-names>HW</given-names></name><name><surname>Bazinet</surname><given-names>JE</given-names></name><name><surname>Couch</surname><given-names>CH</given-names></name><name><surname>Tzeng</surname><given-names>CP</given-names></name><name><surname>Harmin</surname><given-names>DA</given-names></name><name><surname>Greenberg</surname><given-names>ME</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Npas4 regulates excitatory-inhibitory balance within neural circuits through cell-type-specific gene programs</article-title><source>Cell</source><volume>157</volume><fpage>1216</fpage><lpage>1229</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2014.03.058</pub-id><pub-id pub-id-type="pmid">24855953</pub-id></element-citation></ref><ref id="bib89"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>X</given-names></name><name><surname>Lin</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Npas4: linking neuronal activity to memory</article-title><source>Trends in Neurosciences</source><volume>39</volume><fpage>264</fpage><lpage>275</lpage><pub-id pub-id-type="doi">10.1016/j.tins.2016.02.003</pub-id><pub-id pub-id-type="pmid">26987258</pub-id></element-citation></ref><ref id="bib90"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Suto</surname><given-names>T</given-names></name><name><surname>Fukuda</surname><given-names>M</given-names></name><name><surname>Ito</surname><given-names>M</given-names></name><name><surname>Uehara</surname><given-names>T</given-names></name><name><surname>Mikuni</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Multichannel near-infrared spectroscopy in depression and schizophrenia: cognitive brain activation study</article-title><source>Biological Psychiatry</source><volume>55</volume><fpage>501</fpage><lpage>511</lpage><pub-id pub-id-type="doi">10.1016/j.biopsych.2003.09.008</pub-id><pub-id pub-id-type="pmid">15023578</pub-id></element-citation></ref><ref id="bib91"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taniguchi</surname><given-names>M.</given-names></name><name><surname>Carreira</surname><given-names>MB</given-names></name><name><surname>Smith</surname><given-names>LN</given-names></name><name><surname>Zirlin</surname><given-names>BC</given-names></name><name><surname>Neve</surname><given-names>RL</given-names></name><name><surname>Cowan</surname><given-names>CW</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Histone deacetylase 5 limits cocaine reward through cAMP-induced nuclear import</article-title><source>Neuron</source><volume>73</volume><fpage>108</fpage><lpage>120</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2011.10.032</pub-id><pub-id pub-id-type="pmid">22243750</pub-id></element-citation></ref><ref id="bib92"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taniguchi</surname><given-names>M</given-names></name><name><surname>Carreira</surname><given-names>MB</given-names></name><name><surname>Cooper</surname><given-names>YA</given-names></name><name><surname>Bobadilla</surname><given-names>AC</given-names></name><name><surname>Heinsbroek</surname><given-names>JA</given-names></name><name><surname>Koike</surname><given-names>N</given-names></name><name><surname>Larson</surname><given-names>EB</given-names></name><name><surname>Balmuth</surname><given-names>EA</given-names></name><name><surname>Hughes</surname><given-names>BW</given-names></name><name><surname>Penrod</surname><given-names>RD</given-names></name><name><surname>Kumar</surname><given-names>J</given-names></name><name><surname>Smith</surname><given-names>LN</given-names></name><name><surname>Guzman</surname><given-names>D</given-names></name><name><surname>Takahashi</surname><given-names>JS</given-names></name><name><surname>Kim</surname><given-names>TK</given-names></name><name><surname>Kalivas</surname><given-names>PW</given-names></name><name><surname>Self</surname><given-names>DW</given-names></name><name><surname>Lin</surname><given-names>Y</given-names></name><name><surname>Cowan</surname><given-names>CW</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Hdac5 and its target gene, NPAS4, function in the nucleus accumbens to regulate cocaine-conditioned behaviors</article-title><source>Neuron</source><volume>96</volume><fpage>130</fpage><lpage>144</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2017.09.015</pub-id><pub-id pub-id-type="pmid">28957664</pub-id></element-citation></ref><ref id="bib93"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Treadway</surname><given-names>MT</given-names></name><name><surname>Zald</surname><given-names>DH</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Reconsidering anhedonia in depression: lessons from translational neuroscience</article-title><source>Neuroscience and Biobehavioral Reviews</source><volume>35</volume><fpage>537</fpage><lpage>555</lpage><pub-id pub-id-type="doi">10.1016/j.neubiorev.2010.06.006</pub-id><pub-id pub-id-type="pmid">20603146</pub-id></element-citation></ref><ref id="bib94"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Venzala</surname><given-names>E</given-names></name><name><surname>García-García</surname><given-names>AL</given-names></name><name><surname>Elizalde</surname><given-names>N</given-names></name><name><surname>Delagrange</surname><given-names>P</given-names></name><name><surname>Tordera</surname><given-names>RM</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Chronic social defeat stress model: behavioral features, antidepressant action, and interaction with biological risk factors</article-title><source>Psychopharmacology</source><volume>224</volume><fpage>313</fpage><lpage>325</lpage><pub-id pub-id-type="doi">10.1007/s00213-012-2754-5</pub-id><pub-id pub-id-type="pmid">22707231</pub-id></element-citation></ref><ref id="bib95"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Venzala</surname><given-names>E</given-names></name><name><surname>García-García</surname><given-names>AL</given-names></name><name><surname>Elizalde</surname><given-names>N</given-names></name><name><surname>Tordera</surname><given-names>RM</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Social vs. environmental stress models of depression from a behavioural and neurochemical approach</article-title><source>European Neuropsychopharmacology</source><volume>23</volume><fpage>697</fpage><lpage>708</lpage><pub-id pub-id-type="doi">10.1016/j.euroneuro.2012.05.010</pub-id><pub-id pub-id-type="pmid">22743048</pub-id></element-citation></ref><ref id="bib96"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vialou</surname><given-names>V</given-names></name><name><surname>Bagot</surname><given-names>RC</given-names></name><name><surname>Cahill</surname><given-names>ME</given-names></name><name><surname>Ferguson</surname><given-names>D</given-names></name><name><surname>Robison</surname><given-names>AJ</given-names></name><name><surname>Dietz</surname><given-names>DM</given-names></name><name><surname>Fallon</surname><given-names>B</given-names></name><name><surname>Mazei-Robison</surname><given-names>M</given-names></name><name><surname>Ku</surname><given-names>SM</given-names></name><name><surname>Harrigan</surname><given-names>E</given-names></name><name><surname>Winstanley</surname><given-names>CA</given-names></name><name><surname>Joshi</surname><given-names>T</given-names></name><name><surname>Feng</surname><given-names>J</given-names></name><name><surname>Berton</surname><given-names>O</given-names></name><name><surname>Nestler</surname><given-names>EJ</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Prefrontal cortical circuit for depression- and anxiety-related behaviors mediated by cholecystokinin: role of δfosb</article-title><source>The Journal of Neuroscience</source><volume>34</volume><fpage>3878</fpage><lpage>3887</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.1787-13.2014</pub-id><pub-id pub-id-type="pmid">24623766</pub-id></element-citation></ref><ref id="bib97"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>D</given-names></name><name><surname>Liu</surname><given-names>S</given-names></name><name><surname>Warrell</surname><given-names>J</given-names></name><name><surname>Won</surname><given-names>H</given-names></name><name><surname>Shi</surname><given-names>X</given-names></name><name><surname>Navarro</surname><given-names>FCP</given-names></name><name><surname>Clarke</surname><given-names>D</given-names></name><name><surname>Gu</surname><given-names>M</given-names></name><name><surname>Emani</surname><given-names>P</given-names></name><name><surname>Yang</surname><given-names>YT</given-names></name><name><surname>Xu</surname><given-names>M</given-names></name><name><surname>Gandal</surname><given-names>MJ</given-names></name><name><surname>Lou</surname><given-names>S</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Park</surname><given-names>JJ</given-names></name><name><surname>Yan</surname><given-names>C</given-names></name><name><surname>Rhie</surname><given-names>SK</given-names></name><name><surname>Manakongtreecheep</surname><given-names>K</given-names></name><name><surname>Zhou</surname><given-names>H</given-names></name><name><surname>Nathan</surname><given-names>A</given-names></name><name><surname>Peters</surname><given-names>M</given-names></name><name><surname>Mattei</surname><given-names>E</given-names></name><name><surname>Fitzgerald</surname><given-names>D</given-names></name><name><surname>Brunetti</surname><given-names>T</given-names></name><name><surname>Moore</surname><given-names>J</given-names></name><name><surname>Jiang</surname><given-names>Y</given-names></name><name><surname>Girdhar</surname><given-names>K</given-names></name><name><surname>Hoffman</surname><given-names>GE</given-names></name><name><surname>Kalayci</surname><given-names>S</given-names></name><name><surname>Gümüş</surname><given-names>ZH</given-names></name><name><surname>Crawford</surname><given-names>GE</given-names></name><name><surname>Roussos</surname><given-names>P</given-names></name><name><surname>Akbarian</surname><given-names>S</given-names></name><name><surname>Jaffe</surname><given-names>AE</given-names></name><name><surname>White</surname><given-names>KP</given-names></name><name><surname>Weng</surname><given-names>Z</given-names></name><name><surname>Sestan</surname><given-names>N</given-names></name><name><surname>Geschwind</surname><given-names>DH</given-names></name><name><surname>Knowles</surname><given-names>JA</given-names></name><name><surname>Gerstein</surname><given-names>MB</given-names></name><collab>PsychENCODE Consortium</collab></person-group><year iso-8601-date="2018">2018</year><article-title>Comprehensive functional genomic resource and integrative model for the human brain</article-title><source>Science</source><volume>362</volume><elocation-id>eaat8464</elocation-id><pub-id pub-id-type="doi">10.1126/science.aat8464</pub-id><pub-id pub-id-type="pmid">30545857</pub-id></element-citation></ref><ref id="bib98"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Watanabe</surname><given-names>T</given-names></name><name><surname>Tanaka</surname><given-names>G</given-names></name><name><surname>Hamada</surname><given-names>S</given-names></name><name><surname>Namiki</surname><given-names>C</given-names></name><name><surname>Suzuki</surname><given-names>T</given-names></name><name><surname>Nakajima</surname><given-names>M</given-names></name><name><surname>Furihata</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Dose-dependent alterations in gene expression in mouse liver induced by diethylnitrosamine and ethylnitrosourea and determined by quantitative real-time PCR</article-title><source>Mutation Research</source><volume>673</volume><fpage>9</fpage><lpage>20</lpage><pub-id pub-id-type="doi">10.1016/j.mrgentox.2008.11.004</pub-id><pub-id pub-id-type="pmid">19100860</pub-id></element-citation></ref><ref id="bib99"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ye</surname><given-names>L</given-names></name><name><surname>Allen</surname><given-names>WE</given-names></name><name><surname>Thompson</surname><given-names>KR</given-names></name><name><surname>Tian</surname><given-names>Q</given-names></name><name><surname>Hsueh</surname><given-names>B</given-names></name><name><surname>Ramakrishnan</surname><given-names>C</given-names></name><name><surname>Wang</surname><given-names>A-C</given-names></name><name><surname>Jennings</surname><given-names>JH</given-names></name><name><surname>Adhikari</surname><given-names>A</given-names></name><name><surname>Halpern</surname><given-names>CH</given-names></name><name><surname>Witten</surname><given-names>IB</given-names></name><name><surname>Barth</surname><given-names>AL</given-names></name><name><surname>Luo</surname><given-names>L</given-names></name><name><surname>McNab</surname><given-names>JA</given-names></name><name><surname>Deisseroth</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Wiring and molecular features of prefrontal ensembles representing distinct experiences</article-title><source>Cell</source><volume>165</volume><fpage>1776</fpage><lpage>1788</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2016.05.010</pub-id><pub-id pub-id-type="pmid">27238022</pub-id></element-citation></ref><ref id="bib100"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yuen</surname><given-names>EY</given-names></name><name><surname>Wei</surname><given-names>J</given-names></name><name><surname>Liu</surname><given-names>W</given-names></name><name><surname>Zhong</surname><given-names>P</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Yan</surname><given-names>Z</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Repeated stress causes cognitive impairment by suppressing glutamate receptor expression and function in prefrontal cortex</article-title><source>Neuron</source><volume>73</volume><fpage>962</fpage><lpage>977</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2011.12.033</pub-id><pub-id pub-id-type="pmid">22405206</pub-id></element-citation></ref><ref id="bib101"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yun</surname><given-names>J</given-names></name><name><surname>Koike</surname><given-names>H</given-names></name><name><surname>Ibi</surname><given-names>D</given-names></name><name><surname>Toth</surname><given-names>E</given-names></name><name><surname>Mizoguchi</surname><given-names>H</given-names></name><name><surname>Nitta</surname><given-names>A</given-names></name><name><surname>Yoneyama</surname><given-names>M</given-names></name><name><surname>Ogita</surname><given-names>K</given-names></name><name><surname>Yoneda</surname><given-names>Y</given-names></name><name><surname>Nabeshima</surname><given-names>T</given-names></name><name><surname>Nagai</surname><given-names>T</given-names></name><name><surname>Yamada</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Chronic restraint stress impairs neurogenesis and hippocampus-dependent fear memory in mice: possible involvement of a brain-specific transcription factor npas4</article-title><source>Journal of Neurochemistry</source><volume>114</volume><fpage>1840</fpage><lpage>1851</lpage><pub-id pub-id-type="doi">10.1111/j.1471-4159.2010.06893.x</pub-id><pub-id pub-id-type="pmid">20626564</pub-id></element-citation></ref><ref id="bib102"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Z</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Chen</surname><given-names>L</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Guo</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Ketamine regulates phosphorylation of CRMP2 to mediate dendritic spine plasticity</article-title><source>Journal of Molecular Neuroscience</source><volume>70</volume><fpage>353</fpage><lpage>364</lpage><pub-id pub-id-type="doi">10.1007/s12031-019-01419-4</pub-id><pub-id pub-id-type="pmid">31808033</pub-id></element-citation></ref></ref-list></back><sub-article article-type="editor-report" id="sa0"><front-stub><article-id pub-id-type="doi">10.7554/eLife.75631.sa0</article-id><title-group><article-title>Editor's evaluation</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Wassum</surname><given-names>Kate M</given-names></name><role specific-use="editor">Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/046rm7j60</institution-id><institution>University of California, Los Angeles</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group><related-object id="sa0ro1" object-id-type="id" object-id="10.1101/2021.03.04.433930" link-type="continued-by" xlink:href="https://sciety.org/articles/activity/10.1101/2021.03.04.433930"/></front-stub><body><p>This important manuscript shows compelling evidence for a role for the transcription factor NPAS4 in the medial prefrontal cortex in regulating stress-induced behavior, pyramidal neuron spine density, and gene expression. There is beautiful depth of mechanistic insight into how chronic stress produces anhedonia-like behavior. This paper will be of interest to the field of stress neurobiology and neuropsychiatry.</p></body></sub-article><sub-article article-type="decision-letter" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.75631.sa1</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Wassum</surname><given-names>Kate M</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/046rm7j60</institution-id><institution>University of California, Los Angeles</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group><contrib-group><contrib contrib-type="reviewer"><name><surname>Russo</surname><given-names>Scott J</given-names></name><role>Reviewer</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/04a9tmd77</institution-id><institution>Icahn School of Medicine at Mount Sinai</institution></institution-wrap><country>United States</country></aff></contrib><contrib contrib-type="reviewer"><name><surname>Peña</surname><given-names>Catherine Jensen</given-names></name><role>Reviewer</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00hx57361</institution-id><institution>Princeton University</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group></front-stub><body><boxed-text id="sa2-box1"><p>Our editorial process produces two outputs: (i) <ext-link ext-link-type="uri" xlink:href="https://sciety.org/articles/activity/10.1101/2021.03.04.433930">public reviews</ext-link> designed to be posted alongside <ext-link ext-link-type="uri" xlink:href="https://www.biorxiv.org/content/10.1101/2021.03.04.433930v2">the preprint</ext-link> for the benefit of readers; (ii) feedback on the manuscript for the authors, including requests for revisions, shown below. We also include an acceptance summary that explains what the editors found interesting or important about the work.</p></boxed-text><p><bold>Decision letter after peer review:</bold></p><p>Thank you for submitting your article &quot;NPAS4 in the medial prefrontal cortex mediates chronic social defeat stress-induced anhedonia and dendritic spine loss&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by 3 peer reviewers, and the evaluation has been overseen by Kate Wassum as the Senior and Reviewing Editor. The following individuals involved in review of your submission have agreed to reveal their identity: Scott J Russo (Reviewer #2); Catherine Jensen Peña (Reviewer #3).</p><p>The reviewers have discussed their reviews with one another, and the Reviewing Editor has drafted this to help you prepare a revised submission.</p><p>This is a very interesting manuscript that shows a role for mPFC NPAS4 in regulating stress induced behavior, pyramidal neuron spine density, and gene expression. We appreciated that the manuscript is well written, the rigorous statistical approach, and novel results. We have a concerns about some of the conclusions and the depth of some of the analyses that should be addressed in a revision. We think addressing these concerns is likely to require additional experiments. Below are the essential revisions.</p><p>Essential revisions:</p><p>1. The abstract and results both state that reward motivation is altered in the NPAS4 shRNA group. However, figure 3 does not convincingly show this. There is no interpretable effect of shRNA on sucrose delivery, discrimination, or breakpoint. The authors claim that the significant correlation by linear regression between breakpoint and SI ratio in control but not NPAS4 shRNA groups can be interpreted as a change in reward motivation, and they use an appropriate ANCOVA analysis to show that these two factors are correlated in the control but not the shNPAS4 group. However, the interpretation of this lack of correlation is unclear. If the other data show that NPAS4 knockdown has no effect on SI or operant sucrose consumption, how can an effect on the correlation between these behaviors be meaningful? If the authors are stating that the lack of NPAS4 prevents the mice with a social withdrawal phenotype from developing an anhedonic breakpoint phenotype, wouldn't it be equally valid to say that lack of NPAS4 causes mice with no social withdrawal phenotype to develop an anhedonic breakpoint phenotype? And what would either conclusion mean for our understanding of the mechanisms of stress effects on these behaviors? Moreover, how do we relate these correlations or lack of correlations with supplemental figure 2, which shows no correlation between SI ratio and sucrose preference in any group?</p><p>Additional data is needed to either more convincingly support the conclusion that CSDS produced anhedonia and deficits in motivation that are rescued by Npas4 manipulation or to provide a clearer behavioral anchor for the interaction between CSDS and mPFC Npas4.</p><p>2. Why not stratify &quot;susceptible&quot; and &quot;resilient&quot; mice after CSDS? Does Npas4 correlate with susceptibility? Authors found that among CSDS-exposed mice, those &quot;susceptible&quot; according to social interaction also showed lower reward motivation, whereas resilient mice had higher reward motivation, and Npas4 knockdown in PFC reversed/broke this correlation. Perhaps a stratification of susceptible and resilient (which may require more N) would help provide a cleaner behavioral effect?</p><p>3. Admittedly it's difficult to target subregions of the mPFC in mice (i.e., infralimbic v. prelimbic) but we wonder if viral placement can explain the high variability observed in behavior? For example, when analyzing viral expression did the authors notice whether individual differences in viral expression patterns (ie. more intense expression in one subregion over another) correlate with differences behavior? This may be particularly relevant for data from the effort based task in Figure 3.</p><p>4. The authors use shRNA to knockdown NPAS4 expression in mPFC and find interesting effects on sucrose preference. However, it is possible that these effects are mediated by the shRNA targeting genes other than NPAS4 or that the role of mPFC NPAS4 expression in this behavior is indirect, and NPAS4 itself does not drive the anhedonic response to stress. Validation of the efficacy and selectively of the Npas4 shRNA approach in mPFC needs to be demonstrated or reference to this in the literature more clearly described.</p><p>5. The results of the RNAseq experiments are interesting, but lack depth. Typically, some validation of at least a few of the putative target genes is required to confidently interpret the results of an unbiased sequencing experiment. qPCR for individual target genes is a good start, but ChIP experiments to show that at least some of the putative NPAS4 targets are actually bound by NPAS4 in mPFC would be stronger, and showing by ChIP that this binding is regulated by CSDS would be ideal.</p><p>As presented, it seems as though sequencing was only in control mice, though given the protective effect of Npas4 knockdown it would be interesting to see the normal and lack of transcriptional effect after CSDS with knockdown – especially given NPAS4's role in experience/activity-dependent transcriptional regulation. This would significantly enhance the manuscript. But if it is not feasible, then considerable discussion should be given to this limitation.</p><p>6. A change in total dendritic spine number is an interesting initial finding, but this portion of the study lacks depth. The fact that there is no change in spine head diameter suggests that there may be a change in synapse number without change in synapse strength. Therefore, functional analyses of glutamatergic synapses (mEPSPs, AMPA/NMDA ratio, etc) examining the effects of NPAS4 knockdown or overexpression would improve the study substantially. If this is not possible, then some discussion of this possibility and limitation is warranted.</p><p>7. RNA seq and qPCR data from Figure 5 and supplement Figure 4 suggests that NPAS4 regulates somatostatin (Sst). Given that Sst neurons don't express NPAS4, this would suggest a cell extrinsic mechanism (ie. changes in NPAS4 in CAMK<sup>+</sup> cells alters SST neurons). Can the authors comment on this in the discussion? Are there other genes from interneurons that seem to be regulated by such extrinsic mechanisms. Is there a way to filter the data sets by cell type (ie. pyramidal neurons versus interneurons) so as to infer cell type specific expression across all transcripts?</p><p>8. Given recent improvements in CSDS across sexes, more of a rationale is needed for the exclusions of females from this study. This major limitation of the manuscript also needs to be discussed.</p><p>9. If not interneurons, what other cell types in mPFC account for the 20-25% of cells that express NPAS4 but not CAMK<sup>+</sup>? Is NPAS4 upregulated by stress in them? Also, it would be better to show the data in Figure 1D as NPAS4 expression within each cell type instead of % of cellular marker. This way the reader can see that NPAS4 is only upregulated in CAMK<sup>+</sup> cells.</p><p>10. One has to wonder when we suppress IEGs and TF's in general what's really happening. Does this just dampen transcriptional response broadly? Does activation of other IEGs make up for lack of NPAS4? Is there something special about NPAS4 or would knocking down Fos have the same effect? Note that additional experiments to answer these broad questions are not expected.</p><p>11. In addition to the very helpful tables, please report all statistics in the main manuscript, consistent with <italic>eLife</italic>'s policy: https://reviewer.elifesciences.org/author-guide/full &quot;Report exact p-values wherever possible alongside the summary statistics and 95% confidence intervals. These should be reported for all key questions and not only when the p-value is less than 0.05.&quot;</p><p>[Editors' note: further revisions were suggested prior to acceptance, as described below.]</p><p>Thank you for resubmitting your work entitled &quot;NPAS4 in the medial prefrontal cortex mediates chronic social defeat stress-induced anhedonia-like behavior and reductions in excitatory synapses&quot; for further consideration by <italic>eLife</italic>. Your revised article has been evaluated by Kate Wassum (Senior and Reviewing Editor).</p><p>The manuscript has been improved but there are some remaining issues that need to be addressed, as outlined below:</p><p>Reviewer 3 has two points that should be straightforward to address:</p><p>– Please consider discussing the fact that the qPCR validation only validated Npas4 itself, and there was no effect of stress on the other genes.</p><p>– The figures also indicate a main effect of Npas4 KD for other genes, but statistics are missing from this section of the results.</p><p>– Please include summary statistics (e.g., t, F values) and degrees of freedom in your statistical reporting in the main manuscript (results or figure legends).</p><p><italic>Reviewer #1 (Recommendations for the authors):</italic></p><p>The authors did an outstanding job of addressing the most pressing concerns of both reviews. The inclusion of new behavioral and electrophysiological data fills in critical gaps in the original manuscript, and the main interpretations are now well-supported by the data. I feel the manuscript will make an important contribution to the field, and I recommend it be published in its current form.</p><p><italic>Reviewer #2 (Recommendations for the authors):</italic></p><p>I believe the authors have adequately revised the manuscript. I have no further concerns.</p><p><italic>Reviewer #3 (Recommendations for the authors):</italic></p><p>The authors have done a substantial amount of work on this manuscript, including new experiments and analyses. The new patch-clamp experiments in particular add substantial depth and mechanism to the study. The relationship between mPFC Npas4 and behavior is more convincing.</p><p>What do the authors make of the fact that the qPCR validation only validated Npas4 itself, and there was no effect of stress on the other genes? The figures also indicate a main effect of Npas4 KD for other genes, but statistics are missing from this section of the results.</p><p>Related to the response to reviewer comment 2: Equal numbers of susceptible and resilient mice are not needed to stratify susceptible vs resilient or perform a correlation analysis; nevertheless, I don't feel this is required.</p><p>Overall, I think the revised figures, discussion, and response to reviewers improve the depth of the science and better contextualize the findings and approaches.</p></body></sub-article><sub-article article-type="reply" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.75631.sa2</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>Essential revisions:</p><p>1. The abstract and results both state that reward motivation is altered in the NPAS4 shRNA group. However, figure 3 does not convincingly show this. There is no interpretable effect of shRNA on sucrose delivery, discrimination, or breakpoint. The authors claim that the significant correlation by linear regression between breakpoint and SI ratio in control but not NPAS4 shRNA groups can be interpreted as a change in reward motivation, and they use an appropriate ANCOVA analysis to show that these two factors are correlated in the control but not the shNPAS4 group. However, the interpretation of this lack of correlation is unclear. If the other data show that NPAS4 knockdown has no effect on SI or operant sucrose consumption, how can an effect on the correlation between these behaviors be meaningful? If the authors are stating that the lack of NPAS4 prevents the mice with a social withdrawal phenotype from developing an anhedonic breakpoint phenotype, wouldn't it be equally valid to say that lack of NPAS4 causes mice with no social withdrawal phenotype to develop an anhedonic breakpoint phenotype? And what would either conclusion mean for our understanding of the mechanisms of stress effects on these behaviors? Moreover, how do we relate these correlations or lack of correlations with supplemental figure 2, which shows no correlation between SI ratio and sucrose preference in any group?</p><p>Additional data is needed to either more convincingly support the conclusion that CSDS produced anhedonia and deficits in motivation that are rescued by Npas4 manipulation or to provide a clearer behavioral anchor for the interaction between CSDS and mPFC Npas4.</p><p>2. Why not stratify &quot;susceptible&quot; and &quot;resilient&quot; mice after CSDS? Does Npas4 correlate with susceptibility? Authors found that among CSDS-exposed mice, those &quot;susceptible&quot; according to social interaction also showed lower reward motivation, whereas resilient mice had higher reward motivation, and Npas4 knockdown in PFC reversed/broke this correlation. Perhaps a stratification of susceptible and resilient (which may require more N) would help provide a cleaner behavioral effect?</p></disp-quote><p>We thank the reviewer for these helpful comments and suggestions. In the revised manuscript, we have now added three new cohorts of animals for CSDS and the subsequent behavioral assays (Figure 2C-H; Figure 3A-D). With more statistical power, we observed that <italic>Npas4</italic> shRNA in the mPFC produced a main effect of <italic>Npas4</italic> in the sucrose PR breakpoint analysis (Figure 3C). Post-hoc analysis, given the a priori hypothesis that stress-susceptible animals show distinct deficits in behavior (Krishnan et al., 2007, <italic>Cell</italic>), identified that CSDS-susceptible animals expressing <italic>Npas4</italic> shRNA<sup>PFC</sup> exhibited a significantly higher sucrose PR breakpoint when compared to controls (Figure 3D), suggesting that NPAS4 in PFC of stress-susceptible animals functions to suppress motivation to seek natural rewards. In these new additional cohorts, we had a number of animals that were severely injured by CSDS, and our veterinary staff requested that we discontinue with those mice, so we were unable to continue through the behavioral battery. In other words, although some animals exhibited the stress-susceptible phenotype in the social interaction assay, we were unable to continue with the sucrose SA assay due to ethical concerns. Other factors likely contributed to the low proportion of susceptible mice, including the biological sex of the investigator. Several cohorts of CSDS were conducted by the female investigator, that demonstrated a significantly lower proportion of susceptible mice compared to the experiment performed by male investigators (Georgiou et al., <italic>Nature Neuroscience</italic>, 2022). These scenario contributed to the lower sample numbers in the susceptible animals in the sucrose SA tests, even after adding multiple new cohorts. Unfortunately, we did not obtain an equal number of susceptible and resilient animals, despite our valiant efforts to increase the power in the susceptible category to enable stratification and statistical analysis of SI subgroups.</p><disp-quote content-type="editor-comment"><p>3. Admittedly it's difficult to target subregions of the mPFC in mice (i.e., infralimbic v. prelimbic) but we wonder if viral placement can explain the high variability observed in behavior? For example, when analyzing viral expression did the authors notice whether individual differences in viral expression patterns (ie. more intense expression in one subregion over another) correlate with differences behavior? This may be particularly relevant for data from the effort based task in Figure 3.</p></disp-quote><p>Our AAV2 and stereotaxic targeting coordinates produced strong viral-mediated gene expression throughout both the infralimbic (IL) and prelimbic cortex (PrL). For those injections that produced a slight subregion bias, we did not detect any obvious differential effects on behavior. As the differential functions of PrL and IL subregions are well documented in reward-related behaviors, it would be an interesting future direction to pursue, and we have included additional text in the revised discussion to address this possibility and limitation.</p><disp-quote content-type="editor-comment"><p>4. The authors use shRNA to knockdown NPAS4 expression in mPFC and find interesting effects on sucrose preference. However, it is possible that these effects are mediated by the shRNA targeting genes other than NPAS4 or that the role of mPFC NPAS4 expression in this behavior is indirect, and NPAS4 itself does not drive the anhedonic response to stress. Validation of the efficacy and selectively of the Npas4 shRNA approach in mPFC needs to be demonstrated or reference to this in the literature more clearly described.</p></disp-quote><p>We agree that off-target effects of an shRNA are always of concern. The <italic>Npas4</italic> shRNA utilized in our study has been used frequently to reduce NPAS4 expression, and it has been validated in multiple experimental contexts (Lin et al., 2008; Ramamoorthi et al., 2011; Ploski et al., 2011; Taniguchi et al., 2017). Previous studies, including ours, have observed similar effects of <italic>Npas4</italic> shRNA and conditional knockout (<italic>Npas4</italic><sup>fl/fl</sup>+Cre) mice in electrophysical recordings of hippocampal slices and in cocaine-conditioned behaviors in the NAc, and while we could repeat all of our experiment with a second shRNA or floxed Npas4 mice, we feel the expense and animal life costs are too great. However, we now reference these prior studies, and we denote in the revised discussion that we can’t rule out off-target effects contributing to the observed phenotypes.</p><disp-quote content-type="editor-comment"><p>5. The results of the RNAseq experiments are interesting, but lack depth. Typically, some validation of at least a few of the putative target genes is required to confidently interpret the results of an unbiased sequencing experiment. qPCR for individual target genes is a good start, but ChIP experiments to show that at least some of the putative NPAS4 targets are actually bound by NPAS4 in mPFC would be stronger, and showing by ChIP that this binding is regulated by CSDS would be ideal.</p><p>As presented, it seems as though sequencing was only in control mice, though given the protective effect of Npas4 knockdown it would be interesting to see the normal and lack of transcriptional effect after CSDS with knockdown – especially given NPAS4's role in experience/activity-dependent transcriptional regulation. This would significantly enhance the manuscript. But if it is not feasible, then considerable discussion should be given to this limitation.</p></disp-quote><p>To partially address the reviewer’s concern, we now compare our RNA-seq data with previously published NPAS4 ChIP-seq data (Figure 5E) (Kim et al., 2010; Brigidi et al., 2019). The new analysis reveals significant enrichment of NPAS4 genomic binding at many of our DEGs, which suggests that many of the observed DEGs are likely to be <italic>direct</italic> NPAS4 target genes (Figure 5).We agree that a new ChIP-seq study combined with a new RNA-seq study (+/- acute vs. chronic social defeat stress) with mPFC tissues is the ideal future direction for this study. Part of the challenge with this approach is the uncertainty about the optimal time point after stress (acute or chronic) since NPAS4 is rapidly and transiently produced by stress so analysis at multiple time points (e.g., 5 mins, 15 mins, 1 hr, and 24 hrs) +/- acute vs. chronic social defeat will be required to truly understand direct vs. indirect targets genes. We now comment on this limitation of our current data sets in the revised discussion, and we hope the reviewer will agree that addressing this issue is beyond the scope of our data-rich first report on mPFC NPAS4 in CSDS-induced anhedonia-like behavior.</p><disp-quote content-type="editor-comment"><p>6. A change in total dendritic spine number is an interesting initial finding, but this portion of the study lacks depth. The fact that there is no change in spine head diameter suggests that there may be a change in synapse number without change in synapse strength. Therefore, functional analyses of glutamatergic synapses (mEPSPs, AMPA/NMDA ratio, etc) examining the effects of NPAS4 knockdown or overexpression would improve the study substantially. If this is not possible, then some discussion of this possibility and limitation is warranted.</p></disp-quote><p>We agree that functional synaptic analysis is important. In the revised manuscript we now add new patch-clamp recording data from mPFC deep-layer pyramidal neurons. We observe a significant role for NPAS4 on glutamatergic synapse function. Consistent with the stress-induced decrease in dendritic spine density, we find that CSDS produced a significant increase in the inter- event interval of mEPSCs in the SC shRNA control mice, and this mini frequency effect was blocked by <italic>Npas4</italic> shRNA<sup>PFC</sup>. In addition, <italic>Npas4</italic> shRNA significantly increased mEPSC amplitude independent of CSDS. Using evoked EPSCs, we found that CSDS significantly increased the paired-plus ratio in the shRNA controls, but <italic>Npas4</italic> shRNA blocked this effect (Figure 4G-H), revealing an NPAS4-dependent effect of CSDS to reduce presynaptic function. Since NPAS4 shRNA is expressed in the postsynaptic cell being recorded, it seems likely that this CSDS and NPAS4 effect is cell non-autonomous; however, some glutamatergic inputs to the mPFC pyramidal neuron might come from local inputs that also express NPAS4 shRNA. Understanding the underlying stress and NPAS4-dependent mechanisms will be an important future direction. Together, our new functional excitatory synapse analyses (Figure 4C-F) extend the structural synapse loss documented in the original manuscript and provide additional insights into NPAS4’s role in both “no stress” and CSDS conditions (Figure 4B).</p><disp-quote content-type="editor-comment"><p>7. RNA seq and qPCR data from Figure 5 and supplement Figure 4 suggests that NPAS4 regulates somatostatin (Sst). Given that Sst neurons don't express NPAS4, this would suggest a cell extrinsic mechanism (ie. changes in NPAS4 in CAMK<sup>+</sup> cells alters SST neurons). Can the authors comment on this in the discussion? Are there other genes from interneurons that seem to be regulated by such extrinsic mechanisms. Is there a way to filter the data sets by cell type (ie. pyramidal neurons versus interneurons) so as to infer cell type specific expression across all transcripts?</p></disp-quote><p>We agree that functional synaptic analysis is important. In the revised manuscript we now add new patch-clamp recording data from mPFC deep-layer pyramidal neurons. We observe a significant role for NPAS4 on glutamatergic synapse function. Consistent with the stress-induced decrease in dendritic spine density, we find that CSDS produced a significant increase in the inter- event interval of mEPSCs in the SC shRNA control mice, and this mini frequency effect was blocked by <italic>Npas4</italic> shRNA<sup>PFC</sup>. In addition, <italic>Npas4</italic> shRNA significantly increased mEPSC amplitude independent of CSDS. Using evoked EPSCs, we found that CSDS significantly increased the paired-plus ratio in the shRNA controls, but <italic>Npas4</italic> shRNA blocked this effect (Figure 4G-H), revealing an NPAS4-dependent effect of CSDS to reduce presynaptic function. Since NPAS4 shRNA is expressed in the postsynaptic cell being recorded, it seems likely that this CSDS and NPAS4 effect is cell non-autonomous; however, some glutamatergic inputs to the mPFC pyramidal neuron might come from local inputs that also express NPAS4 shRNA. Understanding the underlying stress and NPAS4-dependent mechanisms will be an important future direction. Together, our new functional excitatory synapse analyses (Figure 4C-F) extend the structural synapse loss documented in the original manuscript and provide additional insights into NPAS4’s role in both “no stress” and CSDS conditions (Figure 4B).</p><disp-quote content-type="editor-comment"><p>8. Given recent improvements in CSDS across sexes, more of a rationale is needed for the exclusions of females from this study. This major limitation of the manuscript also needs to be discussed.</p></disp-quote><p>We completely agree, and we would love to repeat all of our key findings in a chronic stress design that allows for inclusion of females in a future study. We now clearly acknowledge in the revised manuscript (paragraph 2 of the discussion) that the male-only findings are a major limitation of our current study. In the 11 years since we began this NPAS4/CSDS project, there have been several competing approaches that allow female analysis, but we’ve had very limited success getting them to work reliably and convincingly, which is a common refrain in conversations with other CSDS investigators we’ve encountered. We hope to shift to a different chronic stress model in the future to extend our current findings and compare possible sex-effects.</p><disp-quote content-type="editor-comment"><p>9. If not interneurons, what other cell types in mPFC account for the 20-25% of cells that express NPAS4 but not CAMK<sup>+</sup>? Is NPAS4 upregulated by stress in them? Also, it would be better to show the data in Figure 1D as NPAS4 expression within each cell type instead of % of cellular marker. This way the reader can see that NPAS4 is only upregulated in CAMK<sup>+</sup> cells.</p></disp-quote><p>We appreciate the great suggestion and have revised Figure 1D indulging adding Figure 1H. We now also include recent snRNA-seq analysis of <italic>Npas4</italic> mRNA expression in mPFC tissues of C57BL/6J mice (Figure 1A-D). Similar to BrainRNAseq.org, we observe that Npas4-positive neurons in mPFC snRNA-seq are predominantly excitatory neuron clusters (~92%) with the remainder found in multiple interneuron types, including PV, Sst, and Adarb2 clusters (Figure 1C-1D). As such, we strongly suspect that the ~20% NPAS4+ cells that did not co-localize with CaMKIIα IHC staining represent neurons with subthreshold levels of CaMKIIα (below antibody detection) and/or are interneuron populations not measured (e.g., Adarb2). Future scRNA-seq studies examining acute and chronic social defeat stress at various time points after the stress experiences and with cell type-specific NPAS4 manipulations will be important to fully understand NPAS4’s cell type- specific distribution and roles in stress-induced anhedonia.</p><disp-quote content-type="editor-comment"><p>10. One has to wonder when we suppress IEGs and TF's in general what's really happening. Does this just dampen transcriptional response broadly? Does activation of other IEGs make up for lack of NPAS4? Is there something special about NPAS4 or would knocking down Fos have the same effect? Note that additional experiments to answer these broad questions are not expected.</p></disp-quote><p>The question raised by the reviewer is very interesting. Our data showed that the reduction of NPAS4 increased the mEPSC amplitude and upregulated genes involved in glutamatergic synapses (e.g. <italic>Arc)</italic>, suggesting that reduction of NPAS4 enhanced, directly or indirectly, IEG transcriptional responses. While we did not compare +/- CSDS, under basal conditions it appears that suppression of NPAS4 promotes IEG expression (e.g., <italic>Fos</italic> and <italic>Arc</italic>). We note that this observation is in contrast to a report in hippocampal cultured neurons where loss of NPAS4 reduced broad IEG induction following KCl depolarization (Ramamoorthi et al., 2011). This could represent differences in developing vs. adult neurons, hippocampus vs. cortex, or culture vs. in vivo study designs.</p><disp-quote content-type="editor-comment"><p>11. In addition to the very helpful tables, please report all statistics in the main manuscript, consistent with eLife's policy: https://reviewer.elifesciences.org/author-guide/full &quot;Report exact p-values wherever possible alongside the summary statistics and 95% confidence intervals. These should be reported for all key questions and not only when the p-value is less than 0.05.&quot;</p></disp-quote><p>We now provide all statistical information in the revised manuscript.</p><p>[Editors' note: further revisions were suggested prior to acceptance, as described below.]</p><disp-quote content-type="editor-comment"><p>The manuscript has been improved but there are some remaining issues that need to be addressed, as outlined below:</p><p>Reviewer 3 has two points that should be straightforward to address:</p><p>– Please consider discussing the fact that the qPCR validation only validated Npas4 itself, and there was no effect of stress on the other genes.</p></disp-quote><p>We have revised the Discussion section to reflect the results that NPAS4 impacts several genes, but there was no effect from acute social defeat stress on the expression of those genes. In the revised manuscript, we have discussed the need for future transcriptome analysis to investigate NPAS4-mediated transcriptome in response to stress.</p><disp-quote content-type="editor-comment"><p>– The figures also indicate a main effect of Npas4 KD for other genes, but statistics are missing from this section of the results.</p></disp-quote><p>We now provide statistical information of main effect of <italic>Npas4</italic> KD in the revised manuscript.</p><disp-quote content-type="editor-comment"><p>– Please include summary statistics (e.g., t, F values) and degrees of freedom in your statistical reporting in the main manuscript (results or figure legends).</p></disp-quote><p>We provide summary statistics (t and F values, and degrees of freedom) information in the revised main manuscript.</p></body></sub-article></article>